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Abstract 
Cellular senescence is a cell fate characterised by the permanent arrest from the cell 
cycle with an altered, mainly proinflammatory, secretory phenotype. Although, a positive 
process in development and regeneration, the accumulation of senescent cells, as seen in 
tissues of aged humans, can cause many negative effects. Within skeletal muscle the 
resident stem cells, Pax7+ve and CD56+ve satellite cells / muscle precursor cells (MPCs), are 
essential for muscle maintenance and repair following damage. Impairments either in 
their inherent behaviour, such as by being senesced, or by being negatively influenced by 
their environment, such as by the senescence associated secretory phenotype (SASP) of 
local senescent cells, may impair muscle regeneration in later life and contribute to the 
age-related loss of skeletal muscle mass, sarcopenia. Furthermore, regeneration is also 
dependent on the interaction of MPCs with other key cell types in muscle, principally 
fibroblasts, therefore understanding the senescent characteristics of both cell types is 
essential to gain further insight into skeletal muscle ageing. Currently, little is known 
about the senescent phenotype of human skeletal muscle derived cells.  
The aim of the work in this thesis was thus to investigate the senescent phenotype 
of human primary skeletal muscle derived MPCs and fibroblasts in a primary cell culture 
system. Once characterised this phenotype would then be used to investigate senescence 
within skeletal muscle cells obtained from very old and frail hip fracture patients. MPCs 
were sorted using CD56+ve magnetic beads after extraction and expansion from muscle 
biopsy samples taken from young healthy male volunteers (n=6, 22±1 years). Fibroblasts 
were derived from the negative fraction. In the first series of experiments cumulative 
population doublings (CPD) across multiple passages was used to induce cellular 
replicative senescence (RS). In the second, cells were treated with Doxorubicin (DOX; 0.2 
µM) for 24h to induce a senescent phenotype and then investigated at a number of 
timepoints up to 35 days post treatment. In both approaches, senescence was 
determined by the presence of senescence-associated β-galactosidase (SA β-gal) and the 
protein expression of p16, together with the absence of proliferation marker, Ki67. With 
expression determined using custom built cell-by-cell image analysis programs. The mRNA 
levels of established SASP factors (e.g. PAI-1, TGF-β1, IL-8 and IGFBP-3, amongst others) 
were also measured as was the differentiation capacity of MPCs for myogenic fusion. 
In the RS study only two of the six MPC populations remained highly myogenic 
through to RS. Senescence of these two populations of MPCs was shown by increased 
number of SA β-gal-positive and p16 expressing cells, and decreased Ki67 expression. The 
senescent, late passage MPCs showed a markedly reduced myogenic fusion index, 
compared to proliferative MPCs. The fibroblast experiments were terminated at the same 
time as the equivalent MPC cultures reached senescence. At this point, none of the 
fibroblast populations had reached RS, as evidenced by no changes in SA β-gal or p16, 
although there was a trend for slower population doubling times when compared to early 
passage rates and significantly decreased Ki67. When both MPCs and fibroblasts were 
exposed to DOX for 24h, senescence was demonstrated shortly after, with 99% of both 
cell types being SA β-gal-positive four days after DOX treatment, Ki67 expression markedly 
reduced and MPCs being less able to fuse and form myotubes. SASP factor (i.e. IGFBP7, 
PAI-1, IGFBP3) mRNA expression from this 4-day time point until 35 days post-DOX 
treatment varied over time and magnitude in both MPCs and fibroblasts. MPCs isolated 
from skeletal muscle of old (82±9 yrs) hip fracture patients showed significant differences 
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in senescence marker and SASP factor expression, compared to young donor cells after a 
similar time in culture. 
In conclusion, RS is hard to achieve in human primary muscle cultures because even 
highly purified MPCs populations can eventually be overrun by initially small populations 
of fibroblasts, whilst the sorted fibroblast cultures, from the same biopsy samples, appear 
to take a much longer time to reach RS than the MPCs. DOX treatment allows a 
synchronised and rapid induction of senescence in both cell types eliminating these 
problems. Here the results showed both varying temporal and quantitative responses of 
the different SASP factors between the two cell types. The data highlight the complexity 
and dynamism of the senescent state within different cell types derived from human 
skeletal muscle. When myoblasts are taken from a very elderly frail human population 
undergoing hip fracture surgery, markers of senescence are elevated compared to young 
myoblasts after similar exposure to cell culture. These findings suggest that cellular 
senescence may start to be an issue within skeletal muscle cells very late in life. Therefore, 
this work could contribute to supporting research into healthy human ageing by 
investigating strategies which prevent the accumulation, or remove, these senescent 
cells.
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Introduction 
On the subject of ageing, increased life expectancy of the global population is largely 
a result of advances in public health and medicine over the last 100 years. However, just 
living for longer is not always beneficial if the additional years are not accompanied by 
prolonged healthspan, the period of life where individuals are independent, active and 
disease free. In the UK, men and women are, on average, living 16-19 years in ill health at 
the end of their lives leading to poor quality of life, declining function and frailty (ONS, 
2019; Harper, 2014). These issues also create significant challenges for relatives and states 
to provide medical and social care emphasising the importance of understanding what 
mechanisms are behind this age associated decline.  
Ageing humans show a deterioration in skeletal muscle mass and quality, termed 
sarcopenia. Skeletal muscle is a key contributor to the loss of independence in older adults 
due to its role in locomotion allowing people to perform tasks of everyday living, such as 
shopping and attending social activities, that maintain good quality of life. Therefore, 
skeletal muscle ageing is an important area to research which is likely to prolong the 
period of healthspan. It is argued that sarcopenia is mostly mediated by physical activity 
into later life, however even in highly active individuals there is still an observed age-
related decline in mass and function suggesting an inherent age process in this tissue 
(Pollock et al., 2015; Lazarus & Harridge, 2017).  
With regards to tissue ageing, the process of cellular senescence has been 
implemented as a key contributor to the age-related decline. Cellular senescence was first 
discovered in the early 1960s when Hayflick and Moorhead showed that cells in culture 
could undergo a finite number of divisions before entering a state of proliferative arrest 
(Hayflick & Moorhead, 1961). But it then took 50 years for a causal effect of cellular 
senescence to ageing to be confirmed when it was shown that the global removal of 
senescent cells improved the healthspan of wildtype mice (Baker et al., 2016). The treated 
mice showed improvements across many tissues showing improved structure, function 
and regenerative potential, as well as, compressing end of life morbidity. These results 
have increased the search for senolytics, agents that selectively target and kill senescent 
cells without affecting non senescent cells (Kirkland & Tchkonia, 2017). Some of these 
senolytics are currently in human clinical trials and the preliminary results are promising. 
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The improvements shown in skeletal muscle in the senescent cell depleted mice were 
seen in strength and endurance performance, as well as, muscle quality and regeneration 
(Xu et al., 2018). Thus, suggesting that cellular senescence may be linked to age related 
skeletal muscle loss. However, most work with human primary skeletal muscle cells has 
not found increased senescence cell burden in older adults (Alsharidah et al., 2013; 
Barberi et al., 2013; Bigot et al., 2015). This discrepancy could be due to skeletal muscle 
being a tissue comprised of many different cell types that integrate to perform its 
function. Therefore, there are many contributing mechanisms to its worsening ageing 
phenotype. Breakdown in any of these mechanisms could result in the ageing skeletal 
muscle phenotype but the focus of this thesis is on the potential contribution of senescent 
cells within the resident stem cell populations. 
To investigate senescence and ageing in skeletal muscle, animal models and human 
cell lines have been important for observing mechanistic changes and conserved biology 
during skeletal muscle ageing. However, because cell lines are fundamentally altered, 
they may respond differently to and lack the heterogeneity of human primary cells. The 
use of primary cells, whilst providing a more appropriate model, is more technically 
challenging. The heterogeneity introduces biological and methodological challenges 
which make human primary work technically difficult, yet these experiments are 
imperative to understanding the ageing phenotype within human skeletal muscle. 
Previous studies in human cells have been clouded by mixed cell populations and only 
focus on the myogenic satellite cell progeny, myogenic precursor cells, also known as 
myoblasts. However, skeletal muscle fibroblasts have been shown to play key roles in 
development and regeneration of skeletal muscle, such as providing the extracellular 
scaffolding to hold the muscle fibres, and it is therefore also important to understand 
what age-related changes are occurring within this cell population in parallel with the 
myogenic precursor cells. Very little is known about the senescent phenotype of either 
cell type, especially when derived from human sources, therefore it is of importance to 
understand the senescent phenotype of these populations, as well as, if cells with this 
phenotype are present in human skeletal muscle in vivo. 
The overall aim of this thesis is therefore to investigate and characterise the 
senescent phenotype of the two main precursor cell populations found within adult 
human skeletal muscle, namely skeletal muscle myogenic precursor cells and skeletal 
muscle origin fibroblasts, using a primary cell culture model. 
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1. Chapter 1: Literature review 
1.1. Skeletal muscle  
Skeletal muscle is derived from myogenic progenitor cells found in the myotome of 
somites in the developing embryo (Ito et al., 2012). Skeletal muscle development then 
occurs in successive phases from the embryo through to adult skeletal muscle with 
discernible populations of myoblasts at each stage (Hutcheson et al., 2009). Embryonic 
myogenesis establishes the basic muscle pattern as embryonic myoblasts differentiate 
into primary fibres. During the foetal and neonatal stages of myogenesis muscle growth 
and maturation is accelerated as foetal myoblasts fuse together with primary fibres to 
make secondary fibres whilst rapidly increasing myonuclear number (Biressi et al., 2007). 
Over time these fibres develop into adult muscle as their gene expression changes with 
the help of skeletal muscle origin fibroblasts and other cell types present in the 
surrounding environment (Mathew et al., 2011). 
Adult skeletal muscle accounts for between 30-40% of body mass, making it the most 
abundant tissue by weight within the human body (Janssen et al., 2000). Skeletal muscle 
is not only required for its main purpose of producing movement and force through 
contraction but also for its roles in posture, breathing and thermoregulation. Skeletal 
muscle is also the most metabolically active tissue consuming up to 80% of ingested 
glucose and storing 50-75% of the body’s total protein (Frontera & Ochala, 2015). The 
overall size of a skeletal muscle varies depending on its anatomical attachment sites and 
movement requirements, but is ultimately determined by the number and size of its 
constituent muscle fibres (Frontera & Ochala, 2015). The individual muscle fibres of 
skeletal muscle are organised into bundles known as fascicles. Within each muscle fibre 
are many myofibrils that are tightly packed with sarcomeres, the smallest contractile unit 
of skeletal muscle (Mukund & Subramaniam, 2019; Figure 1.1).  
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Figure 1.1. Muscle structure and the satellite cell niche.  
Schematic showing the structure of skeletal muscle. The satellite cell niche is on the plasmalemma 
of the myofibre, beneath the surrounding basal lamina (a). A quiescent murine satellite cell 
retained in its niche on a myofibre isolated from the extensor digitorum longus muscle of an adult 
mouse (b). The satellite cell has been co-immunolabelled for Caveolin 1 (b; green) and the 
transcription factor PAX7 (b; red-nuclear). DAPI counterstaining reveals the myonuclei of the 
myofibre. Reproduced from Zammit, (2017). 
Muscle fibres do not necessarily span the whole length of the muscle but are 
embedded within a connective tissue matrix which is continuous throughout, attaching 
to bones via fibrous collagenous connective tissue called tendons (Jones et al., 2004). This 
connective tissue is continuous through the whole muscle surrounding each muscle 
(epimysium), fascicle (perimysium) and muscle fibre (endomysium; Passerieux et al., 
2007; Gillies & Lieber, 2011). Force produced within the muscle fibres is therefore 
transferred to the bones through this connective tissue structure.  
Force is generated within skeletal muscle by the transmission of a voluntarily 
innervated electrical signal from the somatic nervous system through chemical energy 
into mechanical work via the sliding filament model (Huxley, 1957; Huxley & Simmons, 
1971). The axons of α-motor neurons synapse on the neuromuscular junction of extrafusal 
muscle fibres on the motor end-plate, all innervated fibres by a single α-motor neuron are 
collectively called a motor unit. The post synaptic activation of nicotinic acetylcholine 
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receptors causes a depolarisation potential that opens voltage gated Ca2+ channels 
releasing calcium ions (Ca2+) from the sarcoplasmic reticulum into the sarcomeres 
(Rebbeck et al., 2014). The release of Ca2+ reveals myosin binding sites on actin filaments 
by moving the troponin - tropomyosin complex. Thus, allowing the formation of cross 
bridges between myosin heavy chain heads and the uncovered actin filament binding 
sites. Once an inorganic phosphate ion is released from the ATP molecule bound to 
myosin heavy chain the power stroke is initiated as the myosin head pulling on the actin 
filament, reducing the distance between the z discs, shortening the length of the 
sarcomere by pulling “sliding” of the actin filaments towards the M-line (Gautel & 
Djinović-Carugo, 2016). The myosin heads then detach with the release of the ADP 
molecule returning to their rigor state completing one cross-bridge cycle. The cross-bridge 
cycle is then repeated with the myosin head reattaching further along the actin molecule 
further shortening the sarcomere length (Fitts, 2008). 
There are different types of myosin heavy chain (MHC) that are determined by their 
enzymatic activity (Brooke & Kaiser, 1970). The different MHCs vary in their speed of ADP 
release slowing the time between power-strokes because whilst ADP is still attached to 
the myosin head it prevents it from reattaching further along the actin molecule 
(Caremani et al., 2015). Although most human fibres contain a mix of myosin heavy chains 
muscle fibres are often classified by their predominant myosin heavy chain as type I 
(slowest), IIa (fast) and IIx (fastest; Harridge et al., 1996; D’Antona et al., 2006). 
A single muscle fibre is a single cell which contains many nuclei spaced along its 
length. Muscle fibres are considered post mitotic cells as their myonuclei are terminally 
differentiated and unable to divide to produce new nuclei (Moss & Leblond, 1970). To 
maximise cytoplasmic space for the contractile apparatus within non-regenerating adult 
fibres the myonuclei are located on the periphery of the fibres (Roman et al., 2017). These 
nuclei are long lived in humans, with a report utilising the peak in 14C availability after the 
post-war nuclear bomb tests being incorporated into DNA to date nuclei suggesting 
myonuclei survive upwards of 15 years (Spalding et al., 2005). It has also been suggested 
that this is a conservative estimate and that survival of human myonuclei could 
conceivably be lifelong (Gundersen, 2016). The main role of myonuclei is to maintain the 
contractile apparatus of the muscle fibres via the regulation of protein synthesis and 
breakdown. The contractile filaments can be damaged by being lengthened under tension 
or sarcomeres popping from forces which rips apart the myosin-actin cross bridges. This 
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minor damage can be repaired by increasing transcription of the contractile proteins from 
the myonuclei that surround the fibre. However, when further damage is caused muscle 
regeneration is required by activation of the skeletal muscle stem cells, satellite cells 
(Zammit et al., 2006). 
1.2. Skeletal muscle regeneration 
Muscle regeneration was first described in animals and humans in the 1800’s by 
observations of proliferating cells in areas of diseased muscle, repairing muscle after 
injury and muscle fibres forming in tumours (Valentin, 1835; Schwann, 1839 cited in 
Scharner & Zammit, 2011). The extraordinary regenerative potential of muscle was shown 
in vivo when a finely minced sample of a rat’s gastrocnemius muscle regained its original 
structure soon after being put back into the animal (reviewed in Carlson, 1973). Further 
studies have shown that complete ablation of a mouse skeletal muscle via snake venom 
toxin-induced injury can be fully restored within ten days (Yan et al. 2003; Otto et al. 
2008). Although, it was noted that the final size and functional capacity were almost 
always less than that of the original muscle.  
The first reported in vitro muscle regeneration experiment was described in 1917 
where myotubes, multinucleated cells resembling primitive muscle fibres, were formed 
by cells seen to be explanting from embryonic chick muscle (Lewis & Lewis, 1917). This 
finding was then also reported from adult human muscle explants (Pogogeff & Murray, 
1946). It was unclear as to what cells were involved in muscle regeneration and the topic 
was hotly debated. Competing theories suggested that new myofibres were formed from 
the splitting or budding from old myofibres, that dedifferentiating myonuclei were 
responsible, that circulating cells could fuse with remaining fibres or form new muscle, as 
well as, the possibility that skeletal muscle had its own stem/progenitor cells (reviewed in 
Scharner & Zammit, 2011). 
1.2.1. Satellite cells 
A candidate muscle stem/progenitor cell was first described by Mauro in 1961, 
corroborated by Katz et al., in the same year (Katz, 1961) when they discovered a 
mononucleated cell occupying a unique position between the basal lamina and the 
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sarcolemma of the muscle fibre in frog muscle using electron microscopy (Figure 1.2; 
Mauro, 1961). These cells were called satellite cells due to their anatomical location on 
the periphery of muscle fibres. Satellite cells were subsequently shown to be present in 
fruit bats and white mice with additional description that they had centrioles, Golgi 
apparatus and a few small spherical mitochondria (Muir et al., 1965). Moss & Leblond, 
(1970) confirmed that satellite cells were capable of undergoing mitosis by observing the 
incorporation of labelled DNA nucleotide, thymidine-3H, into satellite cells of rat Tibialis 
Anterior muscles and not into true myonuclei. 
 
Figure 1.2. Satellite cell in its anatomical niche. 
Electron micrograph of the first mammalian satellite cell observed in rat sartorious muscle. The 
membrane of the satellite cell (sp) can be seen between the muscle cell membrane (mp) and the 
basement membrane (bm). Reproduced from Mauro, (1961).  
At first it was only possible to identify satellite cells in situ by their anatomical niche 
location between the basal lamina and the sarcolemma using electron microscopy. 
However, since then molecular markers have been identified to label satellite cells. Paired 
box protein 7 (Pax7) is widely accepted as the definitive satellite cell marker and has been 
found to be an important regulator for the maintenance of  the satellite cell pool, with a 
subset also expressing the paralogous Pax3 (Seale & Rudnicki, 2000; Seale, 2000; 
Buckingham & Relaix, 2007). Roughly 96% of human satellite cells were Pax7+ve whilst the 
remaining cells expressed combinations of the cell-surface markers CD34, CD31 and CD45 
(Charville et al., 2015). The key marker of human satellite cells used throughout this thesis 
is neural cell adhesion molecule (NCAM), also known, and subsequently in this thesis, as 
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CD56. The location of CD56 on the cell surface makes it an ideal marker for viable cell 
sorting. Whereas, Pax7 as a nuclear transcription factor is unable to be used as the marker 
for cell sorting of viable cell populations. Although these markers are common to most 
cells that populate these niche locations, there is still a large heterogeneity in their wider 
marker expression (for review see Boldrin et al., 2010). 
Genetic ablation studies have provided evidence that satellite cells are sufficient and 
essential for the regeneration of skeletal muscle fibres (Sambasivan et al., 2011; Lepper 
et al., 2011). Although the vast majority of cells that regenerate muscle fibres are of 
satellite cell origin, there are groups of cells that have been shown to be able to also 
differentiate into myotubes in culture e.g. mesenchymal derived stem cells (Jankowski et 
al., 2002), endothelial-associated cells (De Angelis et al., 1999) and bone marrow cells 
(Asakura, 2012). However, their contribution to overall myogenesis in vivo was suggested 
to be minimal (Sherwood et al., 2004; Yin et al., 2013). Pax7-ve/PW1+ve Interstitial 
progenitor cells, termed  PICS, have also been suggested to harbour myogenic potential 
in mice and pigs however they are as yet undescribed in humans (Mitchell et al., 2010; 
Lewis et al., 2014; Cottle et al., 2017). 
Stem cells are often found within anatomical niches which are microenvironments 
that maintain the stem cells in a quiescent state, as well as, protecting them from DNA 
damage and other signals that could cause them to become faulty or unnecessarily 
activated (Yin et al., 2013). The satellite cell niche architecture is provided by a network 
of collagen IV containing laminins which anchors the satellite cell through interaction with 
alpha 7/beta 1-integrins on the cell surface (Blanco-Bose et al., 2001). But also contains 
additional extracellular matrix proteins such as fibronectin, decorin glycoproteins and 
other proteoglycans that bind inactive growth factor precursors and buffer the effects of 
signalling (Montarras et al., 2013). The niche maintains satellite cells in a mitotically 
quiescent (G0 phase) state where satellite cells have minimal metabolic activity and 
therefore undergo very little intrinsic stress.  
Quiescence is not a passive state but is tightly regulated by high transcriptional 
activity involving the up regulation of notch signalling, cyclin-dependent kinase inhibition, 
regulation of G-protein signaling and Sprouty 1, as well as, many microRNAs (Shea et al., 
2010; Cheung et al., 2012; Mourikis et al., 2012; Bjornson et al., 2012). The culmination 
of these signals result in low expression of cyclins, cyclin dependent kinases and 
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checkpoint kinases preventing cell cycle progression (Fukada et al., 2007). However, the 
niche does not keep satellite cells in a quiescent state permanently.  
The niche structure allows for mechanical signals from the sarcomeres to be 
translated into intracellular chemical signals (Boppart et al., 2006). Additionally, extrinsic 
signals can reach thresholds which result in the activation of the satellite cells when 
muscle is damaged sufficiently to require repair (Comai & Tajbakhsh, 2014). Satellite cells 
have also been found in a GALERT state where they are still quiescent although they enter 
the cell cycle more quickly than G0 cells. This primed state is thought to be induced by 
hepatocyte growth factor (Hgf) in tissues that were not primarily damaged as an 
expectation for further damage (Rodgers et al., 2014).  
When muscle fibres are damaged the chemical and physical damage signals are 
transferred to the quiescent satellite cells in the niche and a very rapid activation process 
occurs (Cooper et al., 1999). Key activators of satellite cells are the expression of fibroblast 
growth factor 2 (FGF2), Insulin like growth factor-1 (IGF-1) and Transforming growth 
factor beta (TGF-β) (Yablonka-Reuveni et al., 1999b; Crown et al., 2000; Seale & Rudnicki, 
2000). These signals stimulate the migration of satellite cells to the site of injury and 
proliferation to produce a pool of muscle precursor cells (MPCs) or myoblasts (Yin et al. 
2013). Once satellite cells are activated the process of regeneration begins. Firstly, adult 
satellite cells must divide and expand the population of cells before undergoing 
differentiation, otherwise there will be insufficient nuclei to support the muscle fibres. 
Adult satellite cells are thought to divide asymmetrically which also allows for the 
maintenance of the satellite cell population with a small population of cells ready to take 
up the niche locations and return to a quiescent state. (Olguin & Olwin, 2004; Collins et 
al., 2005; Shea et al., 2010; von Maltzahn et al., 2013). The remaining expanded 
population of cells are thus directed through terminal differentiation under the control of 
the myogenic regulatory factors (MRFs): MYF5, MyoD, Myogenin and MRF4 (Mice) or 
MRF6/Hercuin in Humans (Hernández-Hernández et al., 2017; Zammit, 2017). 
1.2.2. Myogenic regulatory factors 
The MRFs are a family of basic helix–loop–helix central domain transcription factors, 
which drive myogenesis, the expression sequence of which is outlined in Figure 1.3. They 
are involved in both protein interactions to form heterodimers and in DNA binding to 
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transactivate muscle-specific genes (Hernández-Hernández et al., 2017). The satellite cell 
marker Pax7 can directly regulate the expression of the earliest marker of myogenic 
commitment, Myf5 and MyoD, which occurs promptly after activation of the satellite cells 
(Cornelison & Wold, 1997; McKinnell et al., 2008; Buckingham & Relaix, 2015). These MRF 
genes are so critical to the muscle lineage that the activation of the Myf5 gene in a wide 
range of cultured cells induces the expression of MyoD and drives the cells to become 
myogenic cells (Weintraub et al., 1989). 
 
 
Figure 1.3. Expression of the myogenic regulatory factors during myogenic differentiation. 
Quiescent satellite cells express Pax7 and Myf5. Upon activation, they upregulate MyoD and start 
to proliferate creating a pool of muscle precursor cells. Some of the progeny down-regulate MyoD 
and self-renew to replenish the Pax7+ve satellite cell population. However, the majority 
differentiate, down-regulating Pax7, Myf5 and MyoD and increasing expression of MRF4 and 
myogenin. These cells then fuse into damaged myofibers or form new myofibres. Reproduced from 
Boldrin et al., (2010). 
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The loss of MyoD expression in adult mice satellite cells results in reduced 
differentiation capacity and fusion competence (Sabourin et al., 1999; Yablonka-Reuveni 
et al., 1999a). This is because MyoD directly activates its own expression by binding to the 
DNA immediately upstream of the MyoD gene keeping the gene active (Tapscott, 2005) 
and also signals the expression of Myogenin, and MRF6 (MYF4 in mice), which is the 
crucial step in transition from proliferation to differentiation (Grounds et al., 1992; Bigot 
et al., 2008). There is also evidence to suggest that Myf5+ve satellite cells and MyoD+ve 
precursor cells are not able to repopulate the satellite cell’s anatomical niche therefore 
MyoD is considered the determinant step in commitment to myogenic differentiation and 
is upregulated within 24 hours of inducing differentiation in culture (Halevy et al., 1995; 
Bigot et al., 2008; Wang et al., 2014). 
To maintain a satellite cell population there needs to be a fraction of cells that 
migrate back to the niche location and become quiescent. In cell culture experiments not 
all cells fuse to form myotubes, the minority of remaining cells are thought of as “reserve 
cells” which could be representative of the satellite cell population in vivo (Zammit, 2006; 
Bigot et al., 2015). The overexpression of Pax7 is thought to cause satellite cell re-entry to 
quiescence (Olguin 2004). With Kuang et al., (2007) suggesting that PAX7+ve/MYF5-ve 
satellite cells divide asymmetrically where one daughter cell remains negative for MRF5 
and returns to quiescence whereas the other daughter cell becomes MRF5+ve and 
becomes committed to differentiation. It is thought that between 10-20% of satellite cells 
undergo this asymmetric division and return to a quiescent state for future regeneration 
(Kuang et al., 2007; Bigot et al., 2015).  
The Pax7+ve/MYF5+ve satellite cells which are committed to the myogenic 
differentiation program then expand via symmetrical division upregulating proliferating 
cell nuclear antigen (PCNA) and activation of the Ras-ERK pathway which suppresses the 
differentiation inducing actions of MyoD and MEF2 (Yokoyama et al., 2007). The interplay 
between the Notch and Wnt β-Catenin pathways, along with many other possible factors, 
control the switch from myogenic proliferation into differentiation (von Maltzahn et al., 
2012; Agley et al., 2017; Asfour et al., 2018). With regards to the MRFs, this is signalled by 
the downregulation of Pax7 and upregulation of MyoD, Myogenin and MRF4 in mice, 
MRF6 in human (Hernández-Hernández et al., 2017). This upregulation of MyoD causes 
cell cycle exit through the G1 checkpoint initiated by the upregulation of p21, p57, and 
p19 (Guo et al., 1995; Bigot et al., 2008). Myoblasts also accumulate double strand DNA 
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breaks via caspase 3 which may be involved in their terminal differentiation (Larsen et al., 
2010).  
Upregulation of Myogenin allows the non-dividing myoblasts to fuse together or to fuse 
with the damaged myofibres (Zammit, 2017). Myogenin knockout is lethal perinatally to 
mice because their myoblasts cannot fuse to form muscle fibres (Nabeshlma et al., 1993). 
Additionally, two cell membrane proteins, myomaker and myomerger, have also been 
shown to be essential for the fusion of myoblasts since knockdown of either prevented 
myoblast fusion (Millay et al., 2013; Leikina et al., 2018). Once fused, the multinucleated 
cells begin to express contractile proteins, such as myosin heavy chain (MHC). The first 
types of MHC expressed are embryonic and neonatal forms and as the fibres regenerate 
they are then replaced by the adult MHC forms, depending on the innervating motor 
nerve (Carosio et al., 2011). 
1.2.3. Fibroblasts 
Synthesis, maintenance and repair of the connective tissue layers of skeletal muscle, 
the epi-, endo- and peri- mysium, is under the control of local stromal fibroblasts and 
fibro-adipocytes (FAPS; Haniffa et al., 2009). Fibroblasts are mesenchymal cells found 
within the connective tissue stroma of most organs and there is a large heterogeneity 
between anatomical locations as they are specialised to their tissue of origin (Chang et al., 
2002). Fibroblasts are often identified by elimination of other cell types as non-
endothelial, non-epithelial, non-hematopoietic and by the capacity to produce and 
remodel extracellular matrix (Haniffa et al., 2009). However, TE7, a fibroblast-specific 
connective tissue protein, has been demonstrated to distinguish fibroblasts in many 
tissues from other human cell types such as monocyte-derived fibrocytes and endothelial 
cells (Goodpaster et al., 2008; Pilling et al., 2009). True fibroblast markers that distinguish 
between sub types are still elusive (Mathew et al., 2011), but human skeletal muscle origin 
fibroblasts have been shown to express TE7, collagen VI, PDGFRa, vimentin and 
fibronectin (Agley et al., 2013). There is a potential for these skeletal muscle origin 
fibroblasts, or a subset, to be undifferentiated bipotent ‘fibro-adipogenic’ precursors 
(FAPs) which has been found in mouse skeletal muscle (Joe et al., 2010; Uezumi et al., 
2010). Although, this relationship between FAPs and fibroblasts is unclear in humans as 
only some isolated fibroblast populations extracted from human primary muscle biopsies 
show adipogenic potential (Agley et al., 2013). 
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During development skeletal muscle fibroblasts play an important role in the 
organisation of the connective tissue leading to the highly ordered final structure of 
skeletal muscle (Clase et al., 2000; Kardon et al., 2003). In adult muscle their genetic 
ablation impaired muscle regeneration in vivo (Murphy et al., 2011) which is supported 
by the observation that their addition enhanced myoblast fusion in culture (Mathew et 
al., 2011). Fibroblasts and FAPS are known to secrete factors which signal for myoblast 
terminal differentiation: IGF-1, interleukin-6 (IL-6) and Wnt family proteins Wnt1, Wnt3A 
and Wnt5A. These factors have a second role as they also initiate extracellular matrix 
remodelling (Joe et al., 2010; Uezumi et al., 2010; Wosczyna & Rando, 2018).  Fibroblasts 
may also be important for phagocytosis of necrotic debris and respond to immune cell 
secretions by proliferation before being selectively targeted for apoptosis by macrophage 
TNF-α secretion (Heredia et al., 2013; Lemos et al., 2015). 
Overall skeletal muscle regeneration is a highly integrative process involving multiple 
cell types including MPCs, fibroblasts and many different blood cells types (Yang & Hu, 
2018). The intricate intra- and extra- cellular signalling cascades to coordinate the process 
which, although complex, is highly effective during development and in young adults 
(Wosczyna & Rando, 2018). However, the regeneration process may be dysregulated or 
impaired as organisms age. 
1.3. Sarcopenia 
Human ageing is the gradual decline in organ and tissue function with increasing 
chronological time, leading eventually to increased risk of disease, loss of function and 
death (Kennedy et al., 2014; Lees et al., 2016). Most human physiological systems show 
peak performance in the third decade of life with declining performance thereafter with 
the rate of decline accelerating between sixth and seventh decades. This decline is 
highlighted most elegantly by observing the integrative physiological decline in world 
record times for master athletes (Lazarus & Harridge, 2017). Within the tissue of interest 
of this thesis, skeletal muscle, the ageing process manifests itself as an age-related loss of 
skeletal muscle, which is known as sarcopenia - literally translated as “flesh loss” 
(Rosenberg, 1997).  
Sarcopenia is a geriatric syndrome characterised by progressive and generalised loss 
of skeletal muscle mass and strength leading to physical disability and poor quality of life 
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(Cruz-Jentoft et al., 2010). The current clinical definition of sarcopenia is defined by the 
presence of low muscle mass, two standard deviations below the lean mass of sex-specific 
healthy young controls, with low strength and a risk of deleterious outcomes, such as 
frailty, an increased propensity to fall, or the loss of independence (Delmonico et al., 2007; 
Dennison et al., 2017; Cruz-Jentoft et al., 2019). 
A cross sectional study suggested muscle mass loss of between 25-40%, measured 
by MRI, in both male and females aged 20 to 60 years (Janssen et al., 2000). Longitudinal 
research suggests that the rate of declines in muscle mass loss is between 1-2% per 
decade from the age of 50 years and accelerates to as much as 3% per decade beyond age 
60 (Hughes et al., 2001; Rolland et al., 2008). The decline in muscle strength is also 
reported to be 20-40% in the seventh and eighth decades of life (Larsson et al., 1979; 
Overend et al., 1992), with larger losses (>50%) reported in the ninth decade (Murray et 
al., 1985). Muscle power (strength x speed) is also reduced with ageing and is strongly 
associated with functional decline (Bassey et al., 1992). The reduction in muscle power is 
considerable from the fifth decade of life and is of greater magnitude than decrements in 
strength (Metter et al., 1997). 
The mass and functional loss seen in sarcopenic muscles is most likely due to reduced 
number and size of myofibers. With a reported 10-40% atrophy in type II fibre atrophy 
whereas type I muscle fibres appears mostly unaffected by the ageing process (Verdijk et 
al., 2007; Snijders et al., 2009). The age related loss of fibres is accompanied by an 
increase in fibrosis, fat accumulation and scar tissue formation (Wagatsuma, 2007; 
Mahdy, 2018). Scar tissue, in the form of fibrosis connective tissue, accumulates where 
incomplete or slow muscle tissue regeneration occurs reducing muscle quality. Examples 
of the quality of aged muscle are shown in Figure 1.4. 
There is a growing consensus to better define the ageing population under study 
because physically active individuals show fewer signs of sarcopenia. Aged exercisers do 
still have a decline in performance with increasing age, as shown by cross sectional data 
from age group world record times in sprinting, marathon running and swimming (Lazarus 
& Harridge, 2017). A study by Pollock et al., (2015) showed a similar trend for declining 
performance with age in a cross-sectional study of highly active elderly masters cyclists. 
Masters athletes also show superior muscle strength and power compared to their age-
matched non-exercised counterparts (Pearson et al., 2002), although type II fibre atrophy 
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is evident in master sprinters and therefore may not solely be explained by inactivity 
(Korhonen et al., 2009). The true extent to which there is a decline in age-related muscle 
mass and function is masked by inactivity but there are still clear signs of an inherent 
ageing effect in the highly active. 
Skeletal muscle is a multifunctional multi-cell type tissue meaning that there are 
many potential contributing factors to an age-related decline in muscle mass and 
function. The prominent mechanisms will be reviewed in brief and focus will be on the 
possible roles of the MPCs and fibroblasts to the ageing phenotype. 
Voluntary skeletal muscle contraction is controlled by the action potentials 
generated by α-motor neurons. Neuronal cells are not replaced and therefore when they 
die the fibres of that motor unit are either incorporated into other surviving motor units 
or are lost to necroptosis (Vandervoort, 2002). This mechanism can account for not only 
the loss of muscle size with ageing but also functional output because the larger motor 
unit size causes loss of fine control of muscles. There may also be potentially greater loss 
of the type II motor units, fast twitch, which could also support the shift in fibre types in 
older muscles as the motor unit determined fibre type, denervated type II fibres becoming 
incorporated into type I motor units would cause fibre type switching. 
Other external mechanisms include changes in endocrine function (Sakuma & 
Yamaguchi, 2012), falling circulating levels of anabolic hormones (Wilkinson et al., 2018) 
and chronic low-grade inflammation known as inflammageing (Franceschi & Campisi, 
2014). The circulation of low, but elevated, levels of inflammatory cytokines and 
chemokines, such as advanced glycation end- products, IL-6, IL-18 and TNF-α, can 
interfere with regular cellular functioning and potentially impair muscle maintenance, 
repair and regeneration (Brooks & Faulkner, 1990; Ndip et al., 2016). Old muscle also 
shows desensitisation to anabolic stimuli such as feeding and exercise, further impairing 
the ability of the muscle to regenerate (Moore et al., 2015). The impaired repair and 
regeneration of muscle fibres would support the findings of increased connective tissue 
fat infiltration into muscles (Mahdy, 2018), as well as, altered protein metabolism (Breen 
& Phillips, 2011). These mechanisms are likely to impact the phenotype of aged skeletal 
muscle.  
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Figure 1.4. Loss of muscle quantity and quality with increased age. 
Cross-sections through the upper thigh from a young male and aged men and women show the 
characteristic decrease in muscle mass and intrusion of fatty connective tissue described by 
sarcopenia. Images were obtained using computerised tomography where white indicates fat and 
connective tissue and grey indicates muscle tissue (Parise & Yarasheski, 2000).  
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1.4. Stem cell loss and dysfunction 
Satellite cells are essential for the repair and maintenance of regenerating muscle 
tissue. Their loss with increasing age could influence the aged phenotype because the 
remaining populations may not be able to fully repair or regenerate skeletal muscle fibres. 
In rodent post-natal muscle, roughly 30% of myogenic cells are considered satellite cells 
with this number decreasing to <5% in adult muscle, accounting for the increased 
myonuclear number seen during development (Allbrook et al., 1971; Gibson & Schultz, 
1983). Snow (1977) showed a further 50% decrease in satellite cell number to 2.4% in 
soleus muscle of 30-month-old mice and rats compared to 8-month-old animals. Gibson 
& Schultz, (1983) suggested there may be a difference in relative satellite cell loss 
between oxidative and glycolytic fibres by showing a decline from 2.9% to 1.9% in 
extensor digitorum longus muscle compared with a declined from 6.6% to 4.9% in soleus 
muscle. A more recent study suggests that there is a reduced number of satellite cells in 
old mice, 20-24 months, compared to young adults, 5-6 month old, but no further loss in 
very old mice, 28-32 months (Sousa-Victor et al., 2014). 
In humans, the results are less clear, an early report showed a reduction in satellite 
cell number from 4% in young adults to 0.6% in one 73 year old man (Schmalbruch & 
Hellhammer, 1976). Another study including more older participants showed a less severe 
decrease in satellite cells from 5% in young to 1.5% in old adults (Renault et al., 2002a). 
Furthermore, while the number of satellite cells as a proportion of myonuclear number 
was lower in old age, the mean number of myonuclei remained constant. The authors 
state that over 200 myofibres were analysed per sample but there was no mention of 
actual number of satellite cells counted per sample. However, another electron 
microscopy study with 14 young and 15 old participants didn’t show a decrease in satellite 
cell number but the  proportion of satellite cells to total nuclei was in the range 1.7-2.8% 
between the groups (Roth et al., 2000). 
Two further studies from a different group (Sajko et al., 2002) claimed that previous 
studies had not been able to accurately count satellite cells suggesting only 6 satellite cells 
were counted per participant in the Schmalbruch & Hellhammer, (1976) study and 4.2 
satellite cells per participant in the Roth et al., (2000) study. Their later study counted an 
average of 117 (range 35-200) satellite cells, identified by calcium-dependent cell 
adhesion molecule M-cadherin staining, within an average of 3824 (1352-5350) myofibres 
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per muscle, from 6 young and 6 old adults (Sajko et al., 2004). In this thorough analysis 
they showed that the proportion of satellite cells (per total number of nuclei or myofibres) 
was higher in young adults, compared to older adults in 10 µm sections. However, over 
the whole of the 1 mm3 muscle tissue sample this difference was not significant. This was 
likely due to high inter-individual variability especially in the young group. Another study 
from the same year also showed a significantly lower absolute number of satellite cells 
per muscle fibre in older, compared to younger, women and men (Kadi et al., 2004). They 
also showed a significantly higher number of myonuclei in older individuals suggesting 
this could be a compensatory mechanism for loss of satellite cells. The interpretation was 
further confounded by the finding that the satellite cell population density differed 
between type 1 and 2 fibres, which previous studies had not determined (Zammit et al., 
2002). When satellite cell loss was counted in the specific fibre types there was an age-
associated decrease in satellite cell number but specifically in type 2 fibres (Verdijk et al., 
2007). Another consideration is that both satellite cell and myonuclear number increase 
due to exercise training and therefore understanding the lifelong physical activity status 
of the participants is important to match for activity level (Snijders et al., 2015; Goh et al., 
2019).  
The lack of consensus on satellite cell loss with age in human studies, even from the 
same muscles, is likely due to inaccuracies in the measurements (Brack & Rando, 2007). 
Satellite cells are scarce, even in healthy muscle, and they are counted in human biopsy 
tissue sections from a very small samples of muscle fibres, which may not be 
representative of the satellite cell distribution across the whole muscle. Although 
techniques such as flow cytometry do yield accurate counts of numbers of cells these 
populations are similarly likely to be biased by the extraction techniques used because 
digesting the whole muscle may cause loss of cells favouring survival of healthy cells. 
Overall, it is most likely that satellite cell number does decrease with age, in common 
with other stem/progenitor cell populations. Irrespective of this, there seems to be 
sufficient satellite cells in elderly muscle to rejuvenate muscle effectively (Brack & Rando, 
2007). Especially as only a very small number of satellite cells are required to fully 
regenerate skeletal muscle (Günther et al., 2013). However, this is dependent on the 
remaining satellite cells being functionally capable of regenerating muscle. One of the key 
ageing mechanisms that has been associated with reduced stem cell function, and the one 
that this thesis focuses on, is cellular senescence (Lopez-Otin et al., 2013). 
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1.5. Cellular senescence  
The first studies of cells in culture suggested that when cells were removed from their 
in vivo constraints they could divide and function indefinitely (Carrel & Ebeling, 1921). 
However, it has subsequently been proposed that the chicken embryo extract used to 
feed the cells was providing a source of new cells into the cultures (references in Shay & 
Wright, 2000). It took until the 1960’s for a study to convincingly show that normal human 
cells had a limited replicative capacity in culture. Hayflick & Moorhead, (1961) showed 
that human foetal diploid fibroblasts could be serially passaged for a consistent number 
of population doublings (approximately 55 divisions) before reaching proliferative arrest. 
This finding was interpreted as cellular ageing of mortal cells and that only cancerous cells 
were immortal (Hayflick, 1965). The limit to proliferative capacity of normal mortal cells 
became known as replicative senescence and subsequently “the Hayflick limit” after its 
discoverer. A replicative limit has since been shown in many other cell types, including 
adult skeletal muscle myoblasts (Decary et al., 1996; Kang, 1998; Spaulding et al., 1999; 
Wagner et al., 2001; Coppé et al., 2010b). 
Due to the consistency of the replicative lifespan of the same cell population, even 
after cryopreservation, it was postulated that there must be some form of mitotic counter 
remembering how many divisions a cell had undergone. Telomeres, short tandem repeat 
sequences of TTAGGG nucleotides that cap the end of chromosomes, were suggested to 
be a likely replicometer (Hayflick, 1965; Blackburn et al., 2015). During chromosomal 
transcription DNA polymerase cannot fully transcribe the 3’ end of each DNA strand 
because the enzyme needs nucleotide bases to bind to beyond those being copied 
(Bodnar et al., 1998; Blasco, 2005). Telomeres provide these additional nucleotides 
allowing for the full transcription of the last coding gene with the last section of the 
telomere being lost after each replication resulting in a progressive shortening of the 
telomere. It has been shown in vitro that once telomeres reach a critical length the cell 
will stop proliferating (Di Donna et al., 2003), with initial telomere length correlating very 
highly with the cell population’s in vitro replicative capacity (Allsopp et al., 1992). 
Additionally, the degree of telomere shortening is roughly proportional to risks of 
common comorbidities of ageing (Blackburn et al., 2015). However, it was shown that 
telomere shortening is not always regular because other factors such as DNA damage 
caused by oxidative stress can cause additional bases to be lost (Von Zglinicki, 2002). 
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Therefore, telomere length is not necessarily a precise indicator of replicative capacity, 
but an upper proliferative limit determined by the end-replication problem. 
Telomere length can be restored by the ribonucleoprotein enzyme telomerase that 
extends the 3’ end of telomeres and therefore prevents them from reaching a critically 
short length (Shippen-Lentz & Blackburn, 1990). Telomerase has been found in many 
other non-human cells and immortal cell lines suggesting the importance of the telomere 
in retaining proliferative capacity (Shay & Bacchetti, 1997; Blasco, 2005). In normal human 
cells, telomerase activity has only been found in very few stem cell populations such as 
foetal tissue, bone marrow stem cells, testes, peripheral blood lymphocytes, skin 
epidermis and intestinal crypt cells (Broccoli et al., 1995; Wright et al., 1996; Kyo et al., 
1997; Calado & Young, 2008). It is important to note that the addition of telomerase is 
not always sufficient to immortalise human cell populations. The addition of telomerase 
to normal human fibroblasts increases their proliferative capacity by at least 20 
population doublings but they still reached proliferative arrest suggesting that there were 
other senescence inducing mechanisms (Bodnar et al., 1998). This is supported by rats 
and mice dying with long telomeres suggesting that other mechanisms are involved in 
causing cellular senescence (Blasco et al., 1997). 
As cell culture is a constant environment with relatively low stress, the number of 
population doublings that a normal cell can undergo in vitro is considered to be an 
expression of the maximum potential longevity, under those culture conditions. However, 
in most cases, telomere-driven senescence occurs much sooner due to imperfect 
protection from damage, which results in accelerated telomere loss (Von Zglinicki et al., 
2005). The replicative limit is rarely reached in vivo because of the hundreds of molecular 
disorders that accumulate before the division competent cell reaches replicative capacity 
causing the cell to either succumb to apoptosis, necroptosis or to organismal death well 
before telomeres reach a critical length to prevent DNA replication (Hayflick, 1998; Brooks 
& Myburgh, 2014; Sciorati et al., 2016; Morgan et al., 2018).  
When telomeres become critically short or damaged sufficiently there is an induced 
activation of a sustained DNA damage response (DDR) pathway that leads to a senescent 
cell cycle exit (Blackburn et al., 2015). The loss of telomeres uncaps the end of DNA which 
activates a kinase cascade of ataxia telangiectasia mutated (ATM) and Rad-3 related 
kinase (ATR) followed by checkpoint protein kinase CHK1 and CHK2, resulting in the 
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stabilisation of tumour suppressor protein, p53, which in turn upregulates p21 causing 
the inhibition of cyclin dependent kinase (CDK) activity (Cyclin E/CDK2 complex) 
preventing cell cycle progression as retinoblastoma protein is still in its active, 
hypophosphorylated, state (Figure 1.6; McHugh & Gil, 2018). 
This same cell cycle exit response has been shown to be activated by other damage 
causing factors that do not necessarily cause DNA or telomeric damage such as epigenetic 
stress, reactive oxygen species, endoplasmic reticulum stress, proteotoxic stress, 
nucleolar stress, spindle stress and low BubR1 (Itahana et al., 2004). In these stress-
induced incidences the p53/p21 senescence pathway may, or may not, be involved 
alongside the silencing of INK4a/ARF locus by Polycomb Repressive complexes (Fridman 
& Tainsky, 2008). This silencing allows the upregulation of p16 which maintains Rb in its 
hypophosphorylated by inhibition of a different set of CDKs, Cyclin D1, CDK4 and CDK6 
(Alcorta et al., 1996). It is difficult to determine exactly how an individual cell became 
senescent because the pathways converge on a common cell cycle exit strategy. Both p16 
and p21 keep retinoblastoma tumour suppressor protein (pRB) in an active, 
hypophosphorylated form, preventing E2F transcription factor from transcribing genes 
that are needed for proliferation (Adams, 2009). Although the p53-p21 and p16 cell cycle 
inhibitor pathways are strongly involved in triggering the senescent cell state, it is 
suggested that p53/21 is as an indicator of cellular senescence initiation, whereas p16 is 
expressed throughout cellular senescence maintenance (Stein et al., 1999). However, 
senescence cells have also been found without the expression of either of these cell cycle 
inhibitors further confusing the identification of senescent cells (Hernandez-Segura et al., 
2018). 
The current gold standard marker of senescent cells is the activity of Senescence-
Associated β-Galactosidase (SA-β-Gal; Dimri et al., 1995). The heightened activity of 
lysosomal-origin β-galactosidase is thought to be the result of the expansion of the 
lysosomal compartment and increased autophagy in senescent cells to compensate for 
the accumulation of damaged macromolecules and organelles (Lee et al., 2006). SA-βGal 
has an optimal activity at pH 6, whereas non-senescent cells β-Gal is optimally active at 
pH 4. However, this upregulation of β-Gal at non optimal pH is not only associated with 
senescence but is present in some cell types, such as adult melanocytes and sebaceous 
and eccrine gland cell when still proliferative (Dimri et al., 1995). It is therefore paramount 
to use multiple markers to determine cells as senescent. 
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Markers of DNA damage such as the chromatin modifier phosphorylated histone 
H2aX (γH2aX), that identifies double strand breaks in DNA (d’Adda di Fagagna, 2008), as 
well as, the cell cycle inhibitors p53, p21 and p16 are often used as markers of senescent 
cells, but they are not definitive markers of senescence. DNA damage does not always 
result in senescence and mutations in the cell cycle inhibitors are highly prevalent in 
immortal cancer cells, as well as in some non-senescent cells (Turgeon et al., 2018). 
Therefore, combining these markers with direct markers of proliferation, such as Ki67 or 
BrdU, more clearly identify these cells as senescent. However, this combination of 
markers could still be marking a quiescent or temporary non-diving cell rather than a 
permanently arrested senescent cell. The DNA damage response pathways are also the 
primary trigger for altering the chromatin structure and formation of senescence 
associated heterochromatin foci (Adams, 2009; Rodier et al., 2009). Senescent cells are 
also characterised by morphological changes, enlarged and flattened shape distended 
nuclei, increased microfilament content, prominent Golgi apparatus and increased 
presence of cytoplasmic vacuoles (Renault et al., 2000; Campisi, 2013). 
The most prominent feature of senescent cells is their altered secretory phenotype, 
known as the senescence associated secretory phenotype (SASP; Coppé et al., 2008). 
Despite being unable to proliferate, senescent cells remain metabolically active and can 
display extensive changes in gene and protein expression which is thought to be tissue 
specific with core common pathways (Tchkonia et al., 2013). 
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Figure 1.5 Senescence cell cycle inhibitor pathways. 
The two main pathways activated in response to stressors are the p53/21 and the p16 pathways. 
Following activation of the DNA damage response, this activates a kinase cascade of ataxia 
telangiectasia mutated (ATM) and Rad-3 related kinase (ATR) followed by checkpoint protein 
kinase CHK1 and CHK2, thereby activating p53. p53 then induces p21 transcription, which inhibits 
the Cyclin E/CDK2 complex, resulting in hypophosphorylated retinoblastoma (RB) protein and cell 
cycle exit. p16 and ARF are tumour suppressors residing in the INK4/ARF locus. In response to 
stressors, the INK4A/ARF locus is silenced by Polycomb Repressive complexes (PRCs) and activated. 
This activates p16, thereby inhibiting the Cyclin D1/CDK4/6 complex, resulting in 
hypophosphorylated RB and cell cycle exit. Reproduced from McHugh & Gil, (2018). 
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1.5.1. Senescence associated secretory phenotype 
The SASP is characterised by the secretion of several families of soluble signalling 
molecules, including cytokines, chemokines and growth factors, together with the 
secretion of bioactive lipids, proteases and changes in extracellular matrix components 
(Kuilman et al., 2010; Tchkonia et al., 2013; Malaquin et al., 2016). The key components 
are listed in Table 1, which is reproduced from (Gorgoulis et al., 2019). However, the exact 
composition of the SASP varies between cell types and even between different cells within 
the same cell type, as well as, changing over time (Coppé et al., 2008; Wiley et al., 2017). 
Table 1. Senescence Associated Secretory Phenotype (SASP) factor components 
Class Component 
Interleukins IL-6; IL-7; IL-1; IL-1b; IL-13; IL-15 
Chemokines IL-8; GRO-a, -b, -g; MCP-2; MCP-4; MIP-1a; MIP-3a; 
HCC-4; eotaxin; eotaxin-3; TECK; ENA-78; I-309; I-TAC 
Other inflammatory molecules TGF-β; GM-CSE; G-CSE; IFN-γ; BLC; MIF 
Growth factors; regulators Amphiregulin; epiregulin; heregulin; EGF; bFGF; HGF; 
KGF (FGF7); VEGF; angiogenin; SCF; SDF-1; PIGF; NGF; 
IGFBP-2, -3, -4, -6, -7 
Proteases and regulators MMP-1, -3, -10, -12, -13, -14; TIMP-1; TIMP-2; PAI-1, 
-2; tPA; uPA; cathepsin B 
Receptors; ligands ICAM-1, -3; OPG; sTNFRI; sTNFRII; TRAIL-R3; Fas; 
uPAR; SGP130; EGF-R 
Non-protein molecules PGE2; nitric oxide; ROS 
Insoluble factors Fibronectin; collagens; laminin 
Reproduced from Gorgoulis et al., (2019). 
The SASP is thought to be induced in response to senescence via a signalling loop 
involving IL-1α, miR-146a/b, IL-6, C/EBP-β, p38/NF-κB and mTOR-mediated signalling 
cascades which contribute to the alterations in gene expression (Yoshimoto et al., 2013; 
Tchkonia et al., 2013; Xu et al., 2015a). Part of the SASP’s effect is to reinforce senescence-
associated proliferative arrest by increased PAI-1, insulin-growth factor binding protein 
family (IGFBPs), and TGF-β1 alongside reduced levels of IGF-1 and WNT2 (Adams, 2009). 
PAI-1 is a pro-thrombotic plasma protein that inhibits plasminogen activators, tissue and 
urokinase plasminogen activators participating in wound healing, angiogenesis and 
metastasis, as well as interacting with extracellular proteolytic activity (Kortlever et al., 
2006; Eren et al., 2014). Moreover PAI-1 is an established p53 target and although it is 
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mostly regarded as a marker that correlates with senescence, it is also sufficient to drive 
senescence in fibroblasts (Kortlever et al., 2006). The upregulated IGFBPs sequester IGFs 
supressing their signalling which also plays a role in regulating p53 expression (Kuilman & 
Peeper, 2009). MCF-7 cells, human breast cancer cell line, incubated in media containing 
IGFBP-3 undergo senescence, which is prevented if IGFBP-3 is degraded by tissue 
plasminogen (t-PA) in the same media (Elzi et al., 2012). IGFBP-3, IGFBP-5 and IGFBP-7 
have been shown to interact with an activated BRAF oncogene, upregulating senescence 
through oncogene overexpression, and aiding apoptosis induction (Wajapeyee et al., 
2008). TGF-β is able to reinforce cellular senescence through paracrine mechanisms, by 
generating reactive oxygen species which interact with nearby cells (Hubackova et al., 
2012), and autocrine mechanisms, by establishing a positive feedback loop leading to p21 
and p15 induction (McNeal et al., 2015; Tominaga, 2015). 
Senescent cells also often express increased amounts of immune-regulatory factors, 
namely cytokines, chemokines and their receptors (Adams, 2009). These include IL-6 and 
its receptor IL-6R (Kuilman et al., 2008; Adams, 2009; Kuilman & Peeper, 2009), as well as, 
the seven-spanning transmembrane receptor CXCR2 and its ligands, IL-8, CXCL1, CXCL5, 
and CXCL7 (Acosta et al., 2008; Kuilman et al., 2008). IL-6 reinforces senescence-
associated proliferative arrest of primary cells in an autocrine manner, as well as, being a 
potent attractor and activator of immune cells (Kuilman et al., 2008; Tchkonia et al., 
2013). Likewise, increased CXCR2 and IL-8 reinforce the senescence program by causing 
proliferative arrest, promoting angiogenesis and inhibiting differentiation through 
autocrine mechanisms (Parrinello et al., 2005; Acosta et al., 2008; Orjalo et al., 2009). 
CXCL5 has also been shown to promote angiogenesis but also cell proliferation, migration, 
and invasion (Begley et al., 2008; Kawamura et al., 2012). The SASP can also signal the 
immune system directly via increased natural killer group 2D (NKG2D) ligands, MHC class 
I polypeptide related sequence A (MICA), UL16-binding protein 2 and IL-15 (Roberts et al., 
2001; Xue et al., 2007; Krizhanovsky et al., 2008; Faget et al., 2019). Activation of NKG2D 
signalling can trigger interferon-g (IFNg) production and cytolytic responses toward target 
cells (Swann & Smyth, 2007). This is thought to be important for the role of senescence in 
tumour suppression.  
Senescent cells also increase secretion of extracellular matrix (ECM) remodelling 
factors, such as Matrix Metalloproteinases (MMPs) and decreased expression of 
fibronectin and collagen (Krizhanovsky et al., 2008). MMPs affect the structure of 
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senesced cells through extracellular degradation and remodelling (Freitas-Rodríguez et 
al., 2017). Another function of secreted MMPs is to regulate the activity of cytokines, 
through binding to the cytokines themselves or the ECM (Page-McCaw et al., 2007; 
Adams, 2009). 
Acutely, a SASP may be beneficial in allowing damaged cells to communicate their 
compromised state to neighbouring cells and facilitating their immune-mediated removal 
or to instigate tissue regeneration (Coppé et al., 2010a; Freund et al., 2010). Their distinct 
secretome attracts immune cells to the area to dispose of these damaged cells, reducing 
the risk of oncogenic transformation and stimulating surveillance and clearance of 
senescent cells by the immune system (Campisi & d’Adda di Fagagna, 2007; Freund et al., 
2010; Byun et al., 2015). However, when senescent cells are not cleared and start to 
accumulate, such as in ageing tissues, the chronic expression of SASP factors can lead to 
tissue dysregulation and start a cycle of inducing further senescence. This senescence 
bystander effect is thought to be a contributing factor to the tissue deterioration seen 
during the ageing process.  
1.5.2. Cellular senescence and ageing 
Cellular senescence is a cell fate characterised by the cessation of cellular division 
whilst maintaining metabolic activity and having an altered, inflammatory, secretory 
phenotype. It is thought to be a positive evolutionary adaptation because it prevents 
damaged cells from continuing to divide thereby acting as an anti-tumorigenic mechanism 
promoting survival in young organisms (Von Zglinicki, 2002). The temporary presence of 
senescent cells in development and adult wound healing suggests that their pro-
inflammatory state may be beneficial in development and regeneration processes before 
being cleared by the immune system via apoptosis. However, with increasing age most 
senescent cells become resistant to apoptosis and start to accumulate within several 
tissues, including skeletal muscle. Small numbers of these apoptosis-resistant senescent 
cells are present in the early adult years but are not thought to cause problems to 
homeostasis. However, there becomes a threshold where the pronounced and chronic 
SASP expression from the accumulated senescent cells can induce local and systemic 
inflammation, increasing risk of cancer, impairing tissue homeostasis and inducing 
secondary senescence in nearby cells through paracrine-mediated mechanisms, termed 
the senescent bystander effect (Coppé et al., 2010a; Kuilman et al., 2010; Nelson et al., 
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2012). It is unclear why some senescent cells are not cleared by apoptosis or necroptosis 
but, it could be affected by either desensitisation of immune cells to the SASP, senescent 
cells entering a state whereby they oppose apoptosis or reduce their SASP so they become 
undetectable (deep senescence), or immune cell deficiency (Hampel et al., 2005; Serrano, 
2014). Overall, it is most likely to be that the accumulation of senescent cells does not 
cause negative effects until after reproductive ages and therefore cellular senescence is a 
neutral process unaffected by natural selection. 
As organisms age the proliferative capacity of cells should theoretically decrease as 
the cells undergo more divisions over time. These cells are also more likely to accumulate 
random mutations and DNA damage due to more divisions but also due to increased 
cumulative exposure to radiation, free radicals and other environmental toxins. It is most 
likely that regenerative tissues such as the skin, liver and haematopoietic system are most 
likely to accumulate senescent cells as they require more frequent repeated cell divisions 
to maintain tissue functioning by replacing old or damaged cells even though these stem 
cells possess telomerase activity. Skeletal muscle is also a highly regenerative tissue 
however it may be slightly less affected due to the relatively few times it is called upon to 
undergo regeneration rather than micro-damage ‘wear-and-tear’ repair. 
Indeed, there is a strong correlation between number of senescent cells and 
chronological age in many different organs and tissues including adipose tissue, skin, 
cardiac and skeletal muscle cells analysed both in mice and humans (Krishnamurthy et al., 
2004; Martin et al., 2014). In humans, this has been shown in many tissues including 
cardiac progenitor cells, adipose tissue and potentially in skeletal muscle (Sousa-Victor et 
al., 2014; Xu et al., 2015a; Lewis-McDougall et al., 2019). The causal role of senescent cells 
in ageing and declining tissue function was confirmed when evidence for the beneficial 
effects of senescent cell removal was shown by the clearance of p16+ve cells, via drug 
induced apoptosis, significantly increasing lifespan and healthspan in both BubR1 and 
chronologically aged wild type mice (Baker et al., 2011, 2016).  
Baker and colleagues showed this by genetically inserting an inducible Casp8 
apoptosis cassette, known as “ATTAC”, into the p16Ink4a promotor region to create “INK-
ATTAC”. Whereby apoptosis could only be activated in cells which expressed p16 after the 
systemic introduction of drug AP20187. The drug activated Casp8 by dimerizing the 
membrane-bound myristoylated FK506-binding-protein–caspase 8 (FKBP–Casp8) fusion 
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protein leading to Casp8 induced apoptosis (Baker et al., 2011). The treated wild type 
mice showed reduced senescence cell burden and functional improvements in adipose, 
kidney and heart tissues. But, most relevant to this thesis, they also showed increased 
movement compared to untreated aged matched controls suggesting improvements to 
skeletal muscle when p16+ve cells were eliminated (Baker et al., 2016). This was also 
supported by decreased mRNA for senescence associated genes, p16 and p21, in the 
whole gastrocnemius muscle tissue of these mice (Baker et al., 2016). However, these 
studies were reducing the global level of p16+ve senescent cells and not targeting muscle 
tissues specifically. Therefore, the benefits to skeletal muscle may not be due to the 
removal of senescent cells within skeletal muscle tissue itself but due to the removal of 
senescent cells from other tissues improving the systemic circulatory environment. 
Moreover, there are different cell types within human skeletal muscle which may be 
contributing to the senescent marker expression that are not satellite cells. It is thus 
important to better understand the impact of senescent cells specifically within skeletal 
muscle to determine what impact they may have on the ageing phenotype of skeletal 
muscle. 
1.6. Cellular senescence and skeletal muscle 
The first experiments to observe human muscle cell behaviour ex-vivo were 
performed by Pogogeff & Murray, (1945) who observed the explant expansion of cells 
from muscle tissue which fused to form myotubes. The key work to develop a 
reproducible in vitro primary muscle cell culture was performed by (Blau & Webster, 
1981). Thus laying the foundations for the first studies to investigate senescence and 
ageing in human primary skeletal muscle culture in the late 90’s (Decary et al., 1996, 
1997). This first series of studies investigated the difference in telomere length and 
proliferative capacity of cell populations extracted from different chronologically aged 
humans. It was hypothesised that cells from older humans would have undergone more 
divisions during life and therefore would have a reduced proliferative capacity and shorter 
telomeres. 
Cells were allowed to explant from muscle biopsies samples until they reached 
proliferative arrest from a 5-day, a 5-month-old infant, 9- and 15-year-old children, as well 
as, eight adults aged between 26 and 86 years (Decary et al., 1996, 1997; Renault et al., 
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2000). Skeletal muscle cells from a 5 day old infant could divide 55-60 times which quickly 
declines to 15-20 population doublings in cells extracted from all adult aged donors 
(Renault et al., 2000). Although the total proliferative capacity was similar across the adult 
samples, the cells from older adult donors took longer to grow out of their explants and 
had a higher percentage of non or slow dividing cells, as measured by BrdU incorporation, 
suggesting some internal differences persisting in these cells post isolation. These cells 
also showed a down-regulation of skeletal muscle cytoplasmic structural protein desmin 
as the cells approached senescence, as well as, an increase in the number of desmin 
negative cells which are most likely to be skeletal muscle origin fibroblasts. The finding of 
no difference in adult aged cells replicative capacity were mirrored by the initial mean 
telomere length of the cell populations showing no difference between young and old 
adult donors (Decary et al., 1996; Renault et al., 2002b). However, when assessing 
minimal telomere length a decline with increasing age in extracted muscle cells was 
shown (Decary et al., 1996; Renault et al., 2002b). Even though minimal telomere length 
was significantly decreased the telomeres were still sufficiently long to allow for multiple 
rounds of replication, as shown by there being no difference in the cumulative population 
doublings. 
These studies were limited by small sample sizes, not accounting for potential sex 
differences and not taking into account the health and physical activity status of the 
subjects. The muscle samples used in these studies were acquired during surgery or 
autopsy thus not from healthy participants which could impact their findings. 
Characterization of the subjects’ physical activity levels is important, as overtrained 
endurance athletes have shown abnormally short telomeres in the vastus lateralis (Collins 
et al., 2003), whereas the minimum telomere length within skeletal muscle of power-
lifters tended to be longer than that in untrained young subjects (Kadi et al., 2008). When 
accounting for these factors mean and minimum telomere length was unchanged in the 
vastus lateralis of active aged men and women (Ponsot et al., 2008) suggesting that 
proliferative potential is not an issue in healthy older skeletal muscle.  
In a condition where there is excessive proliferation of satellite cells, such as 
Duchene’s muscular dystrophy (DMD), telomere loss was 14-time greater in dystrophic 
muscle compared to aged matched healthy controls (Decary et al., 1997). The 
regenerative decline in these diseased muscles is attributed to replicative senescence of 
the satellite cells induced by their excessive proliferation during repeated cycles of 
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degeneration and regeneration (Decary et al., 2000). Most importantly the telomeres of 
the aged adults were sufficiently longer, 10-12 kb, than the suggested critically short 
length, 7-9 kb for human muscle cells (Di Donna et al., 2003). However, the early studies 
calculated telomere length of all nuclei within muscle tissue not just satellite cells and as 
satellite cells are <5% of myonuclei, not considering the other cell types in skeletal muscle, 
it would be unlikely to see a significant reduction (Decary et al., 1996; Renault et al., 
2002b). 
Lorenzon et al., (2004) extracted cells from the skeletal muscle of a 2, 21, 48 and 76-
year-old, all of which had high initial percentages of desmin+ve cells (~90%). All three adult 
samples showed variability in number of population doublings, 18-24, 13-19 and 6-12 
from the 21, 48 and 76-year old respectively, suggesting a reduced proliferative capacity 
with increasing age. Schäfer et al., (2006) analysed cell populations extracted from 12 
skeletal muscle biopsies spanning an age range of 2-82 years. All samples started with 
desmin+ve cells percentages above 70%, however some cultures did not maintain this 
initial desmin expression through to replicative senescence becoming overrun with other 
cell types, most likely to be skeletal muscle origin fibroblasts. The populations that lost 
desmin expression divided more than their age matched populations which maintained 
desmin. However, all populations reached replicative senescence within 50 days of 
thawing with cumulative population doublings ranging from 8-26 doublings. When only 
considering the cell populations that started with high desmin expression, 80% or above, 
the authors suggest there may be a slight decline in proliferative capacity with increasing 
age although the n number was reduced to only seven samples spanning the adults years 
and included a sample from a two year old which could skew the correlation as it has 
previously been shown that young children have much higher population doublings than 
adults. Using their correlation, with the limitations discussed, the authors suggest that for 
every 10 years of life senescence occurs two population doublings sooner (Schäfer et al., 
2006).  
These early studies all used few samples to span the whole lifespan. More recently, 
studies employing larger grouped sample sizes have shown that the proliferative capacity 
of adult human stem cells in culture was unaffected by donor age (Pietrangelo et al., 2009; 
Alsharidah et al., 2013; Barberi et al., 2013; Bigot et al., 2015). Pietrangelo et al., (2009) 
compared the replicative capacity of skeletal muscle derived cells from 6 males, aged 38.0 
± 4.1 years with 5 females and 5 males aged 78.5 ± 7.7 years. There was no difference in 
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population doublings achieved with the young adult cells stopping dividing after 17–20 
PDs compared to the elderly 15–20 PDs. However, this study was limited by very varied 
initial desmin expression, between 32.6% and 76% across all ages. Alsharidah et al., (2013) 
showed no difference in the number of population doublings achieved between young 
(aged 20–25 years) and elderly people (aged 67–82 years). There was no difference in 
starting percentage of desmin positive myogenic cells between young or old donors, 
however it was variable with cell population desmin purities between 50-95%. Some 
populations lost desmin expressing cells with time in culture, irrespective of initial desmin 
expression percentages whereas one sample was initially 50% desmin positive yet 
maintained this level of expression through to replicative senescence. Those populations 
which maintained desmin expression underwent 5-12 population doublings whereas 
those which lost desmin expression underwent 15-20 population doublings. Barberi et al., 
(2013) compared five young (age range 15–24-year-old), and 10 old subjects: five old 
sedentary (age range 72–80 year-old) and five old active (age range 68–79 year-old). All 
samples showed similar proliferative capacity and mean telomere length. This study did 
not provide the specific desmin expression percentages of the individual samples but they 
did mention staining for desmin. Bigot et al., (2015) compared five young (15–24 years 
old) and ten old (72–80 years old) healthy subjects, most likely the same participants as 
(Barberi et al., 2013). Here the authors state using a CD56+ve MACS sort of all samples as 
they showed low initial percentages of desmin expressing cells reporting significantly 
lower desmin expression (30% desmin+ve cells) in old donor cell populations compared to 
young (50% desmin+ve cells). MACS sorted young and old groups showed similar early 
passage mean telomere length, rate of cellular division and maximum population 
doublings before replicative senescence.  
Most studies have low n numbers due to the labour intensity of the experiments with 
some populations requiring over 100 days of continuous culture to reach replicative 
senescence (Barberi et al., 2013). Therefore, data from all published studies where age of 
donor, number of mean population doublings and percentage of desmin+ve positive cells 
were reported have been collated and plotted for mean population doublings against age 
of donor (Figure 1.6). The drop in proliferative capacity from birth to adulthood is striking 
compared to the relative stability during the adult years. There are high activity phases 
for satellite cells during development and through adolescence as skeletal muscle 
develops and grows. Once into adulthood, proliferative capacity of myoblasts is relatively 
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stable with no obvious tread for lower proliferative capacity in older adults compared to 
young adults although there is a large degree of individual variability.  
 
Figure 1.6. Population doubling limits of myogenic skeletal muscle cell populations. 
Cumulative population doublings for desmin positive cell populations from all published studies 
that stated percentage of desmin+ve cells and population doubling numbers. Only samples which 
where at least 80% desmin at senescence were included here. 
It was hypothesised that satellite cells would become exhausted in later life due to 
the demands of repeated rounds of regeneration accrued across the lifespan. However, 
this does not seem to be the case, at least at the cell population level. In comparison, 
young DMD patients show reduced proliferative capacity reaching only 13 PDs compared 
to 30 PDs from age matched healthy people (Renault et al., 2000). Here satellite cell 
replicative exhaustion could be potentially reached owing to the requirement of multiple 
rounds of regeneration due to increased muscle damage caused by their disease. Studies 
using in vitro replicative capacity as a measure of ageing are likely to misrepresent the in 
vivo cell population because any senescent cells extracted will be unable to proliferate 
and will therefore be rapidly outgrown by the proliferation of healthy, functioning cells. 
The proliferative capacity of cell populations is also not a very sensitive measure because 
population doublings are exponential therefore the number of cells after 20 PDs is 100’s 
of millions of cells making any slight differences hard to observe. However, if in vivo 
populations still have such vast replicative capacity irrespective of age there are enough 
cells to regenerate the whole muscle. It therefore seems that reduced proliferative 
capacity of satellite cells is not the underpinning factor that causes impaired muscle 
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regenerative capacity with increasing age and that proliferative capacity of the population 
is not an issue in current human lifespan. 
In vivo, myoblasts are a transient cell population which expand rapidly then 
terminally differentiate into myocytes. Under cell culture conditions these cells will 
differentiate and fuse together if left to become confluent in high serum conditions, as 
well as, at lower confluency in low serum conditions. The myogenic differentiation assay 
is therefore a model system of the early stages of regeneration and is useful to identify 
any functional differences in vitro which may reflect the in vivo phenotype. 
As has been suggested, there are considered to be enough cells with proliferative 
potential in vivo to fully regenerate whole skeletal muscles, however they must also be 
functionally able to differentiate if they are to restore muscle function. The early studies 
presented previously also looked at differentiation capacity from their different aged 
human donors. Renault et al., (2000) showed that myotube formation, as measured by 
fusion index, was not different between different aged adults. Whereas, Lorenzon et al., 
(2004) did show age related impairment in fusion capacity. Although, this study was using 
unsorted cells (but 90% desmin+ve) from a 2, 21, 48 and 76-year-old. Cells from the 48-
year-old took longer to fuse but eventually formed myotubes whereas cells from the 76-
year-old were unable to form myotubes even after 10 days. Although, these cells did show 
an increase in myogenin, the MRF that signals commitment to differentiation, suggesting 
these cells may have a very delayed differentiation or an inability to complete fusion. 
Jacquemin et al., (2004) also showed lower fusion index and fewer nuclei per myotube 
from unsorted, but with desmin+ve cell percentage above 70%, cells grown from muscle 
explants from a 65-year-old when compared to a 17-year-old. However, as both studies 
only used one biopsy per age limited conclusions can be drawn from their findings. 
In a study using samples from 3 young (29-48 years) and 6 old (69-87 years) donors 
Fulle et al., (2005) showed a trend for poorer fusion of myoblasts from older donors 33.7% 
compared to 56.7% in younger adults. Older donor cells also had a reduced antioxidant 
activity of catalase and glutathione transferase compared to newborn and younger adults. 
They exhibited lower membrane fluidity and higher basal cytoplasmic calcium levels. 
These results suggest that within aged skeletal muscle there is altered antioxidant 
capacity which could interfere with calcium handling impairing contractile function. 
However, the conclusions are limited by low numbers of desmin+ve cells, around 60%, in 
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both young and old adults. Therefore, these results must be taken in a general effect on 
"muscle mononucleated cells" than on myoblasts specifically. A similar study by Beccafico 
et al., (2007), also using mixed cell populations from 3 young (~30 years, ~55% desmin) 
and 3 old (~83 years, ~40% desmin), showed a lower fusion index from old donor cells, 
~25%, after 7 days of differentiation than young donor cells, ~45%. Myotubes formed by 
the old donor cells also showed more oxidative damage in the form of lipid peroxidation. 
This increase in lipid peroxidation could affect membrane fluidity as reported by Fulle et 
al., (2005) and explain why they did not see any calcium spike in the old participants, 
although the poor myotube formation could also explain this.  
The first study of differentiation capacity with sizeable groups of participants was 
performed by Beccafico et al., (2011) who investigated eleven old (77.3±6.4 years) and 
ten young (28.7±5.9 years) cell populations with over 95% desmin+ve muscle precursor 
cells, as measured by positive tyrosine-protein kinase Met (c-Met) staining. In this study 
they showed old cells differentiated less efficiently than young and had lower Pax7 
expression, reduced ability to express MyoD, Myogenin and MHC, as well as, lower RAGE 
and higher S100B levels. Sousa-Victor et al., (2014) also showed lower fusion from older 
donors but they only measured fusion after 48 hours whereas Beccafico et al., (2011) took 
their differentiation out to six days. Previous studies have shown that old cells take longer 
to fuse but do eventually fuse fully therefore this could just be delayed differentiation 
rather than inability to use. In contrast, Alsharidah et al., (2013) showed there was no 
difference in fusion index, myotube size or expression patterns of MyoD, myogenin or 
MHC between different aged donors. Conversely, Bigot et al., (2015) actually showed 
increased fusion of older donor cells. The authors suggest that there were fewer unfused 
cells due to epigenetic repression of SPRTY-1 expression preventing the cells ability to 
return to quiescence. This would leave differences in the reserve cell populations rather 
than the differentiating populations and could suggest a possible mechanism for the 
reduced satellite cell number with ageing. Overall, the fusion competence of cells from 
different aged humans is variable with variably between and within studies, even when 
percentage of desmin positive cells is controlled for. 
A recent meta-analysis looking at senescence burden in aged human tissue 
highlighted the lack of research into senescence post-mitotic tissues such as skeletal 
muscle. This meta-analysis found no human skeletal muscle studies which met their entry 
criteria into the meta-analysis (Tuttle et al., 2020). Within the studies to look at 
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senescence within human skeletal muscle contradictory results have been reported when 
analysing expression of the commonly utilised senescent markers. Carlson & Conboy, 
(2007) show increased whole skeletal muscle tissue protein levels of p21 and p15 but not 
p16 in older people. Barberi et al., (2013) observed similar results when looking at mRNA 
in early passage myogenic precursor cells showing increases in p53 and p21 but not p16 
mRNA expression in cells from aged donors. Bigot et al., (2015) also showed no difference 
in p16 mRNA expression or in the number of SA β-gal positive cells in populations of 
human muscle precursor cells. Whereas, Sousa-Victor et al., (2014) showed an age-
related increase in SA β-gal positive cells, elevated p16 and p15, as well as, increased 
γH2aX expression. Conversely, Alsharidah et al., (2013) found no difference in γH2aX. The 
conflicting results between these studies could be due to the different age criteria used 
to define for the aged group. With the Sousa-Victor et al., (2014) study using significantly 
older donors suggesting that there was a potentially late life decline in these “geriatric” 
people that was not captured by the previous studies. This could also relate to the 
physiological function of the individuals as older individuals are more likely to be frail and 
senescence may be associated with frailty. 
The current literature on senescence in human skeletal muscle cell culture studies is 
conflicting. There are some methodological considerations that could account for these 
differences in observed results. Satellite cells are maintained in a state of quiescence for 
most of their life in vivo. One of the major problems with in vitro studies is that once 
extracted from a muscle biopsy, quiescent satellite cells become activated and do not 
naturally re-enter quiescence (Machado et al., 2017). The activated cells start to divide 
and differentiate, altering their transcriptome and phenotypic markers (Charville et al., 
2015). The expansion of the extracted cell populations will affect the detection of 
senescent cells because senescent cells, by definition, do not divide and cannot re-enter 
the cell cycle. Therefore, if senescent cells survive the extraction process they will not 
divide. The expansion of healthy proliferating cells will diminish the percentage of 
senescent cells within the population which could account for some of the discrepancies 
in the early passage marker expression due to different extraction methods and different 
time points used. Therefore, it is important to understand what the phenotype of 
senescent muscle origin cells are so that they can be identified before being overrun by 
expanding cells. 
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1.7. Replicative senescence – ageing in vitro 
The early passage comparison of young and old MPCs have shown that old satellite 
cells function can be restored by removing them from their old environment and replacing 
them in a youthful environment. This suggests that satellite cells from older individuals 
are at least mostly able to be rejuvenated. Understanding which factors are causing the 
impairment as well as which factors have restorative capabilities is a pertinent question. 
It has been established that extracted cells from old muscle are altered by the culture 
environment in which they are grown masking or altering their phenotype, although this 
is encouraging for improving the in vivo phenotype, it makes identifying and investigating 
causal factors difficult. Many different methods could therefore be employed to try to 
artificially identify these factors and what effects they have on satellite cell functioning. 
Indeed, many studies have investigated these with animal models, cell lines and primary 
cell cultures. However, there are key differences between human and mouse physiology 
down to the cellular level. Therefore, a human culture aged, senescent, cell population 
may be able to shed light onto specific factors which impact satellite cell functioning, as 
well as, provide a human model in which to test the effects of such factors. 
When culture MPC populations approach senescence their cell morphology starts to 
change, the cells become larger and flatter with a more pronounced intermediate 
filament network (Renault et al., 2000). This early study also suggested that the cells 
started to down regulate desmin expression (Renault et al., 2000). However, later studies 
using multiple markers show that there is often an increase in TE7 positive fibroblasts as 
desmin positive myoblasts decrease (Schäfer et al., 2006; Alsharidah et al., 2013). 
Analysis of the gene expression changes of senescent cells from one 5-day old, one  
52 year old and a 79-year-old has been investigated using cDNA arrays (Bortoli et al., 
2003). These were pilot data due to only three participants analysed across a wide age 
range and the new-born cells were considered early passage after 21 population 
doublings whereas the older participants were analysed after 1 population doubling. 
Additionally, comparing new-born to old adults is comparison of development to old 
adulthood rather than age related changes in adult myoblasts. From this analysis four 
potential markers of pre senescent myoblasts were identified: up regulation of allograft 
inflammatory factor 1 and actin alpha 1, as well as, down regulation of serine proteinase 
inhibitor and colon cancer antigen 7. There was also shown to be a shift in mitochondria 
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metabolism genes with senescence away from carbohydrate metabolism. The cells from 
the same 5-day old muscle sample where also analysed via proteomics and demonstrated 
targeted oxidative damage to proteins which were related to impairment in cellular 
energy metabolism (Baraibar et al., 2016). 
Studies with more participants in their comparison groups showed increased p16 
mRNA expression and shorter mean telomere length at replicative senescence (Barberi et 
al., 2013). Another study showed that expression of proliferation marker Ki67 was 
heterogeneous however the general trend across all populations was for a reduction in 
expression to zero as the population reached senescence and the number of cells positive 
for DNA damage increased from less than 10% during early passage to around 90% at 
senescence (Alsharidah et al., 2013). The main limitation of this study was that some 
myoblast populations did not maintain their initial high percentage of desmin+ve cells and 
therefore could not be analysed as senescent myogenic populations. It is unclear why 
some highly myogenic populations lost desmin+ve cells whereas one cell populations 
started and reached replicative senescence with 50% desmin+ve cells. 
The ability of culture aged cells to differentiate and engraft has also been 
investigated. Late passage cells from a 5-day old new-born, approx. 10 population 
doubling before senescent, were less successful at grafting into immune compromised 
mouse muscle fibres than early passage cells from the same biopsy. Fewer cells were 
detected but also lower percentages of total cells incorporation into mosaic fibres at both 
4 and 8 weeks (Cooper et al., 2003). These results were also seen in cell culture models 
where senescent cells were less mobile and took longer to differentiate eventually 
forming thinner, smaller myotubes (Renault et al., 2000). Lorenzon et al., (2004) reported 
that culture aged myogenic cells from a 2-year-old donor differentiated similarly to freshly 
isolated cells from a 21 and 48-year-old in terms of fusion index and nuclei per myotube 
after 10 days. Array analysis of RNA expression of these myotubes showed upregulated 
pyruvate kinase and GLUT4 down regulation after differentiation of senescent cells in all 
three participants, one 5-day old, one 52-year-old and one 79-year-old (Bortoli et al., 
2005). 
Bigot et al., (2008) compared the ability of freshly isolated and senesced myoblasts 
to form myotubes. Early passage cells formed larger myotubes with 90% of nuclei being 
incorporated into myotubes containing more than 50 nuclei. Whereas, senescent cells 
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formed smaller myotubes with only 2% of nuclei being incorporated into myotubes 
containing more than 50 nuclei and 63% being incorporated into myotubes containing 
less 25 nuclei. These results were supported by lower and delayed expression of MyoD 
and myogenin RNA and proteins in the senescent population. This reduced fusion was 
also the case when senescent cells were plated at density double that of confluence 
suggesting an inherent defect in differentiation. However, this study only looked at one 
biopsy from a 5-year-old infant and a 17-year-old.   
Using only the cell populations which maintained high desmin expression though to 
replicative senescence (n=5), Alsharidah et al., (2013) showed that as the cells were aged 
in culture their ability to differentiate gradually declined. Myoblasts were induced to 
differentiate at early passage, after 16 days and 28 days in culture, then at replicative 
senescence. Incremental reductions in the expression of MyoD, myogenin and MHC were 
observed as the number of passages increased suggesting slower differentiation. The size 
of myotubes formed and percentage of nuclei incorporated into these myotubes, fusion 
index, were significantly reduced at senescence. This delay in differentiation could be due 
to the regulatory cytokine TGF-β which was shown to be more concentrated during the 
first 48 hours of differentiation in senescent compared to early passage myoblasts. TGF-β 
was confirmed as a transient inhibitor of differentiation with the addition of 300 pg ml-1 
to early passage myoblasts preventing the expression of Myogenin and MHC seen in 
differentiation. When the TGF-β concentration was reduced to 100 pg ml-1 Myogenin and 
MHC expression increased, and normal differentiation was restored. 
Overall, little is still known about the senescent phenotype of human myoblasts. It is 
known that their ability to differentiate is impaired, but the underlying mechanisms are 
not fully elucidated, although TGF-β is known to be involved. Senescent markers at 
replicative senescence are not well characterised and often only in very low numbers of 
participants. Such studies have also been hampered by difficulty maintaining high initial 
desmin expression in these primary cell populations as they become overrun with skeletal 
muscle origin fibroblasts. This highlights the importance of understanding the 
contributions of other cell types within skeletal muscle to the tissue’s senescent 
phenotype, as well as, determining if other senescence induction methods could be used 
to generate senescent populations of primary skeletal muscle cells. 
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1.7.1. Sorting cell types within skeletal muscle biopsy 
Biopsies of skeletal muscle contain many different cell types and therefore yield a 
mixed cell population of mononucleated cells including muscle precursor cells, fibroblasts, 
fat cells, blood cells and immune cells. All studies have been confounded by variability 
within the cell populations myogenic cell proportion and although pre-plating was 
employed to enrich myogenic cell percentages it was only in recently where studies 
regularly started using sorting techniques to further enrich myogenic populations (Barberi 
et al., 2013; Agley et al., 2015; Bigot et al., 2015). Therefore, relatively few studies have 
been performed on highly enriched cell populations. 
The nuclear location of Pax7 make it problematic as a sorting marker of human cells 
because it requires either genetic labelling of the protein or permeabilization, and 
therefore death, of the cell population. Any study requiring a viable population of human 
satellite cells cannot use Pax7 without genetical alteration to the cell and therefore 
another marker, preferably on the cell surface, must be used. Fluorescence Activated Cell 
Sorting (FACS) have been used to sort for myogenic cells by positively selecting for 
CD56+ve/CD29+ve cells (Xu et al., 2015c) or negatively selecting for CD34-ve/CD31-ve/CD45-ve 
cells (Charville et al., 2015). Both methods yielded cell populations with very high 
desmin+ve percentages. Whilst FACS is a very good sorting method, it requires a large 
number of cells for positive and negative controls, especially when using multiple 
markers. The process of forcing cells through high pressure flow is also a stressor for the 
cells which can reduce the viability of the cell population and affect the cells early 
behaviour in cell culture (Hines et al., 2014).  
Magnetic activated cell sorting (MACS) has been shown to be much gentler on the 
cells when compared to FACS as well as being a lot easier and quicker to perform in a 
laboratory setting (Sutermaster & Darling, 2019). A CD56+ve MACS sorting protocol has 
been developed which has been stringently tested to show that CD56+ve cell sorts produce 
a 98% desmin+ve population in human myogenic cells (Agley et al., 2013, 2015). They also 
show that these cells can differentiate into myotubes and are unable to undergo 
adipogenesis.  
Sorted cell populations allow better understanding of the expression of a single cell 
type that are not confounded by other cell types which may be on different senescent 
trajectories. The characterisation of senescent populations of skeletal muscle cells could 
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provide cell type specific markers of senescent cells which could be used for determining 
the senescent state of in vivo populations of cells. Due to the problems and current 
limitations associated with assessing senescence within populations of aged myoblasts in 
vitro other methods need to be utilised to determine the phenotype and tissue specific 
marks of cellular senescence within skeletal muscle cell populations. Studies have been 
mentioned previously that assessed the replicative capacity of human cells in culture as a 
method for determining if cells from aged people were closer to replicative senescence 
than younger donor cells. These studies involved passaging cell to replicative senescence. 
Investigating the phenotype of cells at replicative senescence could help to characterise 
and develop new markers and greater understanding of the characteristics of senescent 
skeletal muscle cell populations. 
1.8. Aims 
The Literature Review has set out to establish the current understanding of ageing 
and cellular senescence with regard to human skeletal muscle cells and identify gaps in 
our knowledge. Human primary cells are the chosen model for this thesis and these 
primary cells were extracted from skeletal muscle biopsies with the myogenic cells 
originating from satellite cells, which in this work will refer to cells in their anatomical 
niche location between and underneath the basal lamina (Mauro, 1961). These cells 
become activated almost instantaneously when the extraction process begins (Machado 
et al., 2017), and therefore the cells used in these experiments and in this thesis will be 
referred to either as muscle precursor cells (MPCs), which refers to the activated and 
partially differentiated cell progeny of satellite cells. The other main mononucleated cell 
type extracted are stromal fibroblasts which are also present in the skeletal muscle 
biopsy. The work in this thesis sets out to provide further insight into this area and had 
the following aims. 
1. To develop bespoke automated quantitative image analysis programs to analyse the 
different type of microscopy images collected throughout this thesis. 
2. To characterise and compare the replicative profiles of sorted CD56+ve (myogenic 
precursor cells) and CD56-ve (fibroblast) cell populations extracted from the same human 
muscle biopsies in terms of markers of senescence and their SASP expression. 
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3. To examine the effects of chemotherapeutic drug, Doxorubicin, at inducing premature 
stress-induced senescence in the two cell types. This again was characterised in terms of 
markers of senescence and their SASP expression. 
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2. Chapter 2: General methods 
This chapter outlines the participant classification and recruitment, the muscle 
biopsy procedure, as well as the previously established core techniques used recurrently 
across multiple studies in this thesis. These include the cellular extraction, magnetic 
activated cell sorting and general cell culture. Analysis techniques such as polymerase 
chain reaction, immunocytochemistry and microscopy. Methods which were required to 
be developed or enhanced are presented in a specific method development chapter, 
Chapter 3.  
2.1. Participants and ethical approval 
Prior ethical approval was obtained from the UK National Health Service Ethics 
Committee (London Research Ethics Committee) and in accordance with the Human 
Tissue Act and Declaration of Helsinki. Co-sponsorship for the project was awarded by 
King’s College London and Guy’s and St Thomas’ Foundation Trust.  
Young participants (18-35 years) were recruited using King’s College London internal 
research study circular email. Before visiting the laboratory, they had received a lay 
overview of the project and completed a pre-screen health questionnaire. On arrival 
participants were talked through the study by the principal investigator and any questions 
they had were answered before providing written consent to take part in the study and 
have the muscle biopsy. 
2.2. Muscle biopsy 
The muscle biopsy procedure occurred in the muscle biopsy suite situated in 
Shepherd house of King’s College London’s Guy’s campus. Muscle biopsy samples were 
always taken from the mid-belly of the vastus lateralis of the participant’s chosen leg. First 
a sterile field was created around the participant’s leg using sterile surgical drapes. The 
leg was then shaved, if required, around the site of the muscle biopsy. Chlorohexidine was 
used to clean the skin of the leg and allowed to dry. Local anaesthetic (2 % lidocaine) was 
injected into the skin and muscle belly and allowed to infiltrate the surrounding area for 
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10 minutes. Once the anaesthetic has numbed the area, a sterile scalpel blade was used 
to make a 1 cm proximal to distal incision in the skin for the Bergstrӧm needle to be 
inserted through. The needle, with additional suction provided by a sterile syringe and 
connective tubing (Bergstrӧm, 1962; Agley et al., 2013), was then inserted into the muscle 
through the incision site and muscle facia. The window in the needle was then opened 
and suction applied to draw the muscle tissue into the open window. The window was 
then closed making a cut through the muscle tissue. After rotating the needle through 90° 
the cutting was repeated followed by two more rotations and cuts before the needle was 
removed. The tissue was immediately transferred into a collection tube containing ice 
cooled basal skeletal muscle growth medium, which had previously been weighed. The 
tube was then weighed again, and tissue weight was determined by subtracting the 
weight of tube+media from the weight of tissue+tube+media. The typical muscle wet 
weight achieved from this laboratory using this technique is 100-200 mg. Ethical approval 
allows up to three separate needle entries into the muscle, however the laboratory has 
never needed more than a second pass to collect enough tissue (100-150 mg). Each biopsy 
sample was anonymised with a code e.g. Y01 which was used throughout all experiments 
undertaken with the cell populations extracted from that biopsy sample. Due to the 
labour-intensive protocol no more than two biopsies could be processed and analysed at 
one time. Therefore, all experiments for Y01 and Y02 were undertaken before biopsies 
Y03 and Y04 were taken which, in turn, were completed before biopsies Y05 and Y06 were 
taken. 
2.3. Cell extraction 
The biopsy samples were transferred into a sterile laminar flow hood, so cells could 
be extracted under sterile conditions using the published method developed previously 
(Agley et al., 2015). The muscle sample in solution was tipped into a sterile Petri dish and 
the basal media was replaced with digestion media (2-3 ml; 2 mg/ml collagenase D, Roche 
and 2 mg/ml Dispase II, Sigma). Collagenase D and Dispase II were chosen instead of 
Trypsin or pronase because they are less harsh digestion enzymes and are therefore more 
likely to preserve cellular functioning and surface marker expression. To negate any 
differences between enzyme batches new enzymes were ordered then aliquoted into 20x 
stocks in basal medium and frozen for long term storage at -20°C. 
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The tissue was then minced into ~1 mm3 pieces using two sterile surgical scalpels for 
up to 10 minutes. The minced tissue was then transferred to a sterile 15 ml falcon tube 
using a 25 ml stripette due to its large bore hole. The petri dish was washed with more 
digestion media (2-3 ml) 3 times to collect any remaining tissue. The 15 ml falcon tube 
containing tissue in digestion media (total 10 ml) was placed in a 37°C incubator for 1 hour 
with trituration, using a 10 ml stripette, every 15 minutes. Once digestion was complete 
the enzyme reactions was quenched by adding an equal volume of Skeletal Muscle 
Growth Medium (SKGM, Promocell, Table 2). The cells were reclaimed by centrifugation 
at 657 g for 6 minutes. No additional debris or cell type removal occurred as it was thought 
the extra steps could potentially negatively affect cell yield and functioning. The cells were 
re-suspended in SKGM and plated into a T25 cell culture flask for seven days. After 48 
hours the media was removed centrifuged at 657 g for 6 minutes and the cell pellet was 
re-suspended in fresh SKGM and replaced into the culture flask. A further media changed 
occurred 48 hours later however, the media was discarded without centrifugation. Any 
non-adherent cells at this time point are assumed to be dead cells or unwanted cell types 
such as, red blood cells. Seven days after isolation the cells were trypsinised and prepared 
for magnetic activated cell sorting (MACS). This cell extraction method yields 2.8 x 106 ± 
8.87 x 105 cells/g tissue after the 7 day expansion period in SKGM (Agley et al., 2015). This 
cell yield was sufficient for the experiments undertaken therefore, it was thought that 
higher enzyme concentrations were unnecessary and could potentially negatively impact 
cell viability. 
2.3.1. Magnetic Activated Cell Sorting  
After seven days of culture post biopsy, cells were trypsinised (0.04% Trypsin-EDTA 
in PBS) and pelleted. The centrifuged cell pellet was re-suspended in 170 µl sterile filtered 
MACS buffer (1% BSA, 0.05% EDTA, Miltenyi Biotec) and incubated with CD56 magnetic 
antibody (35 µl, Miltenyi Biotec) for 15 minutes, mixed halfway, in the dark at 4°C. The 
solution was then diluted with 10 ml MACS buffer, centrifuged (6 min, 657 g, RT) and re-
suspended in 1 ml MACS buffer. The MACS column was pre lubricated with 1 ml MACS 
buffer before the cell suspension was passed through the column followed by three 1 ml 
washes with MACS buffer. The negative fraction was collected in a tube containing 2 ml 
MACS buffer. Following the final wash, 2.5 ml was added to the column which was 
removed from the magnetic field and the plunger applied to dispense the positive cell 
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fraction into a different tube containing 2 ml MACS buffer. Both fractions were then 
centrifuged and re-suspended in 1 ml SKGM for haemocytometer counts and 
subsequently plated at required densities for experimentation. Throughout this thesis the 
CD56+ve fractions will be referred to with the biopsy sample code and (+), e.g. Y01+. The 
CD56-ve fractions will be referred to with the biopsy sample code and (-), e.g. Y01-. 
Table 2. Cell culture media composition 
Media Component Concentration Company 
Skeletal Muscle Cell Basal Medium - Promocell 
Fetal Calf Serum 5% Promocell 
Fetal Bovine serum 10% PAA Laboratories 
Fetuin (bovine) 50 μg / ml Promocell 
Epidermal Growth Factor 
(recombinant human) 
10 ng / ml Promocell 
Basic Fibroblast Growth Factor 
(recombinant human) 
1 ng / ml Promocell 
Insulin (recombinant human) 10 μg / ml Promocell 
Dexamethasone 0.4 μg / ml Promocell 
Penicillin 100 U/ml Sigma 
Streptomycin 100 µg/ml Sigma 
L- Glutamine 292 µg/ml Sigma 
2.4. Cell culture 
2.4.1. Passaging cell populations 
Skeletal muscle myoblasts start to differentiate and fuse to form myotubes when at 
high density, even if in a high serum medium. Therefore, passaging occurred before cells 
became 80% confluent, which translates to every 3-4 days. Human skeletal muscle 
myoblasts will eventually senesce in cell culture and therefore proliferation rate slows 
over their replicative lifespan which increases the amount of time taken to reach 80% 
confluence and hence increases the time between passages. For experiments which 
required a calculation of population doubling time passage time was kept constant at 
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every 3 days to standardize across all cell populations. Skeletal muscle fibroblasts were 
also passaged every 3-4 days. 
2.4.2. Trypsinisation 
The mononucleated cells extracted from a muscle biopsy are adherent to tissue 
culture plastics. To detach the cells for further applications the culture media was 
removed and retained in a 20 ml universal tube. The flask was then washed with PBS and 
incubated with trypsin (0.04% Trypsin-EDTA in sterile PBS) for 3 minutes at 37°C. Once all 
cells had detached the retained culture media was added to quench the trypsin digestion. 
The cell suspension was then centrifuged (6 min, 657 g, RT) to pellet the cells. The 
supernatant was removed leaving a cell pellet ready for resuspension for counting, sorting 
etc. 
2.4.3. Cell counting 
To obtain a viable cell count cells were first trypsinised, centrifuged and resuspended 
in 1 ml SKGM, as described previously. Depending on estimated cell number 10 μl of cell 
suspension was diluted in a different total volume of counting buffer. Counting buffer 
contained 10 μl of trypan blue with or without the addition of 30 μl or 80 μl PBS, thus 
giving a final dilution of cells:counting buffer at either 1:1, 1:4 or 1:9 respectively. The 
haemocytometer was then set up by breathing moist air onto the coverglass to aid 
attachment to the haemocytometer. 10 μl of diluted cells were then added to each 
chamber of the haemocytometer using capillary action to draw the solution under the 
coverglass. Viable cells, cells which exclude trypan blue, were then counted in the four 
outer quadrants of the haemocytometer for each chamber using a x10 magnification 
objective under a light microscope. The average number of viable counted cells of the two 
chambers was calculated, then divided by the number of chambers counted, 4, then 
multiplied by the dilution factor in counting buffer, i.e. 2, 5 or 10 depending on volume 
used, then multiplied by the dilution factor of the resuspended cell sample, i.e. 1 ml, 
finally multiplied by 10,000 which converts from the volume of the haemocytometer (0.1 
mm3) to 1 cm3, which is equivalent to 1 ml. 
Using the total number of cells in suspension the required volume needed to plate a 
certain number of cells for experiments can be calculated. The volume of cell suspension 
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divided by the total number of cells then multiplied by the required number of cells gives 
the volume of homogenous cell suspension containing that number of cells. The standard 
plating densities for human skeletal muscle myoblasts in this laboratory are 2,500 
cells/cm2 and 7,000 cells/cm2 for proliferation and differentiation respectively. However, 
plating densities differ depending on experiment and are stated for each individual 
experiment. 
2.4.4. Freezing cells 
Aliquots of cells (5x105-1x106) were frozen down across their replicative time course 
as backups if populations became contaminated or as cells populations for future 
experiments. The freezing medium was the same for both myoblast and fibroblast cell 
populations which was, skeletal muscle basal medium with high serum content (20% FBS 
and 1% PS). Each aliquot contained 900 μl of freezing medium and 100 μl DMSO, which 
was added just prior to freezing to prevent cell toxicity. Aliquots were frozen to -80°C 
slowly at roughly -1°C/minute in an isopropyl alcohol buffered Mr Frosty™. Once frozen 
samples were transferred to liquid nitrogen dewars for long term storage. 
2.5. Immunocytochemistry 
Cultured cells were either cytospun on to poly-L-lysine microscopy slides or grown 
on collagen coated coverslips for immunocytochemical analysis. For cytospun samples 
aliquots of cells were prepared at a density of 10,000-20,000 cells per 200 μl. Double 
funnel cytospin slide holders were assembled with poly-L-lysine microscopy slides and the 
200 μl of cell suspension was added to each funnel. The funnel cassettes were then spun 
at 600 rpm for 3 minutes at room temperature. The cytospin spots were then either frozen 
at -80°C or fixed (4% paraformaldehyde in PBS) for 10 min, washed and stored in PBS for 
no longer than 2 weeks. 
Coverslips were used for the myotube formation assay to visual the myotube 
structures formed. The 1.5 thickness glass coverslips were washed (1% acetic acid, 70% 
ethanol) for 4 hours with gentle rocking, then air dried overnight in a laminar flow hood 
with 15 min UV light exposure to sterilise the coverslips. Once dried, coverslips were 
placed in the bottom of 24 well plate wells and covered with collagen (0.5 mg/ μl in dH2O). 
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After 4 hours at room temperature, or overnight at 4°C, collagen solution was removed 
and stored for future use. Coverslips were then sterilised by exposure to UV light for 10 
before being washed with PBS (x3) and stored in PBS+NaN3 at 4°C until use. When 
coverslips were to be used the PBS+ NaN3 was removed and replaced with SKGM. These 
plates were then allowed to equilibrate in a 37°C incubator for 2 hours before cells were 
plated onto them. After the experiment had been completed cells attached to coverslips 
were fixed with 4% PFA for 10 minutes, washed with PBS (x3), then stored in PBS+NaN3 at 
4°C until use. 
Once ready to stain both fixed cytospin and coverslip mounted cells had their cell 
membranes permeabilised (0.1% triton X-100, 1% BSA in PBS) for ten minutes followed 
by the three PBS washes. Blocking solution (1% BSA in PBS+NaN3) was then applied for 
one hour at room temperature before the blocking solution was removed and the samples 
were incubated overnight in diluted primary antibody solutions at 4°C. Primary antibodies 
were diluted as per Table 3 in PBS+NaN3 (1% BSA). Samples were washed three times with 
blocking solution then incubated with diluted fluorescent secondary antibodies (1:1000) 
as per experimental requirements for 1 hour at room temperature protected from light. 
Samples were washed for a final 3 times with PBS+NaN3 before mounting. Cytospin 
samples were covered with 1.5 thickness glass coverslips using prolong gold antifade 
mounting medium. Glass coverslip mounted samples were removed from their wells using 
tweezers and a needle point. The coverslips were then mounted onto poly-L-lysine 
microscopy slides using prolong gold antifade mounting medium. If DAPI was not included 
in the fluorescent secondary antibody mix, prolong gold antifade mounting medium 
containing DAPI was used. 
2.5.1. Senescence associated β-Galactosidase assay 
The SA β-Gal staining kit from cell signalling technologies was used as per 
manufacturer’s instructions. The assay utilises the shift in enzyme kinetics that non-
senescent cells exhibit β-galactosidase activity optimally at pH 4.0 (Kuilman et al., 2010). 
The heightened activity of SA β-Gal in senescent cells can be measured at suboptimal pH 
6.0. At the end of the specific experiment the SKGM media was removed and cells were 
fixed for 10 minutes with 1X fixing solution diluted in PBS. They were then washed with 
PBS (x3) before being incubated with 1 ml of X-gal staining solution (50 μl X-gal (20mg/ml 
in DMF), 10 μl supplement A, 10 μl supplement B, 930 μl 1X staining buffer, pH 6) 
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overnight in a humidified 37°C chamber, without added CO2, in the dark. Cells were then 
washed twice with PBS followed by a 30 s wash in methanol before washing again with 
PBS and stored in PBS+NaN3 at 4°C until imaging. Prior to starting experiments, this SA β-
Gal method was adapted to work on cytospin samples so that all image analysis could be 
performed on cytospun cells. However, technical issues arose with this developed method 
which affected the first four biopsy samples collected: Y01, Y02, Y03 and Y04. The final 
two biopsies from the replicative experiments (Y05 and Y06), as well as the hip fracture 
study were assayed for SA β-Gal using the plated protocol described above. The technical 
issue was most likely caused by the very small volumes of staining solution used on 
cytospin samples (200 µl) and therefore any residual washing buffer could affect the very 
tight pH range required by the assay kit. 
 
Table 3. Immunofluorescence staining antibody dilutions. 




Company & code 
CD56 Mouse mc  
IgG1 
1:100 BD biosciences 
347740  




Desmin Mouse mc  
IgG1 
1:250 Dako  
M076001-2 
MyoD1 Mouse mc  
IgG1 
1:20 Novocastra  
NCL-MyoD1 
Myogenin Mouse mc  
IgG1 
1:50 DSHB D7F2 
Myosin Heavy 
Chain 1 
Mouse mc  
IgG2b 
1:200 DSHB MF20 
Anti-human 
fibroblast (TE-7) 
Mouse mc  
IgG1 
1:100 Millipore  
CBL271 
Ki67 Rabbit mc  
IgG1 













p16 Mouse mc  
IgG2b 
1:50 Abcam  
ab54210 
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2.5.2. Microscopy 
The SA β-Gal stained cells were imaged using an Olympus bright field microscope 
equipped with 4x, 10x and 20x air objectives and a colour camera. Cells were identified 
using the phase contract filter which was removed before image acquisition. Images were 
acquired using cellSens software to adjust exposure time and to set white balance. Images 
were analysed with a manual count of number of positive staining cells divided by total 
number of cells counted. 
All fluorescence microscopy took place on an Axiovert upright microscope (Zeiss, 
Germany) equipped with a 10x, 20x and 40x air objectives with a charge-coupled device 
(CCD) camera. Images were acquired using Axiovision software (version 4.3.2 Carl Zeiss 
Microimaging, Germany) on a PC. Fluorescence was detected from emission wavelength 
in the blue, green, red and far red spectral ranges as per the secondary antibodies. 
Bespoke image analysis programs were developed in FIJI and python to analyse the 
fluorescence images for each specific analysis. These programs, as well as a description of 
quantitative fluorescence microscopy are detailed in the image analysis method 
development chapter (Chapter 3). 
2.6. Q RT-PCR 
Prior to each step in the gene transcription analysis the RNA work only bench area 
and pipettes were cleaned was RNase away to reduce any chance of contamination with 
RNases which could degrade the RNA. The RNA was extracted from cells using Qiagen 
RNeasy Plus Mini Kits at room temperature. In preparation for RNA extraction cells were 
either trypsinised and washed twice with PBS or washed twice in their wells. The washed 
cells were then mixed or scraped off the wells with 350 μl of Qiagen lysis buffer RLT. Cells 
were further lysed through QIAshredder spin columns for 2 minutes at 16,000 g. At which 
point the cell lysates were frozen at -80°C so sample from the same experimental series 
could be processed together. Once defrosted an equal volume of ethanol (350 μl; 70% in 
RNAase free water) was added to the lysate. After mixing, 700 μl of the sample was 
transferred into an RNeasy spin column and centrifuged for 15 seconds at 12,000 g. The 
flow through was discarded and 700 μl of Buffer RW1 was added to the same RNeasy spin 
column, the column was again spun for 15 seconds at 12,000 g. The flow through was 
discarded and 500 μl of buffer RPE was added to the RNeasy spin column, the column was 
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again spun for 15 seconds at 12,000g. This step was repeated with the centrifugation 
extended to 2 minutes at 12,000 g to dry out the column. The RNeasy spin column was 
removed and placed into a fresh 1.5 ml Eppendorf (RNA and DNA free) before 30 μl of 
RNase-free water was added to the spin column and centrifuged for 1 min at 12,000 g to 
collect the RNA. Collected RNA was stored on ice and quality and quantity was assessed 
using a NanoDrop spectrophotometer (NanoDrop Technologies). Firstly, the Nanodrop 
was blanked using the same RNase-free water RNA was collected in to give the reference 
intensity to calculate absorbance. RNA concentration of each sample was then measured 
as well as 260/280 nm and 260/230 nm ratios to determine quality. After quantification, 
RNA samples were either stored at -80°C for future use or stored on ice if cDNA 
amplification occurred immediate.     
2.6.1. cDNA amplification 
For cDNA amplification 1 μg of total RNA was used and therefore the volume of each 
RNA sample needed to provide 1 μg of total RNA was calculated using the following 
equation: 
1000 ng / measured RNA conc. (ng/μl) = volume needed for 1 μg RNA 
A stock of the reverse transcription master mix was assembled from an Invitrogen 
reverse transcription kit (Table 4). The total volume of the reaction was 100 μl which was 
made up of the final master mix (61.5 μl), the variable volume of RNA solution and RNase 
free water as required. The reaction mixed was made on ice in PCR tubes with the addition 
of the RNA sample last. 
Table 4. Reverse transcription mastermix components for a single reaction 
Component Volume Final concentration 
10x RT Buffer 10 μl 1X 
25 mM MgCl2 22 μl 5.5 mM 
DNTPs mixture (2.5 mM) 20 μl 500 μM/DNTP 
Random Hexamers (50 um) 5 μl 2.5 μM 
RNase inhibitor (20 U/L) 2 μl 0.4 U/μl 
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Multiscribe reverse transcriptase (50 U/ul) 2.5 μl 1.25 U/μl 
Mastermix Total 61.5 μl 
 
 
The reaction mixture tubes were placed in a MyiQ™ single-colour real time PCR 
detection system (Bio-Rad) which was programmed with the following Reverse 
Transcription reaction protocol: 10 mins at 25°C, 30 mins at 48°C, 5 mins at 95°C then hold 
at 4°C to keep samples cold and prevent degradation until collection. Upon completion of 
reverse transcription, cDNA samples were transferred into RNase free 1.5 ml microfuge 
tubes and stored at -80°C for later polymerase chain reaction (PCR) analysis. 
cDNA samples, iQ SYBR green and forward and reverse primers were thawed on ice 
and protected from light. Once thawed, master mixes for each gene of interest were made 
up and stored on ice protected from light. The master mixes contained per well: 7 μl 
RNase and DNase-free ultra-pure H2O, 10 μl iQ SYBR green dye (Bio-rad), 1 μl forward 
primer, 1 μl reverse primer (list of primer sequences are shown in Table 5). Master mixes 
were made up in excess by three wells per plate to account for loss due to pipetting. 1 μl 
of sample cDNA was then added to the bottom of each corresponding well in a Bio-rad 
white plastic 96-well PCR plate on ice. Each sample was analysed in duplicate or triplicate. 
The required master mix was then added to each well containing cDNA before the plate 
was sealed with clear plastic film which prevented sample evaporation during the plate 
run. Plates were then loaded into a Bio-Rad CFX Connect real-time system with Bio-Rad 
CFX Manager 3.1 software. The sample layout of the plate was transferred into the 
software for automatic sample recognition in analysis. The qRT-PCR cycling protocol used 
was: 5 mins at 95°C to denature the cDNA; followed by 40 cycles of 15 sec denaturation 
at 95°C, 30 sec annealing at 60°C, 30 sec elongation at 72°C. After these cycles the plate 
was either cooled and stored at 4°C or went through a melt curve protocol to check PCR 
specificity of 81 cycles at 55-95°C for 30 sec. The Cq values were exported into Microsoft 
Excel where fold expression values were calculated using the 2-ΔΔCT method using 
GAPDH and β-actin as reference genes. 
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Table 5. Table of primers sequences 
Gene name Forward Primer Reverse Primer 
GAPDH GTCAAGGCTGAGAACGGGAA AAATGAGCCCCAGCCTTCTC 
β-actin GTGGCATCCACGAAACTACC GTACTTGCGCTCAGGAGGAG 
PAI-1 CATCCTGGAACTGCCCTACC AGGGAGAACTTGGGCAGAAC 
TGF-β CTCACCAACCAAAGCCCGAC TCCACATAGGGCTCAACACG 
IGFBP-3 GCGCCAGGAAATGCTAGTGAG CAACTTTGTAGCGCTGGCTG 
IL-8 AGAGCCAGGAAGAAACCACC GGCAAAACTGCACCTTCACAC 
p16 GGGTCGGGTAGAGGAGGTG GCCCATCATCATGACCTGGA 
CXCL-5 ACCACGCAAGGAGTTCATCC GTTCTTCAGGGAGGCTACCAC 
IGFBP-7 GGGTGCTGGTATCTCCTCTAAG TCTGGAGGTTTATAGCTCGGC 
MMP-3 TGGACAAAGGATACAACAGGGAC GGAACCGAGTCAGGTCTGTG 
β-Gal GGAACAGGCAGCAACATCAC TACAAGTTCACACTCGCCCC 
IL-6 ACCCCCAATAAATATAGGACTGGAG ACCAGGCAAGTCTCCTCATTG 
TNF-α CCCATGTTGTAGCAAACCCTC GTAGGCCCCAGTGAGTTCTG 
p21 GCAGACCAGCATGACAGATTTC GATGTAGAGCGGGCCTTTGA 
 
2.7.  Statistical analysis 
Statistical analysis and production of graphs were performed using Prism v8 (GraphPad 
Software), and included normality tests, t-tests and Analyses of Variance (ANOVAs). The 
distribution of data can be assessed using normality tests, such as, the Shapiro-Wilk test 
using the Royston method (Royal Statistical Society, 2019). Where fold change was 
analysed normality was assessed on the raw values. Parametric tests assume a normal, or 
Gaussian distribution, however ANOVA’s have been shown to be robust to normality 
violation (Maxwell & Delaney, 1990). When multiple t-tests were performed for gene 
expression data of the replicative fibroblast experiments the Bonferroni correction was 
applied to reduce the risk of type 1 errors. For the DOX induced senescence time course 
studies Dunnett’s post-Hoc test was used to determine significant changes relative to 
baseline expression (Dunnett, 1955). Where data were not normally distributed non-
parametric tests were applied. Statistical significance was set to p < 0.05. Data are 
presented as mean ± SD and as individual data points. The specific statistical tests 
performed are described with each figure. 
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3. Chapter 3: Development of 
automated image analysis protocols 
3.1. Introduction 
Determining RNA and protein expression by PCR and Western blot typically only 
explains the expression at the cell population level. For example, if there was an observed 
increased expression of cell cycle inhibitor p16 via PCR and Western blot it could suggest 
that the cell population overall had entered a state of cellular senescence. However, for 
instance elevated p16 expression could be driven by a sub-population of cells. Being able 
to determine marker expression change within each cell of a population would provide 
more granularity about the state of individual cells within cell populations. 
Microscopy can be used to visualise populations of cells or the subcellular location of 
target molecules, e.g. transcription regulators in the nucleus or proteins translocated to 
membranes (Bolte & Cordelieres, 2006). The use of fluorophores, either bound directly to 
the primary antibody or conjugated to antibodies specific to the host species of the 
primary antibody, has improved the signal to noise ratio of traditional brightfield 
microscopy and allow for abundance, as well as, spatial measurements to be made about 
that molecule (Waters, 2009). However, the resulting digital image is a representation of 
an optical image of the distribution of the fluorophores (Jost & Waters, 2019). Therefore, 
to measure abundance, microscopy images must be acquired under certain conditions, 
discussed in the method section, because it is vital that fluctuations in pixel intensity 
should reflect changes in antibody abundance, not changes that originate from 
methodological variability (Agley et al., 2012).  
A common practice is the subjective determining of positive and negative cells within 
images to give a binary count. Which, although time consuming, can be highly accurate 
for binary analysis, such as determining the cell types within a cell population. However, 
if the marker expression is not binary but can affect cellular functioning depending on its 
expression level, the analysis relies on subjective classification of expression level in 
determining if a cell is positive for that marker. This can lead to inter- and intra-individual 
variation in classification. Throughout this thesis the senescent markers p16, γH2aX and 
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proliferation marker Ki67 are being analysed by fluorescent microscopy, all of which have 
variable expression levels. Using the earlier example of p16 expression in a cell 
population, with quantitative imaging, the increase in p16 expression could be described 
at the individual cell level. Therefore, quantitative imaging would provide valuable insight 
into the expression of these markers and whether the whole cell population was showing 
signs of becoming senescent. 
To quantitatively analyse images requires the use of software to extract the relevant 
pixel data from the images. There are many image analysis software programmes 
available both commercially and open source. A manual image analysis method using 
Adobe photoshop has previously been published from this laboratory (Agley et al., 2012). 
This method required the user to manual click through steps with subjective selection of 
segmentation thresholds. Although, this image analysis pipeline is effective and 
reproduceable, Adobe Photoshop requires a licence and analysing multiple images takes 
a long time and focused concentration. 
The open source software FIJI, which is the upgrade of ImageJ, is the most popular 
and best supported image analysis software (Arena et al., 2017). FIJI has an underlying 
scripting language called IJ1 Macro language which is a high-level computer programming 
language built on Java script. To make it easier for novice programmers to build image 
analysis programs, called Macros, FIJI has some useful templates and functionality that 
make the automation of workflows much easier. FIJI also has many plugin programs 
developed by the user community for a wide range of analysis problems, 
http://imagej.net/Update_Sites. For example, auto threshold algorithms can binarise grey 
scale images using global histogram-derived thresholding methods. These binary images 
can then be fed into other plugins that can count or take measures of regions of interest 
(ROI) found within these images. Although each individual plugin is a powerful tool it is 
the combination of these plugins that can lead to very complex and biologically useful 
analyses. The combination of auto threshold and ROI detection is frequently used to count 
cells or take measures specifically from ROI measurements intensity of fluorescence. 
These plugins along with others could be used to analyse the images generated from the 
analyses in this thesis. The automation of these image analysis pipelines would also save 
a significant amount of time. 
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3.1.1. Aims 
The aim of this chapter was to develop automated image analysis workflows in FIJI 
image analysis software for the imaging data acquired in the main thesis chapters.  
Programs will be made specifically to determine:  
1. Percentage of cell populations expressing desmin or TE7 
2. Senescent marker fluorescence intensity within all nuclei, or only within nuclei 
of a specific cell type 
3. The number of nuclei incorporated into myotubes 
3.2. Method pipeline for quantitative imaging 
To quantitate from fluorescent images there are some key methodological 
considerations that must be observed in order to minimise errors within the results. The 
methodology for quantitative imaging is the standard protocol for immunocytochemical 
imaging but requires several specific conditions within the protocol. The general 
immunocytochemical methods employed through this thesis are detailed in the general 
methods chapter (section 2.5). Below are the key steps in the image analysis pipeline that 
must be incorporated for images to be used for quantitative analysis and not only as 
representative images. 
3.2.1. Sample preparation 
Prior to quantitative imaging, all samples that are to be directly compared must be 
prepared in the same way. The staining protocol (General methods section 2.5) needs to 
be performed at the same time with the same reagents and incubation times. This is 
because it is vital that fluctuations in pixel intensity should reflect changes in antibody 
abundance, not changes that originate from methodological variability (Waters, 2009). 
One source of variability is that primary antibodies can bind to multiple epitopes of the 
target molecule. Changes in antibody concentration and incubation conditions such as 
temperature or length of incubation may incorporate unintentional variability into 
antibody binding. These factors can vary between different antibody batches therefore 
when antibodies needed replacing the same batch was ordered wherever possible. If the 
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same batch was unavailable the new batch was tested alongside the old batch to see if 
they were comparable. However, as all samples to be directly compared where analysed 
in a single experimental run batch to batch variability was accounted for.  
Background fluorescence should be minimised as much as possible however, 
background fluorescence is present in all samples to some extent and is unavoidable 
(Allen et al., 2013). For example, both the fixative and the permeabilization solution 
contain Aldehyde groups which can auto-fluoresce, so unbound groups need to be 
removed (García-Plazaola et al., 2015). A minimum of three washes with PBS were 
performed after each step to minimise possible autofluorescence from the solutions. All 
samples were blocked with 1% BSA for one hour prior to primary antibody incubation. 
The incubation with a blocking buffer binds all endogenous floating antibodies and helps 
both primary and secondary antibodies bind more specifically reducing nonspecific 
binding and background fluorescence. Between primary and secondary antibodies 
samples were washed with 1% BSA rather than PBS to maintain blocking solution. Sample 
preparation is therefore a critical step for reducing error in quantification, all samples that 
were to be directly compared, i.e. all samples across a time series, were stained at the 
same time under the same conditions. Once samples were prepared, they were stored in 
the dark to protect them from photobleaching before they were imaged.  
3.2.2. Microscope set up and image acquisition 
All fluorescence imaging took place in a temperature controlled dark room with no 
external light source to reduced light from other sources. Additionally, a black reference 
image, the image captured after blocking the light path to the camera, was performed to 
establish the dark noise level within the camera system. The black reference image was 
then used to apply a correction to all subsequent images acquired within that microscopy 
session. 
Once excited by a narrow band of light wavelengths the fluorochromes release 
photons which are detected by a cooled charged coupled device (CCD) camera at many 
individual point locations (pixels; Waters, 2009). The number of photons detected at each 
individual pixel within the specified exposure time is translated into a grey scale value 
dependent on the bit depth of the camera. Usually 256 (8bit) or 4096 (12bit) different 
grey values. Thus, bright pixels will have detected more photons which is translated into 
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a higher grey value. If the maximum detection limit is reached (pixel saturation) then no 
differences in intensity can be measured between saturated pixels. It is therefore 
imperative for quantitative imaging that all pixel intensities fall within the detection limit 
of the camera. It is also best practise to utilise over 50% of the dynamic range (4096 greys) 
to provide a degree of tolerance to increases and decreases of intensity between different 
time points and reduce the impact of background fluorescence in the image (Jost & 
Waters, 2019). Saturated pixels were prevented by setting exposure times using the 
sample with highest expression and monitoring the ‘overexposure’ feature in AxioVision 
software.  
Each pixel captures the local intensity of the fluorophore at the specific site within 
the sample that the pixel relates to. Using the individual pixel locations and intensity 
values a grey scale image of the intensity distribution of the fluorophore across the sample 
is made. Combining fluorophores of different excitation wavelengths allows for multiple 
target molecules to be visualised in the same sample revealing more about the 
localisation of molecules relative to each other within the sample.  
The light source can introduce noise to the pixel intensity values by fluctuations in 
the light intensity emitted, this is minimised by using a LED or Laser light source rather 
than a mercury lamp which is prone to fluctuations in intensity as well as a slow decay in 
emission over time (Bolte & Cordelieres, 2006). The light source used through this thesis 
was a white light LED (Excelitas technologies, X-cite 120 LED Boost). White light contains 
all wavelengths of light which would excite all fluorochromes at once preventing any 
distinguishing between the fluorochromes used. Although each fluorochrome is excited 
by a specific spectral range of light wavelengths, there is overlap between these spectral 
ranges which can results in “bleed-through” of signal into another detection channel 
(Figure 3.1). This bleed through, or nonspecific excitation, can be reduced by using a light 
source with a specific tight wavelength range or using sets of band pass filters which only 
allow a narrow range of wavelength through from a white light source (Pawley, 2006). 
The filter set used to capture all images in this thesis were: 45 HQ Texas red shift free, 44 
FITC special shift free, 49 DAPI shift free band pass filters (Carl Zeiss, Cambridge, UK). 
Bleed through can also be minimised by imaging in order of longest wavelength to 
shortest because there is the most bleed through from the DAPI antibody therefore 
exciting this fluorochrome last minimises the bleed through. 
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Figure 3.1. Fluorescent spectral emission for fluorescent antibodies used. 
Emission spectra for the four fluorophores used throughout this thesis. Data obtained from: 
https://www.thermofisher.com/order/spectra-viewer (Accessed Jan 2020). 
To accurately compare fluorescence images, they must have been imaged in the 
same microscopy session using the same microscope parameters, light intensities and 
exposure times (Waters & Wittmann, 2014). Although all these parameters can be 
recorded and set up again on a different day there is variability in light source power and 
microscope maintenance etc. that can potentially alter the output from identical settings. 
Imaging all samples for direct comparison in the same session minimizes the impact of all 
these variables (Jost & Waters, 2019). Due to the large number of time points and samples 
taken in this thesis, only two samples time courses could be feasibly imaged in a single 
microscopy session. Therefore, when all samples are compared the data is presented 
relative to a reference time point in each individual time course therefore the difference 
in microscopy setting are eliminated.  
Each individual camera has a different density of pixels and total field of view size 
limiting raw measurements to be made in terms of pixels. For measurements to be made 
in microns the calibration of the camera, using a graticule of known length, must be 
performed to determine the number of pixels per micrometre. Once the image had been 
taken the scale bar was applied in the software so that the scale calibration is stored in 
the image file’s metadata. Then finally, to protect the raw image data and metadata all 
image files were stored in the raw Zeiss file format, .zvi. This prevents any loss of data 
through file compression and maintains the file meta data such as microscope information 
and scale calibration. Once images were saved and transferred to the analysis computer, 
they could be stored indefinitely for image analysis. 
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3.2.3. Image analysis 
Each type of analysis followed the same four steps pre-processing, image analysis 
using an automated program, post-processing and then data analysis. Different image 
analysis programs were built to extract the required data from the raw image files. For a 
specific analysis all images were processed in the same way using the same macro.  
3.2.3.1. Pre processing 
Before running images through an image analysis program, the data were pre-
processed to remove any raw images that were identified as invalid during the microscopy 
session such as external light present, overlapping FOV and non-biological debris during 
acquisition. All images that did not clearly violate these conditions were analysed to 
prevent bringing subjective bias into the image selection. All images to be analysed where 
then transferred into a folder named “input” so that they could be analysed as a batch. 
3.2.3.2. Image analysis programs 
The macros applied to the images depended on what analysis of the data being 
obtained from that image is required. The specific macros are detailed later however 
generally each macro can be separated into two sections, segmentation and 
measurement. Segmentation involves selecting the regions of interest (ROI) within each 
image from which the measurements should be made (Arena et al., 2017). E.g. selecting 
only the nuclei so that marker expression can be determined within each individual 
nucleus or selecting only desmin positive cells. Once the image is segmented into the ROI 
then the measurements such as cell counts or pixel intensities can be made on the image. 
The measurements were exported as a single .csv file per run. Each ROI could be identified 
by its label identifying which image it came from and which ROI within that image it 
related to. 
3.2.3.3. Post processing 
Although automatic threshold in a superior unbiased method for ROI selection it does 
not understand the biology underpinning the image. To check that the thresholds had 
selected accurately the required ROI quality control images were built into each program. 
Images of the final ROI selection over the nuclei channel and over the marker of interest 
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channel were saved into the output folder as .jpeg files. These images could be scanned 
quickly to determine if any images did not accurately threshold the nuclei. Images which 
did not threshold due to e.g. excessive background in the nuclei channel where excluded 
from analysis by removing the ROI associated with that image. However, if nuclei masks 
were accurate all images were used. 
3.2.4. Data analysis 
3.2.4.1. Determining cell type percentages and myotube fusion index 
To determine the percentage of desmin positive cells within a cell population the ROI 
counts from both the total nuclei image and then the desmin positive image were 
recorded in the .csv file. In Microsoft Excel the number of nuclei within desmin positive 
cytoplasm was divided into the total nuclei count and multiplied by 100 to give the 
percentage of cells that were desmin positive. This analysis was the same for TE7 positive 
cells. The same format and analysis method were used for myotube fusion index. The 
number of myonuclei was divided into the total number of nuclei and multiplied by 100 
to give the percentage of nuclei within myotubes.  
3.2.4.2. Marker intensity 
The raw data recorded from the marker expression analysis created a table with 
every row representing an individual ROI with all associated measurements in headed 
columns in the same row. This data needed to be reconfigured to separate the 
measurements into individual tables and group the ROI from each time point into 
separate columns. To do this the .csv file was moved into a folder containing a python 
script which reorganised the data to collate the same measurement on one excel sheet 
e.g. all individual mean fluorescent intensity measurements were separated onto an 
individual sheet. Then within this sheet the program separated the nuclei data into the 
different time points by searching the file makes for time point information. This uses the 
spaces between sections of the file name e.g. Y05+ DOX D4 Des+p16, this file name has 4 
sections separated by spaces. The time point information is in the third section, i.e. D4, 
therefore the program groups all nuclei with the exact same third section information the 
column header of the time point name. Separating each timepoint into a new column. 
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Once reordered the program saved the whole workbook as a .xlsx file. This new format 
allows simple copy and paste into Graphpad prism software for cell by cell marker 
expression graphing and statistical analysis. 
3.3. Automated image analysis macros 
All image analysis programs were created using FIJI ImageJ software. FIJI was chosen 
because it is opensource, has a wide range of plugins and has a very active online forum 
support community (Schindelin et al., 2015). FIJI also has easy to use templates and tools 
to help the novice programmer to write image analysis programs, called macros in FIJI.  
The FIJI scripting template “Process Folder” was used to create all macros (Figure 
3.2). This template is a generic folder and file scanning tool that searches for image files 
of a user defined image type e.g. .tif, .zvi, .png, etc. within the files of the specified folder. 
Once the program finds an image of specified type it sequentially opens the file, performs 
the defined functions then subsequently writes the recorded outputs to a predetermined 
output file before searching for the next image file. All images used in this thesis were 
kept in their raw file format .zvi, therefore the file suffix was always set to .zvi (Figure 3.3).  
The template for Process Folder was adapted so that all results from the processed file 
were added into a cumulative results table after all analysis steps had been completed. 
Additional lines were added to clear and close all open windows and print the message 
“Job done!” once the program had found and processed all files in the folder. 
Within the process folder macro is the processFile function. This function is where 
the same analysis steps are applied to each image that met the process folder criteria. 
The exact content of the processFile function is dependent on the analysis required from 
the images which are outlined for each analysis pipeline in the following sections. 
Therefore, the first step to develop a macro is to plan the sequence of analysis steps to 
perform within the pipeline. These steps then needed to be coded into the processFile 
function. To help the novice programmer with coding the steps for each analysis program 
FIJI has a built-in command recorder found in Plugins>Macros>Record. This Recorder 
function records in sequence all computer mouse clicks within the FIJI user interface. 
Therefore, once the steps have been determined to complete the require analysis the 
user simply opens the recorder then manually clicks through the steps on a sample image. 
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Every click is recorded in the recorder as the underlying code which can be exported into 
the process folder script as steps under the processFile function. 
Once the code has been copied it then needs to be edited to change options and to 
allow the program to run smoothly for images with different file names. The iterative 
debugging of the code with test images allows for testing how the program responds if 
certain constraints aren’t met, e.g. if no ROI are found within an image. Once these 
debugging steps were performed the programs were tested with different full data sets 
to determine its efficacy with images taken during different imaging sessions. Once it was 
shown that the program is robust all images were run through the program and the data 
exported in .csv files for post processing and subsequent data analysis.  
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Figure 3.2. Process Folder template script in FIJI. 
Screenshot of the Process Folder template available in FIJI, written in IJ1 Macro language. The 
macro asks for the user for input and output directories as well as file suffix then searches through 
the input directory for all files that end in file suffix. Then, in turn, applies the processFile function 
to each image file with the correct file suffix.  
 
 
Figure 3.3. Dialog window prompt for Process Folder template. 
Screenshot of the dialog box opened when process folder is run. User selects the input directory 
as the folder containing the images to be analysed and the output directory where the any outputs 
from the program are saved. The file suffix related to the image file types the program should 
search for in the input folder to process. File suffix was always .zvi as all images were saved in Zeiss 
raw file format. 
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3.3.1. Cell type population percentage Macro 
Previous studies have shown that the percentage of desmin positive cells can 
decrease over time in culture with an increase in TE7 positive fibroblasts overgrowing the 
myogenic cells (Alsharidah et al., 2013). Therefore, every sample needed to be analysed 
for desmin expression across their lifespan. An automated image analysis program was 
built to determine the percentage of desmin positive cells within each cell populations. 
This program was also used to determine the percentage of TE7 positive cells within the 
fibroblast populations using the same logic.  
The logic behind the program was to first detect all nuclei within the field of view and 
count them, then to remove all nuclei that were not within desmin stained areas, and 
then finally to count the remaining nuclei. Counts of the total number of nuclei detected 
then the number of nuclei after removing non covered nuclei allows for the determination 
of the desmin+ve cell percentage of these cell populations. 
The first step was to create a table for the results to be stored. This table was created 
at the beginning of the processFolder function before it cycled through the input folder 
looking for image files so that the results from each image file could be saved into the 
same table. The for each image processFile created a new line in the table with the image 
filename as the label. All measurements were reset between each image imported and 
scaled to the known calibration for the microscope objective used so that these were 
constant for all images. The image was split into the individual red, green and blue 
channels ready for segmentation of the desmin cytoplasm and the nuclei.  
The selection of nuclei needed to be representative of the actual size of the nuclei as 
these boundaries would define the area of the nuclei. Firstly, a duplicate image was 
created so that an image can be saved of the final nuclear selection over the original image 
to check for accurate nuclei selection in post processing (section 3.2.3.3). To reduced 
background fluorescence signal rolling ball background subtraction, size 50 pixels, was 
applied as nuclei are very bright so the rolling ball can distinguish well between nuclei and 
background fluorescence. The Huang dark auto threshold was applied because it is very 
good at identifying circular objects like nuclei (Huang, 1995). The post-threshold image 
may have left some holes within nuclei so they were filled using “fill holes” and then the 
“watershed” algorithm was also applied to split overlapping nuclei (Figure 3.4B). These 
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steps are critical because analysis of expression needs to be within whole individual 
nuclei. 
The total number of nuclei within the nuclei mask image was determined using 
“analyse particles” to count how many objects were detected in the image. Here it is 
important to have scaled the image so that when analyse particles is run any particles 
which are obviously not nuclei can be removed by setting size exclusion criteria. Nuclear 
size and shape are relatively standard however there is variability, especially when 
culturing to replicative senescence. This step it only to remove particles which are 
obviously too small or too large to be nuclei. After analysing particles, the FIJI ROI manager 
contains details of each ROI, i.e. each nucleus, found within that image. Counting the 
number of ROI in the manager therefore gives a count of the number of nuclei within that 
image. This ROI count is stored in a column called “TotalCount” in the results table created 
at the beginning of the program. 
The next step was to remove nuclei which were not within desmin positive cytoplasm 
from the all nuclei mask. To remove the nuclei which were not associated with desmin 
staining a cytoplasmic selection was created by applying a threshold to the desmin 
channel that was sufficient to select all desmin positive cells by overlapping with the 
nuclei of all desmin positive cells. The Otsu threshold (Otsu, 1979) followed by “Fill Holes” 
was used to create this desmin cytoplasm mask. The resulting binary image can be seen 
in Figure 3.4C and overlayed onto the nuclei channel in Figure 3.4D. 
To remove the nuclei which were not covered the desmin cytoplasm maker a FIJI 
plugin called BinaryReconstruct_.class, developed by G. Landini was used (the plugin is 
available from: Landini G. Advanced shape analysis with ImageJ. Proceedings of the 
Second ImageJ User and Developer Conference, Luxembourg, 6-7 November, 2008. p116-
121. http://www.mecourse.com/landinig/software/software.htm Accessed last on: 
02/07/2019). This is a very powerful morphological operation that reconstructs (retains) 
8-connected particles in an image (called mask) based on markers present in another 
image (called seed). Morphological Reconstruction consists of dilating the seeds inside 
the mask (so particles that do not have seeds are not reconstructed). In biological terms, 
all nuclei in the mask image which are within the cytoplasm threshold image (seed image) 
are retained. All nuclei outside of the cytoplasmic areas, e.g. other cell types, are removed 
for the nuclei mask.  
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The resulting reconstructed image is a binary image of only nuclei of a specific cell 
type (Figure 3.4E). This image is rescaled as it is in pixels rather than converted to 
micrometres using the same calibration as from the original image so that the same size 
exclusion criteria can be applied. Analyse particles and ROI manager count are then run 
to count the number of nuclei within this image to give the number of desmin positive 
cells. This result is again saved into the results table but in the column called 
“DesminCount”. 
This process is completed on all .zvi files found in the input folder and a new row is 
added to the results table for each image. Once all images have been processed the 
program saves the results table as a .csv file and is exported to the select output folder 
for post processing and data analysis as described in sections 3.2.3.3 and 3.2.4.  
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Figure 3.4 The main steps in a macro to determine the percentage of desmin+ve cells from 
microscopy images. 
This macro was developed to determine the number of desmin positive cells within a microscopy 
image. A) shows the example original three colour microscopy image. B) The resulting mask of all 
nuclei after automated thresholding on the DAPI channel. C) shows the desmin cytoplasm mask 
created after automated thresholding of the desmin channel D) shows the outline of the desmin 
mask overlayed on the same all nuclei mask created previously, where it is evident that not all 
nuclei are within desmin staining regions. E) shows the resulting nuclei mask when those nuclei 
that do not have desmin staining are removed. Automated counts of the total and desmin 
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associated nuclei masks allows for determining the percentage of desmin positive cells from the 
image. 
3.3.2. Nucleic marker expression Marco 
The expression of proteins in not always binary, the concentration of the protein can 
affect the functioning of the protein. It is therefore hard to determine a threshold of 
expression to determine when a cell is positive for that marker. Subjective counting 
results in arbitrary thresholding as positive or negative. This type of analysis removes the 
large area of grey visible within the image. Non bias cell by cell analysis can show the true 
variability within a cell population for the expression of that marker.  
The expression of p16, Ki67 and γH2aX are all within the nucleus and the expression 
of these markers can be determined by measuring fluorescence within each cell nuclei. 
However, human primary muscle cell cultures are not always pure populations, so it is 
important to be able to observe the marker expression within only the cell type of interest 
in impure cell populations. Therefore, the cytoplasmic selection described in the cell type 
population percentage macro (section 3.3.1) was used here to remove nuclei that were 
not of a specific cell type when required. 
This program was built to determine the expression of a marker within all nuclei or 
only within nuclei of cells that express a cytoplasmic marker such as desmin or TE7. The 
logic behind this program was to first detect all nuclei within the field of view, then, if 
required, to remove all nuclei that were not within desmin stained areas, and then finally 
to use the nuclei ROI to measure fluorescence intensity within each ROI from the raw 
image of the marker of interest channel. The example provided here and in Figure 3.5 & 
Figure 3.6 are for a program that make nucleus selection in the blue channel, cytoplasmic 
selection is the green channel and analyse nuclear marker of interest in the red channel. 
However, a version of this program was also created to make the cytoplasmic selection is 
the red channel and analyse nuclear marker of interest in the green channel. 
For this program no specific results table needed to be created as the built-in results 
table was able to handle the data created. The first step was therefore to reset all 
measurements and scale the image so that these were constant for all images. The image 
was then split into the individual red, green and blue channels ready for segmentation of 
the desmin cytoplasm and the nuclei. 
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The creation of the nuclei ROI is the same as described in the cell type population 
percentage macro (section 3.3.1 & Figure 3.5B). If marker expression was going to be 
measured in all nuclei then ROI selection was carried out here using the same size 
exclusion, as previously described (section 3.3.1), with the addition of exclude of edges. 
Nuclei on the edges where excluded so that only whole nuclei were analysed. All particles 
which met these criteria were added to the ROI manager. The raw image for the marker 
of interest, red channel, was selected and “From ROI Manager” was run. This command 
applies all regions of interest saved in the ROI manager to the selected image (Figure 
3.5C). Therefore, the predetermined nuclei locations were superimposed on the marker 
expression channel. The command ROIManager(“Measure”) then completed all 
measurements outlined in the set measurements command at the beginning of the 
programme, including; mean fluorescent intensity, area of ROI, etc. the results of these 
measurements were saved into the results table labelled with the source image name and 
which ROI those measurements related to. If marker expression was only to be carried 
out on nuclei of a specific cell type, then additional steps were required to remove the 
nuclei of other cell types before applying the nuclei mask to the marker of interest channel 
(Figure 3.6). The cytoplasmic selection described in the cell type population percentage 
macro section 3.3.1 was used to remove the other cell types. As can be seen from the 
example image in Figure 3.6G the marker expression is visible higher in the nuclei which 
were lost from the total nuclei image in Figure 3.5C. 
Following the measurements within each image, the ROI manager was reset so that 
all ROI from the image were deleted before a new image was opened so only ROI found 
within that image were analysed. Once the programme had read through every image in 
the folder it saved the results table, compiled of all nuclei measurements from all images, 
to a .csv file into the designated output folder. This .csv file was then ready for post 
processing and data analysis as outlined in sections 3.2.3.3 and 3.2.4. 
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Figure 3.5 The main steps in a macro to determine marker expression within all individual nuclei 
from a microscopy image.  
This macro was developed to measure the fluorescent intensity of a marker of interest within the 
nuclei of all cells within an image. A) the original three colour microscopy image B) The resulting 
mask of all nuclei after automated thresholding on the DAPI channel. C) After running ROI selection 
on the all nuclei mask the ROI are applied over the marker of interest channel and marker 
expression is measured within each ROI. This macro was used throughout this thesis to determine 
expression of p16, Ki67 and γH2aX within pure populations of cells. Figure 3.6 describes additional 
steps to only measure expression in nuclei of a specific cell type. 
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Figure 3.6 Additional steps to only measure marker expression within nuclei with desmin positive 
cytoplasm. 
The steps described in Figure 3.5 are sufficient if the cell population is highly pure however the 
image used shows a mixed cell population. D) shows the desmin cytoplasm mask created after 
automated thresholding of the desmin channel E) shows the outline of the desmin mask overlayed 
on the same all nuclei mask created previously, where it is evident that not all nuclei are within 
desmin staining regions. F) shows the resulting nuclei mask when those nuclei that are not within 
desmin stained areas are removed. G) shows that when the ROI are measured in this image the 
nuclei which were highly expressing the marker were removed suggesting the highly expressing 
cells were not desmin positive.  
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3.3.3. Myotube nuclei fusion index Macro 
Muscle fibres contain many terminally differentiated myonuclei. This differentiation 
process can be performed in cell culture with myoblasts differentiating and fusing 
together to form myotubes, precursors to muscle fibres. The ability of myoblasts to fuse 
and form myotubes can be measured by observing how many nuclei fuse into myosin 
heavy chain positive myotubes. Myotube size and number of myonuclei per myotube are 
also used as measured of differentiation (Yamamoto et al., 2008). However, because 
myotubes often span more than a single FOV this is hard to perform accurately without 
imaging the entire cell population (Agley et al., 2012). The number of nuclei within a field 
of view that are fused or are still individual nuclei is a simple measure that gives a strong 
reflection of differentiation capacity. Therefore, this program was created to determine 
the fusion index, the percentage of nuclei within a FOV, that are present in myosin heavy 
chain positive myotubes. 
The logic behind this program was to first detect all nuclei within the field of view 
and count them, then to remove all nuclei that were not within Myosin heavy chain 
positive staining areas, and then finally to count the remaining nuclei. Counts of the total 
number of nuclei detected then the number of nuclei after removing non covered nuclei 
allows for the determination of fusion index of these cell populations. 
A similar table to that described in the cell type population percentage macro was 
created in the processFolder function to store the total and fused nuclei counts from each 
image. The creation of the nuclei ROI is the same as described in the cell type population 
percentage macro (section 3.3.1 &Figure 3.7B), as is the selection of cytoplasmic myosin 
heavy chain positive myotubes area (section 3.3.1 &Figure 3.7C). Binary reconstruct was 
again used to remove nuclei not within the myosin heavy chain staining (section 3.3.1 
&Figure 3.7D&E). The resulting .csv file contained the ROI manager count for total number 
of nuclei and number of fused nuclei. This .csv file was then ready for post processing and 
data analysis as outlined in sections 3.2.3.3 and 3.2.4. 
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Figure 3.7 Myotube formation assay macro main steps 
This macro was developed to determine the number of nuclei fused into myosin heavy chain 
positive myotubes within a microscopy image. A) the original three colour microscopy image B) 
The automated threshold of all nuclei within the field of view. C) The automated threshold of 
myotubes using myosin heavy chain D) Representation of the outlines from the myotube mask 
overlayed on the total nuclei mask. E) The nuclei mask after binary reconstruct removes nuclei that 
are not fused.   
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3.4. Discussion 
This chapter describes the successful building of automated image analysis programs 
for multiple different analyses. Automation of image analysis improves analysis speed and 
data gathering as well as reduces the influence of subjective bias compared to manual 
processing of images (Arena et al., 2017). Although manual counts can be performed 
quickly for certain analyses, such as cell type counts, once the number of images to 
analyse goes beyond tens of images the time commitment to analyse manually is 
disproportionately outweighed by macro building. For one study within this thesis 10 
fields of view were imaged for each of 9 time point from 6 biopsies for each marker of 
interest. This one analysis produced 540 images alone, when the 4 different markers were 
analysed for that series of experiments a total of 2160 images were analysed. Manual 
counts taking roughly 3 minutes per image would have taken approximately 6,480 
minutes. Clicking through each image in a semi-automated program such as using the 
adobe photoshop protocol or FIJI without a macro would have taken around 5 minutes 
per image, totalling 10,800 minutes. The automated programs designed in this chapter 
can analyse 180 images in under 2.5 minutes which would have led to a maximum of 30 
minutes to analyse the same 2160 images. The amount of data produced is also order of 
magnitude greater than a manual count and therefore the performance is only 
comparable to clicking through FIJI which results in a >3000% speed improvement. 
The abundance of raw data and measurements that can be taken and analysed from 
these programs is huge. By collecting raw fluorescence intensity values, it allows the 
presentation of the raw data providing transparency to the observer whilst showing the 
heterogeneity within a sample that is not shown when data is presented as subjective 
binary counts (Jost & Waters, 2019). Additionally, as the images are saved in their raw file 
format, they can be reanalysed for different measures indefinitely.  
The use of open source software such as FIJI and python allows analysis to be 
performed from any computer without the need for an expensive software licence such 
as Adobe Photoshop (Agley et al., 2012). There is also no “blackbox” analysis where 
images are fed into a program and data is retrieved without the user understanding how 
that data was collected because the code is freely available. FIJI was also chosen as it has 
an active online community which was helpful as the binary reconstruct plugin was a 
suggestion from the community (http://forum.imagej.net/). This collaborative scientific 
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community has been evidenced by the publication of a specific FIJI plugin, MuscleJ, for 
analysis of skeletal muscle histology sections, negating the pay to use software (Mayeuf-
Louchart et al., 2018). 
The FIJI macros developed are only compatible with .zvi files as the individual colour 
channels take on specific names once split and need to be called to select the windows. 
However, changing the code to work with other file types, such as Nikon raw data .nd2 
files, would not be difficult. The programs also require high quality images to work 
efficiently. Poor quality images lead to bad thresholding and therefore inaccurate 
selections and marker expression. Although all possible measures were taken to produce 
the highest quality images some images had to be removed from analysis due to high 
levels of background staining preventing accurate detection of nuclei or non-biological 
debris in the image.   
All image acquisition took place on the same widefield fluorescence microscope 
therefore out of focus fluorescence was present in all images (Pawley, 2006). This also 
meant that images were taken in two dimensions, whereas cells and myotubes are three 
dimensional structures. Using a confocal microscope would improve the signal to noise 
ratio within the image by acquiring optical slices through a sample removing out of focus 
light (Allen et al., 2013). The optical slides could also be used to observe the 3D structures 
within the image. Access to an affordable confocal microscope was not possible for this 
work. The noise induced by out of focus light was present in all images and therefore was 
likely to be similar for all images that were directly compared and as cells are a thin 
monolayers the amount of out of focus light may not be a limiting factor (Combs, 2010). 
It was also minimised by following the image acquisition steps out lined in the methods 
sections such as using most of the dynamic range of the CCD camera. 
One of the main advantages of using image analysis programs is automated 
segmentation, the separation of image content into ROIs and background. For complex 
images, such as of tissue structure, it is hard for automated programs to reach the level 
of human segmentation due to human understanding of the structural biology underlying 
the image (Berlage, 2005). However, for relatively simplistic image of cultured cells 
automated segmentation is more accurate, less variable, much faster and, critically, 
unbiased. Where the automated segmentation did encounter problems was when 
analysing differentiation capacity of myoblasts into myotubes. Using fusion index to 
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analyse differentiation capacity may be seen as a simple analysis but without stitching 
FOV together to capture whole myotubes it is the most accurate measure of 
differentiation ability (Kandalla et al., 2011). Measurements made on myosegments may 
not fully reflect the whole myotube and are therefore likely to introduce unknown errors. 
A macro to count the number of nuclei within each individual myosegment was created, 
however during testing it was found to be inadequate because it could not distinguish 
between overlapping myotubes. Additionally, two myosegments in the same FOV could 
be from the same myotube with an adjoining section outside the FOV. The overlapping 
on myotubes is a common feature of cultured myotubes which makes the accurate 
separation of individual myotubes difficult (Duca et al., 1998; Zhu et al., 2007). 
Additionally, a nucleus might be overlying a myotube, rather than being within the 
myotube and incorrectly counted as a myonucleus. It may be possible for automated 
thresholding to separate overlapping myotubes and overlying nuclei if confocal images 
were taken throughout the whole three-dimensional myotubes allowing for the 
segmentation of myotubes based on their distribution in the z axis. 
In conclusion, fluorescence microscopy is a powerful biological technique with far 
reaching applications. This chapter demonstrates the development of bespoke image 
analysis programs that were used throughout this thesis to provide fast, unbiased analysis 
of hundreds of images. The programs provide more detailed analysis than manual 
methods allowing for more detailed analysis and highlights further the biological 
heterogeneity present within cell populations. The knowledge gained from this will 
provide the basis for further developments in apply fluorescence imaging and image 
analysis to skeletal muscle research. 
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4. Chapter 4: Replicative senescent 
phenotypes of human skeletal muscle 
precursor cells 
4.1. Introduction 
Cellular senescence of myoblasts is one potential mechanism contributing to the age-
related decline in skeletal muscle mass and function in humans (Schafer et al., 2005; 
Sousa-Victor et al., 2014). Whole skeletal muscle tissue from older adults shows increased 
senescence associated markers, such as p21 protein (Carlson & Conboy, 2007), but 
skeletal muscle tissue consists of many different cell types which may be differentially 
expressing these senescent markers. Measuring tissue expression also does not allow the 
functional assessment of senescent cells. Understanding the senescent phenotype and 
functioning of skeletal muscle cells in vitro could provide cell type specific markers to 
identify senescent cells both at early passage in vitro as well as in vivo. 
Previous cell culture studies show few differences in senescent marker expression or 
cell functioning in biopsy extracted cells from different aged donors (Carlson et al., 2009; 
Pietrangelo et al., 2009; Alsharidah et al., 2013; Barberi et al., 2013; Sousa-Victor et al., 
2014; Bigot et al., 2015; García-Prat et al., 2016). This could be an artefact of using 
cultured cells because measurements of senescent markers do not occur immediately 
after extraction but after several passages in culture conditions. During these passages 
senescent cells become a tiny minority population as the proliferative cells divide whilst 
the senescence cells cannot. After serially passaging cell populations to replicative 
senescence myoblasts have been shown to have defective cell function and increased 
senescent marker expression (Renault et al., 2000; Cooper et al., 2003; Bigot et al., 2008; 
Alsharidah et al., 2013; Baraibar et al., 2016). However, these experiments are often 
confounded by either using starting populations with low percentages of desmin+ve cells 
or by the reduction of the cell populations’ desmin+ve cell percentages across serial 
passages.  
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There are other precursor cell populations present in digested muscle tissue, such as 
skeletal muscle origin fibroblasts which tend to predominate over all other cell types 
(Agley et al., 2013, 2015). Whilst it is known that fibroblasts interact with myoblasts to 
facilitate optimal repair in vivo (Murphy et al., 2011), in human primary myoblast cultures 
the expansion of fibroblasts is often seen as a contaminant. Their expansion can confound 
myoblast cultures as they notoriously have long proliferative lifespans (Kaji & Matsuo, 
1979) and often overrun un-purified myogenic cell populations (Schäfer et al., 2006; 
Alsharidah et al., 2013). 
To identify the senescence phenotype of different human skeletal muscle-derived 
cells, pure cell populations need to be studied. Replicative senescence is considered the 
gold standard method for producing populations of senescent cells. However, human 
skeletal muscle studies have struggled to consistently obtain cultures which comprise 
pure populations of senescent myoblasts (Decary et al., 1997; Renault et al., 2002b; 
Lorenzon et al., 2004; Alsharidah et al., 2013). The recent development of a CD56 MACS 
sorting protocol for human myogenic cells has allowed for the purification to 95-99% 
desmin positive myoblasts after a single sort (Agley et al., 2015). These initially enriched 
cell populations would thus improve the probability of maintaining high myogenic cell 
percentages through to replicative senescence. The initial sorting also allows for the 
investigation of the fibroblast-rich CD56-ve sort fraction and the opportunity to investigate 
the differences in replicative profiles of the two main skeletal muscle origin precursor cell 
types. To date no studies have compared the two main cell types isolated from the same 
human muscle biopsy sample in parallel experiments. This chapter describes a study into 
the replicative phenotypes of the two main human skeletal muscle-derived precursor 
populations, myoblasts and fibroblasts. 
4.1.1. Aims 
To characterise the replicative senescent phenotype of sorted populations of skeletal 
muscle-derived CD56+ve myoblasts and CD56-ve fibroblasts obtained from the same vastus 
lateralis muscle biopsy sample. The characterisation was in terms of senescent marker 
and SASP expression. 
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It was hypothesised that the two cell types would demonstrate different trajectories 




Six healthy young (22±1 years) male participants donated muscle biopsy samples 
from the vastus lateralis as described in the general methods chapter 2 section 2.2. 
4.2.2. Cell extraction and culture conditions 
The cell extraction, sorting and general cell culture protocols used in this chapter are 
outlined in Chapter 2, General Methods. Briefly, human skeletal muscle samples were 
obtained using the Bergström needle technique with applied suction; these samples were 
then enzymatically digested to extract the mononucleated cell populations. The cells were 
left to proliferative for seven days after extraction before being sorted using CD56 
magnetic beads. The CD56+ve and CD56-ve sort populations were then plated for 
experimentation simultaneously so that direct comparisons could be made between the 
cell populations extracted from the same biopsy. Throughout this chapter the CD56+ve 
fraction will be referred to with the biopsy sample code and (+), e.g. Y01+. The CD56-ve 
fraction will be referred to with the biopsy sample code and (-), e.g. Y01-. 
4.2.3. Handling of purified cell populations 
All cell populations were passaged every 72-hours starting after the MACS sort on 
day seven post biopsy. Passaging of both CD56 sort fractions continued until the CD56+ve 
cell population either reached replicative senescence, as determined by zero increases in 
cumulative population doublings (see section 4.2.4), or at a time point when it was 
assumed that the population has reduced numbers of myogenic expressing cells. High 
desmin expressing cell numbers were deemed to be lost when a slowing of doubling rate 
across two passages was followed by an observable increase in doubling rate.   
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4.2.4. Population doubling time 
Cumulative population doublings were calculated for all cell populations across every 
passage using the following formula; where N1 is the number of cells counted at the end 
of the passage and N0 is the seeded cell number.  
Population doublings = Log2(N1/N0)/Log2 
4.2.5. Determining cell type proportions within the cell populations  
Subsets of 20,000 cells from each population were cytospun, as described in the 
general methods section 2.5, at the end of every 72-hour passage. Passage 1 was started 
on day 7 after biopsy, post MACS sort. Percentage of desmin expressing cells in the 
CD56+ve, and TE7 expressing cells in the CD56-ve, fraction were analysed every other 
passage by immunocytochemical staining described in the general methods section 2.5.  
4.2.6. Senescent marker expression 
At the end of each 72-hour passage cytospun samples of 20,000 cells were collected, 
as described in the general methods section 2.5. Immunocytochemical staining for 
markers of senescence p16, Ki67 and γH2aX was carried out as described in the general 
methods section 2.5. They were then analysed as described in the method development 
chapter 3.3.2. Staining for senescence associated β-Galactosidase was carried out by two 
different methods, both are described in the general methods 2.5.1. 
4.2.7. SASP factor expression 
Cell pellets were collected at the end of every passage for mRNA extraction and RT 
q-PCR as described in the general methods 2.6. 
4.2.8. Myotube formation 
Myotube differentiation was carried out at early passage and at the time point when 
cells reached replicative senescence, or when experiments were stopped as described in 
chapter 2 section 2.5. 




4.3.1. Initial biopsy characteristics 
To determine the in vitro senescent phenotype of human skeletal muscle derived 
precursor cells, skeletal muscle biopsies of the vastus lateralis were taken from young 
healthy male volunteers. The biopsy tissue was enzymatically digested to extract the 
mono-nucleated cell populations, which were plated in culture and allowed to expand. At 
7 days post-extraction, the heterogeneous cell population was sorted using CD56 
magnetic beads to select for CD56+ve skeletal muscle precursor cells. The CD56-ve cell 
population was also retained to investigate the predominant cell population, skeletal 
muscle origin fibroblasts. 
The total number of cells after seven days in culture showed no relationship to the 
initial biopsy weight. This cell count was attained from the summation of counts from the 
CD56 positive and negative fractions after MACS sorting prior to plating for experiments 
therefore providing a visualisation of the total cell population extracted from each biopsy. 
The number of cells obtained was varied as shown by the standard deviation, 1.48 x 106 ± 
9.56 x 105 cells (Figure 4.1). The proportion of total cell number that expressed CD56 was 
relatively constant at 67.27 ± 6.38% for all biopsies (Panel B of Figure 4.1).  
  




Figure 4.1.Total cell yield 7 day after biopsy and prior to sorting is variable but contains 
predominantly CD56+ve cells.  
After seven days, extracted cell populations were sorted for CD56 via MACS. The post sorted 
CD56+ve and CD56-ve cell populations were counted and summed to give a total cell number 
extracted from the biopsy. A) Shows the total cell number (sum of CD56+ve and CD56-ve counts) 
plotted against the initial biopsy weight.  B) Shows the percentage of extracted cells that where 
CD56+ve myogenic cells and CD56-ve fibrogenic cells from each individual biopsy, calculated as 
described in the text. 
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4.4. Skeletal muscle myoblasts results 
4.4.1. Replicative myogenic expression within CD56+ve populations  
To determine the percentage of myogenic cells within the CD56+ve populations, cells 
were stained for myogenic marker desmin at selected time points across their replicative 
lifespans. The CD56 MACS sorting occurred seven days post biopsy and the number of 
cells isolated was sufficient to determine post sort cell type proportions at ten days in 
culture post biopsy. Representative images of cells derived from each individual biopsy at 
early passage (ten days post biopsy) and at the time point at which they reached 
replicative senescence or were stopped (denoted as late passage) are shown in Figure 4.2. 
A decrease in the number of desmin positive cells was accompanied by an accumulation 
of fibroblasts, TE7 positive cells, in three samples and these cell cultures were stopped at 
this point. Quantification of desmin expression in CD56+ve cells from all six populations 
show high initial number of desmin positive cells at ten days post biopsy, 97.6 ± 1.7% 
desmin positive cells (Figure 4.3). Of the six CD56+ve samples three maintained high 
numbers of desmin positive cells, >90% desmin positive cells, throughout replicative 
passaging; whereas, three show declining desmin expressing cell numbers, <90% desmin 
positive cells, from 34 days post biopsy onwards. Interestingly, one of the populations 
which maintained high desmin expression, Y05+, also seems to increase expression of TE7 
within desmin positive cells, something which has not been observed before. 
CD56 MACS sorting was attempted in late passage cell populations to remove non 
myogenic cells. However, it was unsuccessful in that a large population of desmin positive 
cells were present in the normally fibroblast-dominated CD56-ve fraction. This would 
suggest that CD56 is not able to select for all myogenic cells at late passage and an 
unknown subset of myogenic cells were being selected for (Figure 4.4). This meant that 
CD56 and desmin are not co-myogenic markers at late passage. 
The three CD56+ve populations which maintained desmin positivity above 90% were 
considered to be highly enriched myogenic cell populations and could therefore be used 
for determination of the myogenic senescent phenotype, provided they also reached 
proliferative arrest. 




Figure 4.2 Representative images of each individual CD56+ve population at early and late passage. 
Sub populations of cells (20,000 cells) from each CD56+ve cell population were cytospun at early 
and late passage and stained for desmin (red), TE7 (green) and DAPI (Blue). Images acquired using 
a 20x magnification objective, Scale bar = 100 µm.  




Figure 4.3 Initial CD56 purification does not prevent loss of desmin expressing cells across the 
replicative lifespan of myoblasts.  
Sub populations of cells (20,000 cells) from each CD56+ve population were cytospun at alternate 
passages across their replicative lifespan and stained for nuclei and desmin to determine myogenic 
cell proportion by a bespoke automated image analysis program. A) The percentage of desmin 
positive cells across the replicative lifespan of individual myoblast populations. Data shown as 
Mean±SD of percentage desmin positive cells per field of view, 10 fields of view per time point, 
minimum of 100 cells analysed in total per time point. B) Representative images of individual 
biopsies which maintained and lost desmin expression stained for DAPI (Blue), TE7 (green) and 
desmin (red). N=6 Images acquired using a 20x magnification objective, Scale bar = 100 µm. 




Figure 4.4 CD56 sorting of late passage cells does not positively select for all desmin positive 
cells. 
Representative images showing high numbers of desmin positive cells in both CD56+ve and CD56-ve 
sort fractions. Images acquired using a 20x magnification objective, Scale bar = 100 µm. 
 
Figure 4.5. Additional CD56+ve cell populations all became overrun with TE7+ve cells. 
A further three CD56+ve cell populations extracted and MACS sorted from skeletal muscle biopsies 
underwent the same passaging experiments. Sub populations of cells (20,000 cells) from these 
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three additional CD56+ve cell populations were cytospun at early and late passage and stained for 
desmin (red), TE7 (green) and DAPI (Blue). Images acquired using a 20x magnification objective, 
Scale bar = 100 µm. All three showed increased numbers of TE7+ve cells after serial passaging. 
4.4.2. Replicative potential of CD56+ve cell populations  
To monitor the replicative profile of each individual CD56+ve population, cells were 
passaged every three days and cumulative population doublings were recorded (Figure 
4.5). Population doublings were stopped due to reaching proliferative arrest, or when a 
slowing proliferative rate was followed by an increased proliferative rate which suggested 
that the cell population had become overrun by another cell type i.e. TE7+ve fibroblasts. 
The cumulative population doublings of the biopsies which maintained >90% myogenic 
expression throughout replicative passaging are shown in Figure 4.5A. Of these three 
biopsies, two reached proliferative arrest, whereas one population, Y05, was still 
proliferating when it was stopped due to observing a slowing in proliferative rate followed 
by an increase in proliferative rate indicative of a population which had become overrun 
with fibroblasts. This cell population, Y05, also showed co-staining of desmin and TE7. 
Figure 4.5B shows the replicative profile of the CD56+ve populations which did not 
maintain high desmin expression. Here, two populations were still dividing when 
experiments where stopped, whereas one, Y06, had reached proliferative arrest.  




Figure 4.6 Cumulative population doublings for individual CD56+ve cell populations.  
Replicative profile of individual biopsies calculated by cumulative population doublings every three 
days. Population doublings = Log2(N1/N0)/Log2 where N1 is the end of passage cell count and N0 
is the number of cells seeded. MACS sorting occurred at day 7 and is used as the initial time point. 
A) Biopsies which maintain high desmin expression. B) Biopsies which did not maintain high desmin 
expression. 
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4.4.3. Myogenic population senescent marker expression  
After combining desmin expression and replicative potential data it is apparent that 
of the three biopsies which maintained high percentages of desmin expressing cells only 
two reached proliferative arrest. Therefore, from the initial six starting biopsies only two, 
Y02 and Y04, had achieved myogenic replicative senescence. Subsequently, these two 
samples were characterised to obtain the myogenic replicative phenotype. As group 
statistical analysis cannot be completed with only two samples, statistical analysis was 
performed using the cell by cell image analysis for each individual cell population at early 
passage and replicative senescence to determine if there was a significant change in 
marker expression within each cell population. 
To determine the marker expression of myoblasts at replicative senescence, 
expression of four markers known to be associated with senescence, p16, γH2aX and 
senescence associated β-Galactosidase (SA β-Gal), and proliferation, Ki67, were assessed. 
Results for SA β-Gal were not usable for these two biopsies due to technical 
methodological issues discussed in the methods section 2.5.1. 
4.4.3.1. Ki67 expressing cells are rare in senescent myoblast 
populations  
Cells that are undergoing mitosis highly express the protein Ki67, whereas non-
dividing cells strongly down regulated its expression (Scholzen & Gerdes, 2000). 
Therefore, to support the plateaus observed in the cumulative population doubling 
curves, sub-populations of each cell population were stained for Ki67. Both Y02+ and Y04+ 
cell populations showed significant reduction in Ki67 expression at replicative senescence 
(P < 0.001, Y02: early passage 761.8±402.2 AU, replicative senescence 367.1±559.6 AU; 
Y04: early passage 1141.5±783.4 AU, replicative senescence 115.3±172.6 AU, Figure 4.6). 
Although, both cell populations still retained a very small number of highly Ki67 expressing 
cells suggesting that not all of the cells had stopped dividing. 
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4.4.3.2. p16 expression is elevated in senescent myoblast populations 
Proliferative arrest as shown by low Ki67 expression is common of many cell 
populations, not necessarily due to being in a senescent state (Sun & Kaufman, 2018). 
Different mechanisms of proliferative arrest are associated with expression of specific cell 
cycle inhibitors (Malumbres et al., 2014). Cellular senescence is often accompanied by 
increased expression of the cell cycle inhibitor p16. Both senescent myoblast populations 
showed significant (P < 0.001, Y02: early passage 330.7±95.9 AU, late passage 
1215.4±277.0 AU; Y04: early passage 272.1±117.3 AU, late passage 440.6±144.8 AU, 
Figure 4.7) increases in p16 expression, albeit to different extents.  
4.4.3.3. γH2aX expression 
DNA damage is a potential cause of cellular senescence and therefore is often seen 
to increase in senescent cells. Double strand breaks in DNA can be observed by staining 
for γH2aX as the protein is involved in histone repair (Nakamura et al., 2008). Y04+ 
showed a significantly lower mean fluorescent intensity γH2aX expression at replicative 
senescence relative to early passage (P < 0.001, early passage 757.4±400.3 AU, replicative 
senescence 232.4±138.5 AU). Whereas, Y02+ showed no statistically significant difference 
in γH2aX expression (P = 0.30, early passage 362.9±205.9 AU, replicative senescence 
352.3±67.2 AU Figure 4.8). 
  






Figure 4.7 Myoblasts express less Ki67 at replicative senescence. 
A) Cell by cell mean fluorescent nuclear Ki67 intensity at early passage and replicative senescence 
for individual myoblast populations which reached myogenic replicative senescence. Each circle 
represents the mean fluorescent intensity of Ki67 of a single nucleus. Black lines indicate cell 
population Mean±SD. B) Representative images of Y04+ early passage and replicative senescent 
cell populations, which maintained myogenicity, stained for DAPI (blue), desmin (green) and Ki67 
(red). Scale bar = 100 µm.  




Figure 4.8 Myoblasts express more p16 at replicative senescence. 
A) Cell by cell mean fluorescent nuclear p16 intensity at early passage and replicative senescence 
for individual myoblast populations from the two biopsies which reached myogenic replicative 
senescence. Each circle represents the mean fluorescent intensity of p16 of a single nucleus. Black 
lines indicate population Mean±SD. B) Representative images of Y02+ early passage and replicative 
senescent cell populations, which maintained myogenicity, stained for DAPI (blue), desmin (green) 
and p16 (red). Scale bar = 100 µm.  




Figure 4.9 γH2aX expression of senescent myoblasts is different between samples. 
A) Cell by cell mean fluorescent nuclear γH2aX intensity at early passage and replicative senescence 
for individual myoblast populations from the two biopsy samples which reached myogenic 
replicative senescence. Each circle represents the mean fluorescent intensity of γH2aX of a single 
nucleus. Black lines indicate population Mean±SD. B) Representative images Y02+ of early passage 
and replicative senescent cell populations, which maintained myogenicity, stained for DAPI (blue), 
desmin (green) and γH2aX (red). Scale bar = 100 µm.  
CHAPTER 4: REPLICATIVE SENESCENT PHENOTYPES OF HUMAN SKELETAL MUSCLE PRECURSOR 
CELLS 112 
 
4.4.4. Myogenic senescence associated secretory phenotype 
A characteristic feature of senescent cells is their altered secretome known as the 
senescence associated secretory phenotype (SASP). The difference in mRNA expression 
of common SASP factors and senescence associated genes, known to be expressed in 
other senescent cell types (Coppé et al., 2010a; Tchkonia et al., 2010; Xu et al., 2015b), 
were determined at replicative senescence and expressed relative to early passage (10 
days after biopsy). In total, twelve senescence associated factors were measured in Y02+ 
and Y04+ and these factors were grouped as follows. Four showed increases in mRNA 
expression at replicative senescence compared to early passage in both samples but to 
different extents, as indicated by the values shown for Y02+ and Y04+ respectively. 
Specifically, PAI-1 (Y02; ~3 and Y04;~190 fold increase); IGFBP3 (Y02; ~12 and Y04; ~90 
fold increase); p16 (~54 and ~27 fold increases); and IL8 (Y02; ~6 and Y04; ~10 fold 
increase) were increased. A second group of four factors which showed reduced 
expression at replicative senescence in both Y02+ and Y04+ as indicated in the following 
results: TGF-β (0.3 fold change in both samples); IL6 (0.5 and 0.99 fold change); MMP (0.7 
and 0.9 fold change); and p21 expression was halved in both samples. A further two 
factors which showed differential changes in expression between the two biopsies: CXCL5 
expression was decreased in Y02+, 0.1 fold, but increased by ~10 fold in Y04+. Whereas, 
IGFBP7 was increased in Y02+, 6 fold, and decreased 0.4 fold in Y04+. The final two SASP 
factors, TNF-α was below the detection limit of the assay in Y04+ and slightly elevated in 
Y02+. Whereas β-gal was unchanged in Y02+ and decreased, 0.6 fold in Y04+.   




Figure 4.10 Replicative senescent myoblasts have altered mRNA expression of known SASP 
factors. 
Fold change in mRNA expression of known SASP factors was determined by RT-qPCR at replicative 
senescence, relative to early passage, in both senescent myogenic cell populations. Individual data 
points are presented as only two samples underwent analysis. SASP factors are ordered from 
highest mean fold change to lowest mean fold change. As described in the text, factors PAI-1, 
IGFBP3, p16 and IL-8 were increased in both samples at replicative senescence. CXCL5 and IGFBP7 
were both increased in one sample but decreased in the other sample. TGF-β, p21, IL-6 and MMP3 
were decreased in both samples. TNF-α was below detection limit in Y04+ and slightly elevated in 
Y02+. Whereas β-gal was unchanged in Y02+ and decreased in Y04+. 
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4.4.5. Differentiation is impaired in senescent myoblasts 
The role of muscle precursor cells in vivo is to fuse together to form new, or repair 
damaged, muscle fibres. In vitro, this process can be observed by lowering serum 
concentration in the media which, coupled with increased seeding density, triggers 
myoblasts to fuse together to form myotubes. The ability of replicative senescent 
myoblasts to differentiate into myotubes was investigated by determining the percentage 
of nuclei incorporated into myotubes after 96 hours of serum removal from the culture 
medium. The two myogenic senescent populations showed reduced fusion index from 
80% fused nuclei in early passage to 50% in replicative senescent cell populations (Figure 
4.10). The myotubes formed were also observed to be visibly thinner and contained fewer 
nuclei per myotube (data not quantified). 
  




Figure 4.11 Replicative senescence myoblasts fuse less well into myotubes. 
Myoblasts at early passage and replicative senescence were induced to differentiate and form 
myotubes. A) The fusion index, percent of nuclei incorporated into myosin heavy chain positive 
myotubes, is lower in populations of replicative senescence cells. B) Representative images of 
biopsies at early passage and late passage directed to differentiate into myotubes and imaged after 
96h. Scale bar = 100 µm.  




The CD56-ve cell populations from the MACS sort were cultured alongside the CD56+ve 
cell population from the same biopsy so that they were exposed to the same conditions. 
Due to the potential for fibroblast populations to take a very long time to reach replicative 
senescence the CD56-ve were stopped when the CD56+ve population had reached 
replicative senescence or when the myogenic population was deemed to have been 
overrun with fibroblasts. The time point at which CD56-ve cell populations were stopped 
is referred to as late passage in the subsequent results. The same experiments were 
carried out on the CD56-ve populations as the CD56+ve populations, the results of which 
are presented below. 
4.5.1. Fibrogenic expression within CD56-ve populations 
To determine the percentage of fibroblasts within the CD56-ve populations, cells were 
stained for fibroblast marker TE7 at selected time points across their replicative lifespans. 
The CD56 MACS sorting occurred seven days post biopsy and the number of cells isolated 
was sufficient to determine cell type proportions within the population at ten days in 
culture post biopsy. Representative images of each individual biopsy at early passage (ten 
days post biopsy) and at the time point at which they were stopped (denoted as late 
passage) are shown in Figure 4.11; where TE7 expression remained high with serial 
passaging. Quantification of TE7 expression in CD56-ve cells from all six populations show 
high initial TE7 expression at 10 days post biopsy accounting for 86.7±9.7% of all cells 
(Figure 4.12). The number of TE7 expressing cells increased throughout replicative 
passaging up to 97.8±1.1% when the experiments were stopped. Thus, all CD56-ve 
populations were determined to be TE7+ve throughout serial passaging and are 
subsequently referred to as fibroblast cell populations. 




Figure 4.12. Representative images of TE7 stained CD56-ve cell populations at early and late 
passage. 
Sub populations of cells (20,000 cells) from each CD56-ve population were cytospun at early and 
late passage and stained for DAPI (Blue), TE7 (green) and desmin (red). Images acquired using a 
20x magnification objective, scale bar = 100 µm. 




Figure 4.13. The number of TE7 expressing cells increase in CD56-ve populations with serial 
passaging.  
Sub populations of cells (20,000 cells) from each CD56-ve population were cytospun at alternate 
passages across their replicative lifespan to determine TE7+ve cell proportion by a bespoke 
automated image analysis program. Data presented as Mean±SD of percentage TE7 positive nuclei 
per field of view, 10 fields of view per time point, minimum of 100 cells analysed in total per time 
point. Open symbols represent CD56-ve cell populations with a corresponding CD56+ve cell 
population which became overrun by fibroblasts. 
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4.5.2. Replicative potential of fibroblast cell populations 
The replicative profile of each individual CD56-ve/TE7+ve fibroblast cell population was 
monitored by cumulative population doublings every three days in the same way as the 
CD56+ve populations. The fibroblast population doubling experiments were stopped after 
the same time in culture as the CD56+ve cell population from the same biopsy. At which 
point all fibroblast cell populations were still dividing (Figure 4.13), although there was a 
trend (p=0.052) for slower population doubling times (32.3±7.8 h) at the last recorded 
passage in the six fibroblast samples, when compared to their early passage rates 
(22.3±2.1 h). There was also no noticeable difference in characteristics of the CD56-ve cell 
populations extracted from biopsies which had a CD56+ve population which lost desmin 
expressing cells compared to those which maintained high percentages of desmin 
expressing cells (Figure 4.13). 
4.5.3. Senescent marker expression within fibroblast cell populations 
To determine the marker expression of CD56-ve/TE7+ve fibroblasts after the same time 
in culture as the desmin+ve myoblasts which had reached replicative senescence, the 
expression of the same four markers known to be associated with senescent cells, Ki67, 
p16, γH2aX and SA β-Gal were assessed. As with the CD56+ve populations technical 
methodologic issues prevented the analysis of all six samples for SA β-Gal, however two 
fibroblast samples, Y05 and Y06, did provide usable results for SA β-Gal.  
4.5.3.1. Ki67 expression is reduced in later passage fibroblasts 
The representative images in Figure 4.14 show Ki67 expression in the late passage 
populations of fibroblasts. The individual cell by cell mean fluorescent intensities indicate 
that there are still a large proportion of cells with high Ki67 expression in the late passage 
populations similar to the early passage population, suggesting both early and late 
passage populations are highly proliferative (Figure 4.15). However, at the whole cell 
population level mean fluorescent intensity of Ki67 was significantly reduced at late 
passage compared to early passage (P = 0.04, fold change=0.69±0.15, Figure 4.16). Taken 
with the trend for slower population doubling times at late passage would suggest a slight 
decrease in the proliferation of the fibroblast cell population. 




Figure 4.14. Fibroblasts are still highly proliferative after serial passaging when CD56+ve 
populations have reached replicative senescence or been overrun by fibroblasts. 
Replicative profile of individual biopsies calculated by cumulative population doublings every three 
days. Population doublings = Log2(N1/N0)/Log2 where N1 is the end of passage cell count and N0 
is the number of cells seeded. MACS sorting occurred at day 7 and is used as the initial time point. 
Open symbols represent fibroblast cell populations with a corresponding CD56+ve cell population 
which became overrun by fibroblasts. 




Figure 4.15. Representative images from individual biopsies of Ki67 expression across replicative 
lifespan of fibroblast cell populations. 
Representative images of fibroblast cell populations across serial passages, stained for DAPI (blue), 
TE7 (green) and Ki67 (red). Images acquired using a 20x magnification objective, Scale bar = 100 
µm.  




Figure 4.16. Individual cell by cell Ki67 expression at early and late passage for individual 
fibroblast cell populations. 
Cell by cell mean fluorescent nuclear Ki67 intensity at early passage and late passage for individual 
fibroblast cell populations. Late passage denotes the time point at which the CD56+ve cell 
population from the same biopsy was stopped. Each circle represents the mean fluorescent 
intensity of Ki67 of a single nucleus. Black lines indicate population Mean±SD. Statistical analysis 
was not performed on these individual populations as the same data was used to be analysed in 
Figure 4.16. 




Figure 4.17. Ki67 expression decreases at late passage in Fibroblasts. 
Summary of individual mean fluorescent nuclear Ki67 intensity for fibroblast cell populations 
presented in Figure 4.15. Each individual’s cell population mean fluorescent intensity is 
represented as a fold change from their own early passage population mean. Error bar represents 
standard deviation between the individuals. N=6,  (p = 0.039) paired t-test. 
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4.5.3.2. p16 expression is unchanged in later passage fibroblasts 
Protein levels of the cell cycle inhibitor p16 was unchanged at the cell population 
level after serial passaging (p = 0.58, Figure 4.19). When observing the individual fibroblast 
cell populations there was only an increase in one sample, Y04, whereas it was either 
unchanged or slightly lower in the other five samples at late passage (Figure 4.18). 
4.5.3.3. γH2aX expression is unchanged in later passage fibroblasts 
DNA double strand breaks, as measured by γH2aX expression, was unchanged in late 
passage fibroblast cells compared to early passage (p = 0.12, Figure 4.22). When analysing 
the individual fibroblast cell populations one sample, Y01, showed an increase in γH2aX 
expression in contrast to the other samples, which didn’t show an increase (Figure 4.21). 
The cell population with increased γH2aX expression, Y01, was different to the cell 
population which showed increased p16 expression, Y04, showing difference between cell 
populations for these senescent markers. 
4.5.3.4. Senescence associated β-Galactosidase expression 
Because of technical error (Methods section 2.5.1), SA β-Gal could only be analysed 
in two of the six fibroblast cell populations, Y05 and Y06, both of which had ~10% of cells 
expressing SA β-Gal at early passage. There was a difference in response to serial 
passaging between the two samples with one population remaining ~10% positive for SA 
β-Gal (Y06) whereas, in the other sample (Y05) the percentage of SA β-Gal positive cells 
increased to ~25% (Figure 4.23). Both populations were therefore lowly expressing SA β-
Gal at late passage.  
4.5.4. SASP factor expression of later passage fibroblasts 
To determine if known SASP factor expression had increased in the fibroblast cell 
populations after serial passaging, even without reaching replicative senescence, gene 
expression at the last proliferative time point was measured. For each cell population 
SASP factor expression was expressed as a fold change relative to the earliest time point 
measured, 10 days after biopsy, for all six samples. After correcting for multiple tests using 
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the Bonferroni correction none of the SASP factors were significantly altered at late 
passage compared to early passage. 
  




Figure 4.18. Representative images of p16 expression across replicative lifespan of individual 
fibroblast cell populations. 
Representative images of fibroblast cell populations across serial passages, stained for DAPI (blue), 
TE7 (green) and p16 (red). Images acquired using a 20x magnification objective, Scale bar = 100 
µm. 




Figure 4.19. Individual cell by cell p16 expression at early and late passage for individual 
fibroblast cell populations. 
Cell by cell mean fluorescent nuclear p16 intensity at early passage and late passage for individual 
fibroblast cell populations. Late passage denotes the time point at which the CD56+ve cell 
population from the same biopsy was stopped. Each circle represents the mean fluorescent 
intensity of p16 of a single nucleus. Black lines indicate population Mean±SD. Statistical analysis 
was not performed on these individual populations as the same data was used to be analysed in 
Figure 4.19. 
 




Figure 4.20. Fibroblasts p16 expression trends up at late passage. 
Summary of individual mean fluorescent nuclear p16 intensity for fibroblast cell populations 
presented in Figure 4.18. Each individual’s population mean fluorescent intensity is represented as 
a fold change from their own early passage population mean. Error bar represents standard 
deviation between the individuals. N=6, non-significant (p = 0.58) paired t-test. 




Figure 4.21. Representative images of γH2aX expression across replicative lifespan of individual 
fibroblast cell populations. 
Representative images of fibroblast cell populations across serial passages, stained for DAPI (blue), 
TE7 (green) and γH2aX (red). Images acquired using a 20x magnification objective, Scale bar = 100 
µm. 




Figure 4.22. Individual cell by cell γH2aX expression at early and late passage for individual 
fibroblast cell populations. 
Cell by cell mean fluorescent nuclear γH2aX intensity at early passage and late passage for 
individual fibroblast cell populations. Late passage denotes the time point at which the CD56+ve cell 
population from the same biopsy was stopped. Each circle represents the mean fluorescent 
intensity of γH2aX of a single nucleus. Black lines indicate population Mean±SD. Statistical analysis 
was not performed on these individual populations as the same data was used to be analysed in 
Figure 4.22. 
 




Figure 4.23. Fibroblast γH2aX expression trends down at late passage. 
Summary of individual mean fluorescent nuclear γH2aX intensity for fibroblast cell populations 
presented in Figure 4.21. Each individual’s population mean fluorescent intensity is represented as 
a fold change from their own early passage population mean. Error bar represents standard 
deviation between the individuals. N=6, non-significant (p = 0.12) paired t-test. 




Figure 4.24. Fibroblast cell populations senescence associated β-Galactosidase. 
A) Percentage of cells staining positive for SA β-Galactosidase at early and late passage. Each data 
point represents the mean percentage SA β-Galactosidase positive cells from 10 non overlapping 
fields of view. B) Representative images of early and late passage CD56-ve cell populations stained 
for SA β-Galactosidase. Images acquired using a 20x magnification objective, Scale bar = 100 µm. 




Figure 4.25. SASP factor gene expression changes in fibroblast cell populations after serial 
passaging. 
Fold change in mRNA expression of known SASP factors was determined by RT-qPCR at late 
passage, relative to early passage, in fibroblast cell populations N=6. Data presented as Mean fold 
change±SD. Statistical analysis using paired t-tests for individual SASP factors reveals sig. difference 
for p16, IGFBP7 and IL6 however all three became non-significant after the Bonferroni correction 
was applied to account for the multiple tests. 
  




The senescent phenotype of the main human skeletal muscle-derived precursor cell 
populations, myoblasts and fibroblasts are currently not well characterised. The main aim 
of these experiments was to extensively characterise the senescence phenotype of 
purified CD56+ve myoblast and CD56-ve skeletal muscle fibroblast cell populations obtained 
from the same muscle biopsies and exposed to the same time and conditions in culture. 
The discussion here firstly focused on characterising the myogenic phenotype at 
replicative senescence before discussing the fibroblasts at the same time point in culture.  
4.6.1. Obtaining myoblast enriched cell populations  
Of the six original biopsy samples two were deemed to have reached replicative 
senescence whilst maintaining a high percentage of desmin expressing cells. Previous 
studies have used cell populations with varying myogenic cell percentages to characterise 
the phenotype of senescent human muscle cell populations (Renault et al., 2000; Fulle et 
al., 2005; Schäfer et al., 2006; Alsharidah et al., 2013). This study took a conservative 
approach and only used myoblast cell populations which had i) achieved replicative 
senescence and ii) maintained >90% desmin expressing cells throughout their replicative 
lifespan. Only these two populations undertook senescent phenotypic analysis. 
The initial percentage of desmin expressing cells within an extracted cell population 
from a muscle biopsy can depend on the specific site within the muscle that the sample 
was taken. There are also unknown effects of the seven days expansion in culture post-
extraction that could also influence the percentage of desmin positive cells within the cell 
population. To standardise and enrich the starting cell population’s desmin+ve cell 
proportion, a MACS sort for the myogenic cell surface marker CD56+ve was performed 
seven days after the cells were extracted from the biopsy. The pre-sort desmin+ve cell 
percentage was not directly measured to maximise cell numbers for replicative 
experiments. However, the pre-sort desmin percentage (67.3 ± 6.4%) was estimated from 
the proportional difference in population size between the post-sort cell counts of the 
CD56+ve and CD56-ve cell populations. The desmin+ve cell percentage of the post-sort 
CD56+ve populations obtained from the six biopsy samples studied was 97.6 ± 1.7%. Thus, 
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all starting populations were determined to be highly desmin positive and were all used 
to obtain early passage myogenic phenotypes. 
The phenotype of early passage non-senescent myogenic cells is important for 
providing a reference for comparison with the replicative senescent cell populations. As 
previous studies have shown there is variability in how long myogenic cell populations 
take to senesce under culture conditions it is important to obtain the early passage 
phenotype at as early time point as feasibly possible (Renault et al., 2002b; Schafer et al., 
2005; Alsharidah et al., 2013). Previous explant studies which wait for accumulation of 
cells extruded from muscle tissues thus the early extruded cells may undergo multiple 
rounds of division before early passage measurements are made therefore, they may 
have more senescent early passage populations (Decary et al., 1997; Renault et al., 2002b; 
Bortoli et al., 2003; Jacquemin et al., 2004; Beccafico et al., 2011). This is also a key issue 
if trying to compare cumulative population doublings as unknown doublings could have 
occurred before measurements began. 
In this study the time course between cell extraction and starting experiments was 
standardised across all biopsies to control for proliferation bias. Cells were extracted on 
the day of the biopsy (day zero) and sorted 7 days later. Thus, all time points are relative 
to the day of biopsy and cumulative population doublings were all started after the CD56 
MACS sorting on day seven post extraction. The early passage phenotype was determined 
at 10 days after biopsy in all cell populations. At this time point, all cell populations were 
large enough to undertake a full characterisation, which was not possible for all samples 
at seven days post biopsy. 
To monitor and determine when cell populations had reached a senescent state, 
cumulative population doublings were measured at every passage across the cell 
population’s replicative lifespan. Of the six CD56+ve cell populations analysed; three 
reached proliferative arrest, as determined by the time point at which no increase in 
cumulative population doublings occurred. The other CD56+ve populations were thought 
to have become overrun by another cell type, most likely to be TE7+ve fibroblasts as seen 
by Alsharidah et al., (2013), so were stopped at this point. This was due to an observation 
of a slowing in population doubling rate, suggesting a population was reaching 
proliferative arrest, but then a subsequent increase in population doubling rate, where 
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the fibroblasts over ran the culture. PDs are a crude description of population growth 
because haemocytometer counts are not precise enough to detect very small changes in 
population number. More accurate cell counts can be obtained using FACS or automatic 
cell counters, but this may not add that much additional information as serial passaging 
of cells creates exponential large numbers of cells. From a single cell undergoing the mean 
cumulative population doublings counted in these experiments would undergo ~25 
doublings would create 224 (over 16 x106) cells and as shown earlier the average size of 
starting CD56+ve population was 400,000 cells. 
Of the three CD56+ve cell populations to reach replicative senescence only two 
maintained high percentages of myogenic cells representing a 33.3% success rate of 
developing replicative senescent populations of desmin positive cells. However, one of 
the populations, Y05+, which showed a slowing then accelerating pattern in cumulative 
population doublings turned out to maintain high desmin expression throughout. 
Interestingly, it was observed that these cells were co-expressing desmin and TE7 which 
have not previously been observed in this laboratory (Figure 4.2). Concurrent analysis of 
population cell type proportions would have prevented the premature ending of this 
sample’s replicative experiments. A better understanding of why certain populations 
seem to be predisposed to overrunning is needed, although it could just be a case of 
length of culture time allowing the TE7 cell population to increase as is starting to be seen 
in two of the biopsies which maintained high desmin+ve cell percentages and reached 
replicative senescence (Figure 4.3A). There is a small trend for declining numbers of 
desmin expressing cells at the latest time points suggest that a minority cell population 
may be still dividing that is altering the cell type proportions of the population. This 
expansion of fibroblasts would suggest that at this time point the myoblasts are not 
producing a strong senescent bystander effect. If the myoblast population does reach the 
replicative senescent state, then their SASP has the potential to cause surrounding cells 
to become senescent (Nelson et al., 2012). However, even though these fibroblasts are in 
the minority they seem to be able to withstand the senescence inducing environment and 
over run the senescent myogenic population. 
To prevent the loss of desmin positive cells and accumulated TE7 expressing 
fibroblasts seen in the other three CD56+ve samples it was thought that re-sorting for CD56 
would prevent the accumulation of non-myogenic cell types within the CD56+ve cell 
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populations. However, the results of pilot experiments suggested that there is a loss of 
CD56 expression with repeated passaging, data not shown. Analysis of the CD56-ve fraction 
of late passage MACS sorts showed an increased proportion of desmin positive cells 
(Figure 4.4), as well as, a larger absolute number of cells. Therefore, CD56 was not actively 
selecting for all myogenic cells across their proliferative lifespan. Another research group 
have also shown modulation in the expression of CD56 in human primary skeletal muscle 
cells across time in culture (Meng et al., 2011). They also suggest that there may be cells 
capable of myogenic linage potential, such as skeletal muscle pericytes within the CD56-
ve cell population which may explain the co expression of desmin and TE7 mentioned 
previously.  
The sorting method employed was developed previously to enrich early passage cells 
for experimentation. It was not specifically designed for long term culture experiments. A 
single MACS sort using a single marker was chosen as it was the gentlest method for cell 
separate and could produce highly enriched cell populations without significantly 
reducing cell yield after a single sort (Agley et al., 2015). Double sorting for the same 
marker, passing the CD56 positive sort fraction from the first sort through a new column, 
may further enrich the myogenic cell population at the expense of a lower cell yield (Agley 
et al., 2015). However, CD56 is not the best marker of skeletal muscle satellite cells or 
muscle precursor cells; the transcription factor Pax7 is currently agreed to be the best 
marker, but it is not a viable candidate for MACS cell sorting which requires cell surface 
markers. Pax7 is also lost as satellite cells become myoblasts therefore Pax7 expressing 
cells are lost with serial passaging (Olguin & Olwin, 2004). Currently there is no well-
established native, cell surface marker, that could be successfully used to purify primary 
human myoblasts across their replicative life span. Therefore, maintaining high numbers 
of myogenic cells is still a significant challenge to reliably obtaining replicative senescence 
populations of myogenic cells. Recently CD82 has been found as a novel marker of human 
muscle satellite cells and double sorting using both CD56 and CD82 has produced highly 
enriched myogenic cell populations (Alexander et al., 2016; Uezumi et al., 2016). 
However, it has yet to be investigated if CD82 expression is maintained throughout the 
replicative lifespan. 
It is clear from the current work that the issues of creating replicative senescent 
populations are not prevented by initial purification of the cell populations. Of the six 
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CD56+ve cell populations only two maintained a myogenic phenotype through to 
proliferative arrest. Three further biopsy samples were taken and treated in the same 
manner but all three also became overrun with TE7+ve fibroblasts (Figure 4.5). 
4.6.2. Replicative senescent phenotype of myoblasts 
With only two of six CD56+ve cell populations maintaining high proportions of 
myogenic cells through to replicative senescence limited conclusions could be drawn 
about their phenotypic characteristics. As mentioned, a further three CD56+ve samples 
were subsequently used to increase the statistical power, however all three also became 
overrun with fibroblasts. 
The two myogenic replicative senescent cell populations were analysed for four 
markers associated with senescence as there is no definitive marker of senescence. The 
most commonly utilised senescent cell marker is the presence of SA β-Gal (Dimri et al., 
1995). Due to technical problems SA β-Gal was unfortunately not assayed correctly for 
the two samples which reached myogenic replicative senescence (Methods section 2.5.1). 
Data is only available Y05+ and Y06+. Y05+ was the sample which was mistakenly stopped 
early during replicative passaging even though it maintained a high myogenic cell 
percentage. Y06+ reached replicative senescence but failed to maintain a high myogenic 
cell percentage. Therefore, neither can be reliably used to infer myogenic replicative 
senescent expression of SA β-Gal. 
The other three senescence markers; p16, γH2aX and lack of Ki67 were measured 
using the automated image analysis program developed in chapter 3. As only two cell 
populations maintained high proportions of myogenic cells through to replicative 
senescence the change in senescent marker expression was observed between early and 
replicative senescence within the individual cell populations. Both populations showed 
decreased Ki67 protein and increased p16 protein. This is consistent with previous studies 
looking at senescent cell populations showing increased p16 mRNA (Barberi et al., 2013). 
However, both cell populations showed lower mean fluorescent intensity of γH2aX at late 
passage compared to early passage which is different to Alsharidah et al., (2013) who 
showed that there are more γH2aX positive cells in senescent populations of myogenic 
cells compared to early passage cells when assessed by binary counting. 
CHAPTER 4: REPLICATIVE SENESCENT PHENOTYPES OF HUMAN SKELETAL MUSCLE PRECURSOR 
CELLS 139 
 
Subjective binary counts are often used to determine if a cell is expressing markers 
such as Ki67, p16 or γH2aX. However, as shown by the individual cell by cell mean 
fluorescent intensity data for all three markers there is a very heterogenous expression of 
these markers within a cell population. Thus, using a subjective cut off point for positivity 
is potentially misleading and easily manipulated. Quantitative analysis can be performed 
using qPCR or western blot. However, these techniques only determine the overall 
increase in senescent marker expression within the cell population therefore they lose 
the cell by cell heterogeneity present within the cell populations. Although the image 
analysis method employed cannot categorically say a cell population has stopped dividing 
it is clearly evident that there is a shift in the populations towards an increased number 
of nuclei with very low mean fluorescent intensity for Ki67 and whole populations shifts 
for more p16 expression which would be indicative of a population that has reached 
replicative senescence. 
The discrepancy in γH2aX results between ours and previous studies could also be 
the result of using this more objective analysis method. It is suggested that each γH2aX 
foci represents a single double strand break and therefore cells with more foci have more 
DNA damage (Rothkamm et al., 2015). This should also be represented by the mean 
fluorescent intensity because more bright pixels within the nucleus would increase the 
mean fluorescent intensity for that nucleus. However, due to the very specific locations 
of γH2aX expression at the DNA double strand break sites very few pixels expressing 
γH2aX as a proportion of total nuclear pixel the difference in mean fluorescent intensity 
may not be seen by the current method. A further development of the program could be 
to threshold within each nucleus for expression of γH2aX then counting how many 
individual objects are detected within the nucleus therefore giving an automated number 
of foci count.  
To summarise the increases in p16 expression and decreased Ki67 expression, 
together with the cells proliferative arrest strengthens the argument that these cell 
populations have reached replicative senescence. The addition of available SA β-Gal data 
in support of these markers would further reinforce this statement. However, in the case 
of these two cell populations increased DNA damage does not seem to be present in the 
senescent state at the population level. 
CHAPTER 4: REPLICATIVE SENESCENT PHENOTYPES OF HUMAN SKELETAL MUSCLE PRECURSOR 
CELLS 140 
 
The key feature of senescent cells is their altered secretory phenotype, their 
senescence associated secretory phenotype (SASP). The SASP is thought to be mainly pro-
inflammatory in nature but with the specific makeup of the SASP being cell type specific 
(Childs et al., 2014). Within the SASP factors used throughout this thesis PAI-1, IGFBP3, 
IGFBP7, IL6, IL8, TGF-β, MMP3, CXCL5 and TNF-α are either directly or secondary to the 
inflammatory SASP (Coppé et al., 2010a). Of the factors used as a small prospective 
marker panel, four, PAI-1, IGFBP3, p16 and IL-8, were shown to be upregulated in both 
myogenic replicative senescent cell populations. The upregulation of p16 mRNA 
complements the data found from the protein image analysis method presented. The 
down regulation of p21 was surprising as it is often associated, alongside p16, as a 
senescence associated cell cycle inhibitor. However, p21 is upregulated in the DNA 
damage response and increased DNA damage was not observed in these cell populations. 
IGFBP3 and IL-8 mRNA expression were upregulated between 8- and 50-fold in both 
biopsies, whereas PAI-1 was 200-fold upregulated in one biopsy and only slightly in the 
other, 2-fold. Previous studies have shown TGF-β protein upregulation (in conditioned 
media) in senescent myoblasts at the early stage of differentiation (Alsharidah et al., 
2013). The current study did not show an upregulation of TGF-β mRNA and expression 
was assessed in proliferative conditions rather than during differentiation initiation.  
The functional capacity of the senescent CD56+ve populations was investigated to 
determine if they were able to undergo full and timely differentiation into myotubes at 
early and late passage. This has importance in a regenerative tissue such as skeletal 
muscle which must undergo multiple round of regeneration throughout life. The fusion 
index results of the current experiments support previous literature in that fewer nuclei 
are incorporated into myotubes when late passage cells are directed to differentiate than 
early passage cells (Renault et al., 2000; Bortoli et al., 2005; Alsharidah et al., 2013). The 
80% nuclei fusion observed in this study was also seen in previous studies (Alsharidah et 
al., 2013). The myotubes formed at late passage and therefore at replicative senescence 
in this study, visibly contained fewer nuclei per myotube and were thinner than those 
formed by early passage cells. 
To summarise, these experiments aimed to characterise the myogenic replicative 
senescence phenotype. It was observed that initial myogenic cell proportion can be 
enhanced by CD56+ve sorting however enrichment does not necessarily last through to 
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replicative senescence. This problem cannot be solved by regular sorting for CD56 
because it has been shown that desmin positive cells accumulate in the CD56-ve fraction 
after later passage sorts suggesting there is modulation of CD56 expression in serially 
passaged myogenic cells. In the two cell populations which maintained myogenicity and 
were deemed to reach proliferative arrest by cumulative population doublings analysis; 
Ki67 expression was significantly reduced, p16 expression was significantly increased and 
cells were less able to differentiate into myotubes. They also showed some elevated SASP 
factor mRNA expression. However, only two samples were analysed and therefore further 
samples must be assayed before valid conclusions can be drawn. 
4.6.3. Fibroblasts do not reach replicative senescence in the same time 
frame as myoblasts from the same biopsy sample 
The generation of senescent myogenic cell populations was hard to achieve due to 
them becoming overrun by skeletal muscle derived TE7+ve fibroblasts. This study also 
aimed to investigate these skeletal muscle origin fibroblast populations in isolation to 
determine how their behaviour differs from the myogenic cells extracted from the same 
biopsies. The CD56-ve population were passaged in parallel to the CD56+ve populations 
from the same biopsies so that the two cell populations could be compared for 
proliferative and senescent characteristics.  
The predominant cell type in the CD56-ve fraction are TE7+ve/Collagen 
VI+ve/Fibronectin+ve fibroblasts (Agley et al., 2015), sharing the same marker as the cell 
type which overrun some of the CD56+ve cell populations. The proliferative capacity of 
these cells is much greater than the CD56+ve cells as all six samples were still highly 
proliferative at the time point their equivalent myogenic population had reached 
senescence. In all cases the fibroblast populations achieved more population doublings in 
the same timespan as their paired CD56+ve populations, with the exception of Y05 which 
showed similar cumulative population doublings for the two cell types. This is of interest 
as Y05 was the only myogenic cell population to maintain a high proportion of desmin 
positive cells and still be proliferative at the time of stopping passaging. As well as, 
containing cells that co-stained for both myogenic, desmin and fibrogenic, TE7 markers. 
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The high proliferative rate and capacity of skeletal muscle origin fibroblasts is 
consistent with that of fibroblasts from other tissues. The original experiments by Hayflick 
were performed on skin fibroblasts and reached 55-65 population doublings before 
stopping dividing and other studies have shown similar results with fibroblasts from 
different tissue sources under culture conditions (Allsopp et al., 1992; Alcorta et al., 1996). 
The fibroblast populations were not followed to replicative senescence due to the long 
time to reach proliferative arrest and the labour intensity of the experiments.  
The senescent marker expression of the fibroblast cell populations supports the 
notion that these cell populations are still highly proliferative and not senescent after the 
same time in culture as CD56+ve cells from the same muscle biopsy. Mean fluorescent 
intensity of Ki67 protein is varied between the cell populations, but when expressed as 
fold change from each individual population at early passage, the level of Ki67 expression 
is significantly reduced. When compared to the myogenic senescent CD56+ve cell 
populations the fold change is much smaller in the CD56-ve cell populations suggesting 
they are more proliferative. Similarly, to the CD56+ve samples there is a proportion of cells 
with very low levels of Ki67 mean fluorescent intensity but in the CD56-ve cell population, 
there is a much larger proportion with high Ki67 expression.  
The CD56-ve cell populations also did not show increased p16 protein expression 
further suggesting that these cell populations were maintaining a proliferative state. Only 
one individual sample, Y04, shows an increased p16 expression at late passage with all 
other samples maintaining similar levels of p16. It is interested to note that there are cells 
with relatively high expression of p16 in both early and late passage cells suggesting that 
there may be senescent cells within these populations. This is supported by the SA β-Gal 
assay, which showed that both samples contained around 10% SA β-Gal positive cells at 
early passage. However, at late passage Y05- increased to around 25% positive cells 
whereas Y06- maintained a similar level of around 10%. When combined with the p16 
expression data there is not an increase in number of higher expressing cells in Y05- at 
late passage suggesting that p16 expression and SA β-Gal may not always co-express in 
senescent cells. Additionally, similarly to the CD56+ve populations, γH2aX mean 
fluorescent intensity did not increase with serial passaging. The expression of SASP factors 
were also not significantly altered after serial passaging further suggesting that these cell 
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populations were not becoming senescent by the time point they were stopped 
proliferating.   
Overall, the CD56-ve cell populations do not show significant upregulation of 
senescent markers or SASP factor expression which is consistent with the population 
doublings data suggesting that they are still maintaining a highly proliferative population. 
Thus, highlighting a difference between the two main progenitor cell populations within 
human skeletal muscle. This finding also supports the observations that purified myogenic 
cell populations can become overrun by fibroblasts cells which may be due to their longer 
replicative capacity of 40-60 population doublings (Hayflick, 1965; Allsopp et al., 1992; 
Alcorta et al., 1996). 
4.7. Conclusions 
Both main progenitor cell types in human skeletal muscle, myoblasts and fibroblasts, 
pose challenges when trying to obtain pure populations of replicative senescent cells. The 
fibroblasts showed no signs of reaching replicative senescence in the timeframe with 
which it took their myogenic counterparts to either reach proliferative arrest or be 
themselves overrun by fibroblasts. The long-term culture of human primary cell 
populations is expensive and time intensive and with the outlined issues stated above are 
currently, in the case of myoblasts, unreliable. Replicative senescence was seen by some 
as the gold standard for senescent cell populations (Campisi, 1997), as they argue it is the 
most representative of an in vivo phenotype. However, due to the heterogeneity of all in 
vivo populations and the fact that cells can become senescent via other pathways this is 
now not thought to be the case (Waaijer et al., 2018). Additionally, these cells are ex vivo, 
maintained in non-physiological conditions and purified populations are not likely to be 
truly representative of an in vivo population. However, if a model could be developed to 
reliably produce senescent populations of highly pure cells, it may provide important 
information as to the functioning of senescent cells within skeletal muscle tissue. The next 
chapter outlines the development and analysis of an induced senescence model which is 
novel in human primary muscle derived myoblasts and fibroblasts. 
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5. Chapter 5: DOX-induced senescent 
phenotypes of human skeletal muscle 
precursor cells 
5.1. Introduction 
The results obtained by attempting to follow myoblasts and fibroblasts to replicative 
senescence were limited in both cell types but for different reasons. For myoblasts, the 
experiments showed that only two of the six purified populations could be successfully 
followed to replicative senescence without “contamination” from fibroblasts. Whereas, 
in the skeletal muscle derived fibroblast populations there were no signs of any of the cell 
populations reaching senescence within 60 days of cell culture. Coupling these findings to 
the expense and labour intensity of culturing cells for this extended period suggests that 
replicative senescence is not currently a reliable or reproducible model for examining 
cellular senescence within these human skeletal muscle derived cell populations. In order 
to overcome these disparate results and allow results with more statistical power to be 
obtained from all biopsy samples, it was decided to attempt to stress-induced senescence 
in both cell types to understand the senescent phenotypes of these cell populations. 
After a review of the literature, the prime candidate that emerged to be used for 
such an intervention was the chemotherapy drug Doxorubicin (DOX). This was because 
DOX has been successfully used to induce senescence in human primary cell populations 
of other muscle cell types cardiomyocytes, cardiac progenitor cells (hCPCs) and vascular 
smooth muscle precursor cells (hVSMCs; Piegari et al., 2013; Bielak-Zmijewska et al., 
2014; Lewis-McDougall et al., 2019). High doses of DOX can cause apoptosis whereas low 
doses in the range of 0.1-1 µm have been shown to induce the senescent phenotype 
(Rebbaa et al., 2003; Eom et al., 2005). The fact that DOX has not been previously 
documented in skeletal muscle opened new possibilities to investigate the mechanisms 
of stress-induced senescence underlying the generation of senescent cell populations of 
skeletal muscle origin.  
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It has been postulated that DOX induces senescence though many mechanisms but 
primarily thought direct intercalation into DNA, preventing the synthesis of macro-
molecules. DOX has also been shown to cause DNA damage by the generation of free 
radicals which cause further damage to DNA, as well as, lipid peroxidation and protein 
carbonyls (De Angelis et al., 2010). DNA is also damaged by the induction of cross-links 
between DNA, interference with DNA unwinding and strand separation, altered helicase 
activity and initiation of DNA damage via inhibition of topoisomerase II (Gewirtz, 1999). 
This DNA damage is initiated immediately after addition of DOX, however, the senescent 
phenotype takes time to develop which is different depending on DOX dose and 
treatment length, as well as, depending on the cell type being treated (Thorn et al., 2011). 
This chapter describes the application of DOX-induced senescence, to human 
primary cell populations derived from skeletal muscle; muscle precursor cells (MPCs) and 
skeletal muscle origin fibroblasts. The aim was to gain further insight into the senescent 
characteristics of these cell populations. These experiments were carried out on the same 
biopsy samples concurrently with replicative experiments and are therefore directly 
comparable with their replicative equivalent.  
5.1.1. Aims 
(1) To use DOX to induce senescence in purified populations of human primary 
myogenic precursor cells and skeletal muscle origin fibroblasts obtained from the same 
muscle biopsy sample. 
(2) To compare senescent marker and SASP expression within both cell types  
It is hypothesised that treatment with DOX will induce senescent phenotypes in both 
human primary myogenic precursor cells and skeletal muscle origin fibroblasts. As 
senescence is a universal cell phenomenon, senescent markers and the SASP will be 
similarly expressed in both cell types. 
 CHAPTER 5: DOX-INDUCED SENESCENT PHENOTYPES OF HUMAN SKELETAL MUSCLE 
PRECURSOR CELLS 146 
 
5.2. Methods 
5.2.1. Participants and muscle biopsies 
The participants from whom muscle biopsy samples were obtained and used in this 
chapter are previously described in the general methods 2.1 and were the same as for 
experiments in the replicative senescence chapter 4. 
5.2.2. Doxorubicin treatment (DOX)  
Informed by a dose response study for DOX on human cardiac progenitor cells 
(Ellison-Hughes lab, 2017; Lewis-McDougall et al., 2019)). A similar pilot experiment was 
undertaken on the skeletal muscle-derived cells. From the cardiac study a dose of 0.2 µm 
exposed for 24 hours was initially chosen to investigate DOX-induced senescence in MPCs 
and fibroblasts. 
Following successful induction of senescence by carrying out this pilot study, cellular 
senescence was induced by incubating myoblasts and skeletal muscle origin fibroblasts 
(day 22 post biopsy) with DOX (0.2 µM) for 24 hours. After 24 hours Doxorubicin was 
removed, and cultures were thoroughly washed (PBS x5) before fresh growth medium 
was added. Induction of senescence was assessed at 1, 4, 7, 10, 14, 21, 28 and 35 days 
after DOX treatment.  
The same markers used to assess replicative senescence were used to assess DOX 
induced senescence; SA β-Gal, immunostaining for p16, Ki67 and γH2aX alongside, RT q-
PCR for SASP factor expression.  
5.2.3. Myotube formation assay 
The myotube formation assay was undertaken with defrosted aliquots of samples 
because the usual method employed to perform the myotube assay was not compatible 
with DOX treatment. The myotube assay is usually performed on cells attached to glass 
coverslips coated in collagen to help the cells adhere. However, when these cells were 
treated with DOX they detached from the coverslips therefore were unable to be used for 
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analysis because the density of cells remaining on the coverslips was too sparse for 
accurate comparison. Other laboratories perform the myotube formation assay in plastic 
wells, however, the refractory index of standard laboratory plastics is not high enough to 
perform the automated cell by cell expression analysis achievable with glass coverslips. 
There are better quality plastics with better refractory indices that are suitable to obtain 
the cell by cell data. Two types of these plastic chamber slides were used, one coated in 
poly-L-lysine the other coated in collagen-IV, to test if DOX treated MPCs remained 
attached. Representative images from the collagen-IV coated sample shows that the cells 
remain adherent to the plastic and cells without DOX treatment are able to undergo 
similar differentiation to those on glass collagen coated glass coverslips. 
 
Figure 5.1 Polymer slides can be used to undertake the myogenic differentiation assay using DOX 
treated myoblasts.  
Myoblasts were induced to differentiate four days after DOX treatment or without DOX treatment. 
After 96h and stained for Stained for DAPI (blue) and Myosin heavy chain (red) Scale bar = 100 µm. 
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5.3. Results DOX-Induced Myoblast  
5.3.1. Desmin expression is maintained after DOX treatment 
Desmin expression of CD56+ve myogenic precursor cells was determined before, and 
at eight time points after DOX treatment. There was a slight, but statistically significant 
(p=0.025), decrease in the number of desmin positive cells only at 35 days post-DOX 
treatment, which was 90.8±2.3%, when compared to pre DOX treatment, 96.1±2.8% 
(Figure 5.2). All time points for all CD56+ve cell populations were considered to be pure 
desmin populations and could then be analysed for senescent marker expression. 
5.3.2. Senescent and proliferation marker expression 
5.3.2.1. Ki67 expression is decreased after DOX treatment 
Representative images suggest that the number of cells expressing cell cycle protein 
Ki67 is decreased 24 hours post DOX treatment and very few cells express Ki67 four days 
after DOX treatment (Figure 5.3). Quantification of Ki67 protein expression shows a 
significant reduction 24 hours post-DOX treatment relative to pre-DOX treatment (P = 
0.02, fold change=0.54±0.26, Figure 5.4). A further reduction, relative to pre-DOX 
treatment, was observed after four days (P = 0.005, fold change=0.07±0.02) which was 
maintained through to 35 days after DOX treatment (P = 0.01, fold change=0.11±0.07). 
Thus, all cell populations were determined to have exited the cell cycle by four days post 
DOX treatment and did not re-enter the cell cycle before 35 days post-DOX treatment.  
5.3.2.2. Delayed increase in p16 expression after DOX treatment 
 To determine if the cell cycle exit observed was linked with increased senescence-
associated cell cycle inhibitors, p16 expression was determined at the same time points. 
There was a transient, but significant increase in nuclear p16 mean fluorescent intensity 
7 days post DOX treatment relative to pre-DOX treatment (P = 0.02, fold 
change=0.07±0.02, Figure 5.6). p16 significantly increased again from 14 days post DOX 
treatment and remained elevated, relative to pre-DOX treatment, through to D35 post 
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DOX treatment (P = 0.008, D14: fold change=1.89±0.32, D35: fold change=2.04±0.4). 
Therefore, p16 was not associated with the onset of cell cycle exit but accumulated over 
time following DOX treatment.  
5.3.2.3. Transient DNA damage immediately after DOX treatment 
DOX is known to cause DNA damage and this is thought to be the mechanism with 
which DOX induces senescence (Thorn et al., 2011). DNA damage was investigated by 
detecting double strand breaks by staining for γH2aX. There was a significant increase in 
mean nuclear γH2aX mean fluorescent intensity one day after DOX treatment compared 
to pre DOX treatment (P = 0.02, fold change=3.3±1.1, Figure 5.8). This elevated DNA 
damage returned to pre-DOX treatment levels by four days post DOX treatment and 
remained unchanged through to D35 post DOX treatment.  
5.3.2.4. Senescence associated β-Galactosidase positive cells 
accumulate after DOX treatment 
The DOX treatment experiments were undertaken at the same time as the replicative 
senescence experiments and therefore, due to the same technical issues (Methods 
section 2.5.1), SA β-Gal could only be determined in Y05+ and Y06+ cell populations. Both 
cell populations started with approximately 25% SA β-Gal positive cells at pre-DOX 
treatment. The percentage of SA β-Gal positive cells was increased 1 day after DOX 
treatment to approximately 50% and further increased to around 100% by four days post 
DOX treatment, which was maintained through to D35 post DOX treatment. 
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Figure 5.2. Desmin expression is maintained after DOX treatment. 
Sub populations of cells (20,000 cells) from each of the 6 individual CD56+ve cell populations were 
cytospun before, and at eight time points after, DOX treatment and stained for nuclei and desmin 
to determine percentage of desmin+ve cells by a bespoke automated image analysis program. The 
percentage of desmin positive cells across the replicative lifespan of individual myoblast 
populations. Individual cell population means determined from percentage desmin positive cells 
per field of view, 10 fields of view per time point, minimum of 100 cells analysed in total per time 
point, N=6 CD56+ve cell populations. Data presented as population Mean±SD. Statistical analysis 
using one-way RM ANOVA with Dunnett’s test for multiple comparisons reveals sig. difference for 
D35 relative to Pre-DOX treatment *P =0.025.  
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Figure 5.3. Representative images of individual CD56+ve cell populations Ki67 expression across 
Doxorubicin time course. 
Sub populations of cells (20,000 cells) from each CD56+ve cell population were cytospun at different 
timepoints across the post DOX treatment time course and stained for desmin (green), Ki67 (red) 
and DAPI (Blue). Scale bar = 100 µm. 
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Figure 5.4. Nuclear Ki67 expression decreases across Doxorubicin treatment time course. 
A) Individual CD56+ve cell popualtions changes in Ki67 mean fluorescent intensity across the 
Doxorubicin treatment time course presented as fold change in mean of all individual nuclei Ki67 
relative to pre-DOX treatment expression. B) Mean of all CD56+ve cell populations mean nuclei Ki67 
mean fluorescent intensity presented as fold change from each individual population pre-DOX 
treatment expression. Statistical analysis (one-way RM ANOVA with Dunnett’s test) shows 
significant differences relative to Pre * indicates P <0.05, **** indicates p < 0.001, N=6). 
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Figure 5.5. Representative images of individual CD56+ve cell populations p16 expression across 
Doxorubicin time course. 
Sub populations of cells (20,000 cells) from each CD56+ve cell population were cytospun at different 
timepoints across the Doxorubicin time course and stained for desmin (green), p16 (red) and DAPI 
(Blue). Scale bar = 100 µm. 
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Figure 5.6. Nuclear p16 expression increases after Doxorubicin treatment. 
A) Individual CD56+ve cell popualtions changes in p16 mean fluorescent intensity across the 
Doxorubicin treatment time course presented as fold change in mean of all individual nuclei 
relative to pre DOX treatment expression. B) Mean of all individual nuclei p16 mean fluorescent 
intensity. * indicate significant different to pre (one-way RM ANOVA with Dunnett’s test, P <0.05, 
N=6).  
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Figure 5.7. Representative images of γH2aX expression across Doxorubicin time course of 
individual biopsies. 
Sub populations of cells (20,000 cells) from each biopsy were cytospun at different timepoints 
across the Doxorubicin time course and stained for desmin (green), γH2aX (red) and DAPI (Blue). 
Scale bar = 100 µm. 
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Figure 5.8. Nuclear γH2aX expression transiently increases 24 hours after Doxorubicin treatment. 
A) individual CD56+ve sample γH2aX Mean of all individual nuclei γH2aX mean fluorescent intensity 
across the Doxorubicin treatment time course. B) Mean of all individual nuclei γH2aX mean 
fluorescent intensity. * indicate significant different to Pre (one-way RM ANOVA with Dunnett’s 
test, P <0.05, N=6). 
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Figure 5.9. Muscle precursor cells express SA β-Gal from four days after DOX treatment. 
A) Sub populations of cells (25,000 cells) from Y05+ and Y06+ cell population were plated for SA β-
Gal analysis before, and at eight time points after, DOX treatment. The percentage of SA β-Gal 
positive cells was determined at each time point for the individual myoblast populations. Data 
shown as individual cell population means determined from percentage SA β-Gal positive cells per 
field of view, 10 fields of view per time point, minimum of 100 cells analysed in total per time point. 
Both cell populations responded very similarly and therefore their symbols are overlapping.  B) 
Representative images of SA β-Gal positive cells Pre, 1 day, 4 days and 35 days after DOX treatment.  
Scale bar = 100 µm. 
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5.3.3. Senescence and SASP factor expression  
The fold change in mRNA expression for each of the individual senescence associated 
and SASP factors over the post DOX time-course relative to each individual CD56+ve cell 
population pre DOX treatment expression level are presented in Figure 5.10 and Figure 
5.11. Figure 5.10 shows the heterogeneity between the individual cell populations 
whereas Figure 5.11 shows the different expression patterns across the time course of 
the different SASP factors. As expected from the immunostaining data, statistical 
significance was seen in the senescence associated cell cycle inhibitors. There was an 
increase in p21 mRNA from one day post DOX treatment through to 35 days post DOX 
treatment with the exception of 28 days post DOX treatment. Whereas, p16 mRNA was 
increased later, from 4 days post DOX treatment through to 35 days post DOX treatment 
with the exception of 21 days post DOX treatment. IL-8 was significantly increased at 28 
days post DOX treatment and β-Gal expression was significantly increased 21 days and 35 
days after DOX treatment. IGFBP-3 was significantly decreased at one day but then 
significantly increases at 21 days post DOX treatment. Two factors, CXCL5 and PAI-1, 
showed decreases across the time course with CXCL5 significantly reduced from 4 days 
post DOX through to 35 days post DOX except for 28 days post DOX. Whereas, PAI-1 
reduced 4 days post DOX treatment through to 21 days post DOX treatment. 
5.3.4. Myotube formation is impaired by DOX treatment 
The myogenic differentiation assay couldn’t be carried out in parallel with the other 
analysis due to technical issues mentioned in the methods. Fusion index of myoblasts four 
days after DOX-treated myoblast populations was significantly lower than untreated cells 
(P < 0.01, 57.8±6.9% reduced to 9.0±3.9% fusion; Figure 5.13). After 35 days in culture, 
myotube formation had spontaneously occurred without the removal of serum in some 
cultures. With the removal of serum there was a large variability in fusion between cell 
populations (23.8±23.1% fusion). However, the morphology of all myotubes post-DOX 
treatment were thinner and contained fewer nuclei that pre-DOX treated cells (Figure 
5.12). 
 CHAPTER 5: DOX-INDUCED SENESCENT PHENOTYPES OF HUMAN SKELETAL MUSCLE 
PRECURSOR CELLS 159 
 
 
Figure 5.10. Individual myoblast cell populations expression of each SASP factor after DOX 
treatment. 
Individual CD56+ve cell populations mRNA expression of twelve known SASP factors presented as 
fold change relative to individual populations pre-DOX treatment expression levels across eight 
time points post DOX treatment. Statistics performed on grouped data in Figure 5.11. Figure 
continues on next page.    
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Figure 1.10. continued.  
Refer back to figure legend on previous page. 
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Figure 5.11. Doxorubicin treated myoblasts have altered mRNA expression of known SASP 
factors. 
mRNA expression of twelve known SASP factors presented as mean fold change relative to each 
individual cell populations pre DOX treatment expression levels across eight time points post DOX 
treatment. * indicate significant different to Pre (one-way RM ANOVA with Dunnett’s test for each 
SASP factor, P <0.05, N=6). Figure continues on next page. 
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Figure 5.11. continued.  
Refer back to figure legend on previous page.  
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Figure 5.12. Myotube formation is impaired by DOX treatment. 
Representative images of DOX treated CD56+ve cell populations before and after being induced to 
differentiate by serum withdrawal for 96 hours at time points before DOX treatment, four days 
and 35 days after DOX treatment. Stained for DAPI (blue) and Myosin heavy chain (red) Scale bar 
= 100 µm. 
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Figure 5.13. DOX treated myoblasts fuse less well into myotubes. 
Myoblasts before DOX treatment, four days and 35 days after DOX treatment were induced to 
differentiate and form myotubes. The fusion index, percent of nuclei incorporated into myosin 
heavy chain positive myotubes, is lower in populations of DOX treated cells. Data shown as 
population Mean±SD n=5. Individual cell population means determined from percentage of fused 
nuclei per field of view, 10 fields of view per time point, minimum of 100 cells analysed in total per 
time point. * indicate significant different between Pre and D4 (one-way RM ANOVA with Tukey’s 
multiple comparisons test, P <0.05, N=6). 
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5.4. Results: DOX-induced Fibroblasts 
5.4.1. TE7 expression is maintained after DOX treatment 
The percentage of TE7 positive cells remained unchanged through to 35 days post 
DOX treatment (P = 0.06). All cell populations were therefore deemed to be pure 
fibroblasts and could be used for analysis of senescence marker expression. 
5.4.2. Senescent and proliferation marker expression 
5.4.2.1. Ki67 expression is decreased after DOX treatment 
Representative images show that the number of cells expressing cell cycle protein 
Ki67 was decreased 24 hours after DOX treatment and very few cells expressed Ki67 four 
days after DOX treatment (Figure 5.15). Quantification of Ki67 protein expression shows 
a significant reduction 24 hours after DOX treatment relative to pre-DOX treatment (P < 
0.001, fold change=0.23±0.13, Figure 5.16). A further reduction, relative to pre-DOX 
treatment, was observed after four days (P < 0.001, fold change=0.08±0.02) which was 
maintained through to 35 days after DOX treatment (P < 0.001, fold change=0.16±0.04). 
Thus, all cell populations were determined to have exited the cell cycle by four days post 
DOX treatment and did not re-enter the cell cycle before 35 days post DOX treatment. 
5.4.2.2. p16 protein levels remains unchanged after DOX treatment 
To determine if the cell cycle exit observed was related to increased senescence 
associated cell cycle inhibitors, p16 expression was determined at the same time points. 
Representative images show the different expression levels between the individual 
fibroblast cell populations (Figure 5.17). No significant increase in mean nuclear p16 mean 
fluorescent intensity was seen at any time point relative to pre-DOX treatment (P = 0.52). 
Therefore, p16 was not associated with the onset of cell cycle exit or senescence induction 
observed in these fibroblasts cell populations. 
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Figure 5.14. TE7 expression is maintained after DOX treatment. 
Sub populations of cells (20,000 cells) from each CD56-ve cell population were cytospun before, and 
at eight time points after, DOX treatment and stained for nuclei and TE7 to determine the 
percentage of TE7 positive cells across the DOX treatment time course for individual fibroblast 
populations by a bespoke automated image analysis program. Data shown as population 
Mean±SD, no significant difference one-way RM ANOVA with Dunnett’s test, P <0.05, N=6. 
Individual cell population means determined from percentage TE7 positive nuclei per field of view, 
10 fields of view per time point, minimum of 100 cells analysed in total per time point. 
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Figure 5.15. Representative images of TE7 expression after DOX treatment. 
Sub populations of cells (20,000 cells) from each CD56-ve cell population were cytospun at different 
timepoints across the Doxorubicin time course and stained for TE7 (green), Ki67 (red) and DAPI 
(Blue). Scale bar = 100 µm. 
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Figure 5.16. Nuclear Ki67 expression decreases across Doxorubicin treatment time course. 
A) individual CD56-ve sample Ki67 Mean of all individual nuclei Ki67 mean fluorescent intensity 
across the Doxorubicin treatment time course. B) Mean of all individual nuclei Ki67 mean 
fluorescent intensity. **** indicate significant different to Pre (one-way RM ANOVA with Dunnett’s 
test, P <0.05, N=6).  
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Figure 5.17. Representative images of p16 expression across Doxorubicin time course of 
individual biopsies. 
Sub populations of cells (20,000 cells) from each biopsy were cytospun at different timepoints 
across the Doxorubicin time course and stained for TE7 (green), p16 (red) and DAPI (Blue). Scale 
bar = 100 µm. 
 
 
 CHAPTER 5: DOX-INDUCED SENESCENT PHENOTYPES OF HUMAN SKELETAL MUSCLE 
PRECURSOR CELLS 170 
 
 
Figure 5.18. Nuclear p16 expression trends to increase across time course after Doxorubicin 
treatment. 
A) individual CD56+ sample p16 Mean of all individual nuclei p16 mean fluorescent intensity across 
the Doxorubicin treatment time course. B) Mean of all individual nuclei p16 mean fluorescent 
intensity, no significant difference using a one-way RM ANOVA with Dunnett’s test, P <0.05, N=6. 
 CHAPTER 5: DOX-INDUCED SENESCENT PHENOTYPES OF HUMAN SKELETAL MUSCLE 
PRECURSOR CELLS 171 
 
5.4.2.3. γH2aX expression is unchanged after DOX treatment 
DOX is known to cause DNA damage and this is thought to be the mechanism with 
which DOX induces senescence (Thorn et al., 2011). DNA damage was investigated by 
detecting double strand breaks by staining for γH2aX. Representative images suggest an 
increase in mean nuclear γH2aX mean fluorescent intensity one day after DOX treatment 
compared to pre-DOX treatment however no statistical significance was found (p = 0.13). 
5.4.2.4. Senescence Associated β-Galactosidase expression 
The DOX treatment experiments were undertaken at the same time as the replicative 
senescence experiments and therefore, due to the same technical issues (Methods 
section 2.5.1), SA β-Gal could only be determined in Y05+ and Y06+ fibroblast cell 
populations. Both cell populations started with around 10% SA β-Gal positive cells at pre-
DOX treatment, day 22 after biopsy, thus showing similar expression to replicative 
passages cells at the same timepoint (Figure 5.21). The percentage of SA β-Gal positive 
cells was increased to around 50% 4 days after DOX treatment and further increased up 
to around 100% by seven days after DOX treatment, which was maintained through to 
D35 post DOX treatment. 
5.4.3. Senescence and SASP factor expression  
Figure 5.22 and Figure 5.23 show the fold change in mRNA expression for each of the 
individual senescence associated and SASP factors over the post DOX time-course relative 
to each individual fibroblast cell population’s pre DOX treatment expression level. Figure 
5.22 shows the heterogeneity between the individual cell populations whereas Figure 
5.23 shows the different expression patterns across the time course of the different SASP 
factors. The senescence associated cell cycle inhibitor p21 was transiently significantly 
increased 1 day after DOX treatment returning to baseline within four days. Upregulation 
of p16 mRNA increased across time reaching significance at 10 and 35 days after DOX 
treatment. There was also a transient significant increase in TGF-β between 7 and 10 days 
post DOX treatment. Finally, IGFBP3 expression was significantly reduced 1 day after DOX 
treatment but this was followed by significant increases 10 days, 14 days and 35 days post 
DOX treatment (Figure 5.23  
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Figure 5.19. Representative images of γH2aX expression across Doxorubicin time course of 
individual biopsies. 
Sub populations of cells (20,000 cells) from each biopsy were cytospun at different timepoints 
across the Doxorubicin time course and stained for TE7 (green), γH2aX (red) and DAPI (Blue). Scale 
bar = 100 µm. 
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Figure 5.20. Nuclear γH2aX expression transiently increases 24 hours after Doxorubicin 
treatment. 
A) individual CD56-ve cell populations γH2aX Mean of all individual nuclei γH2aX mean fluorescent 
intensity across the Doxorubicin treatment time course. B) Mean of all individual nuclei γH2aX 
mean fluorescent intensity. No significant difference using a one-way RM ANOVA with Dunnett’s 
test, P <0.05, N=6.  
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Figure 5.21. Skeletal muscle origin fibroblasts express SA β-Gal from four days after DOX 
treatment. 
A) Sub populations of cells (25,000 cells) from Y05+ and Y06+ cell population were plated for SA β-
Gal analysis before, and at eight time points after, DOX treatment. The percentage of SA β-Gal 
positive cells was determined at each time point for the individual myoblast populations. Data 
shown as individual cell population means determined from percentage SA β-Gal positive cells per 
field of view, 10 fields of view per time point, minimum of 100 cells analysed in total per time point. 
B) Representative images of SA β-Gal positive cells Pre, 1 day, 4 days and 35 days after DOX 
treatment.  Scale bar = 100 µm. 
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Figure 5.22. Individual fibroblast cell populations expression of each SASP factor after DOX 
treatment. 
Individual CD56-ve cell populations mRNA expression of twelve known SASP factors presented as 
fold change relative to individual populations pre-DOX treatment expression levels across eight 
time points post DOX treatment. Statistics performed on grouped data in Figure 5.23. Figure 
continues on next page.    
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Figure 1.21. continued.  
Refer back to figure legend on previous page. 
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Figure 5.23. Expression of each SASP factor after DOX treatment. 
mRNA expression of twelve known SASP factors presented as mean fold change relative to each 
individual cell populations pre-DOX treatment expression levels across eight time points post DOX 
treatment. * indicate significant different to Pre (one-way RM ANOVA with Dunnett’s test for each 
SASP factor, P <0.05, N=6). Figure continues on next page.    
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Figure 5.23. continued.  
Refer back to figure legend on previous page.  
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5.5. Myoblasts and Fibroblasts comparison 
The individual cells type data presented previously was then compiled to compare 
the expression differences between the two cell types to determine if there were 
differences in their response to the identical senescence inducing stimulus, 0.2 µm DOX. 
Both myoblast cell populations entered senescence more quickly than fibroblasts 
reaching roughly 100% SA β-Gal positive after four days compared to the two fibroblast 
cell populations which were 57% and 61% SA β-Gal positive. As SA β-Gal was only analysed 
in two cell populations statistical analysis could not be undertaken. Both cell types showed 
similar significant decreases in Ki67 expression after DOX treatment at both four days and 
35 days post DOX treatment (N=6, p > 0.05). Neither cell type had significant changes in 
p16 protein expression from pre-DOX samples 4-days after DOX treatment. However, 
when there was a significant increase in p16 protein expression in MPCs at 35-days post 
DOX treatment and no significant increase in fibroblasts there was no significant 
difference between cell types when they were compared (p = 0.12). and neither There 
was a significantly higher increase in γH2aX expression in myoblasts compared to 
fibroblasts (N=6, p < 0.001. Figure 5.24). 
The SASP expression of myoblasts and fibroblasts was also compared four and 35 
days after DOX treatment. Here, myoblasts showed significantly higher increases in 
expression of IGFBP7 and IL6 as well as senescence associated marker p21 compared to 
fibroblasts relative to their pre-DOX treatment expression levels (N=6, p < 0.05). After 35 
post DOX treatment myoblasts showed significantly elevated expression of MMP3 (N=6 p 
< 0.001). 
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Figure 5.24 Senescent marker comparison of myoblasts and fibroblasts 
Data from the cell types graphs presented earlier to show the comparison between the paired 
myoblast and fibroblasts populations for expression of senescent markers. A) The percentage of 
SA β-Gal positive cells is higher in both myoblasts cell populations compared to the fibroblasts cell 
populations before DOX treatment and four days after DOX treatment. By 35 days post DOX 
treatment both cell populations were 100% SA β-Gal positive. Statistical analysis could not be 
performed as both groups were N=2. B) Ki67 fold change relative to pre-DOX treatment for each 
individual cell type is not significantly different after either four- or 35-days post DOX treatment 
(N=6, p > 0.05). C) Fold change increase in γH2aX expression was significantly higher in myoblasts 
1 day after Dox treatment compared to fibroblasts before both populations return to pre-DOX 
treatment levels by four days post DOX treatment (N=6, p < 0.001). D) There was no significant 
difference in fold change relative to pre-DOX treatment in p16 expression between myoblasts and 
fibroblasts (N=6, p > 0.05). 
 CHAPTER 5: DOX-INDUCED SENESCENT PHENOTYPES OF HUMAN SKELETAL MUSCLE 
PRECURSOR CELLS 181 
 
 
Figure 5.25 SASP expression difference between myoblasts and fibroblasts 
Data from the cell types graphs presented earlier to show the comparison between the paired 
myoblast and fibroblasts populations for expression of a small panel of SASP factors. A) Four days 
after DOX treatment myoblast cell populations have significantly higher fold changed relative to 
pre-DOX treatment for IGFBP7, IL6 and p21 compared to fibroblasts (N = 6, p < 0.05). B) 35 days 
after DOX treatment myoblast cell populations have significantly higher fold changed relative to 
pre-DOX treatment for MMP3 compared to fibroblasts (N = 6, p < 0.05). 
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5.6. Discussion 
The aim of the work undertaken in the chapter was to study senescent phenotypes 
in human skeletal muscle-derived myoblast and fibroblasts as a result of the induction of 
senescence with the chemotherapy drug, DOX. It was planned that by using a uniform 
trigger for the induction of senescence in all cells the limitation of replicative senescence 
protocols would be removed, and further insight gained.  
     A previous study used hydrogen peroxide (H2O2) to induce senescence in human 
myoblasts (Renault et al., 2002c). Interestingly human myoblasts require very high 
concentrations (1mM) of H2O2 to induce senescence whereas other cell types have been 
shown to only need 50-200 µM (Chen et al., 2001; Dumont et al., 2001). Human myoblasts 
treated with H2O2 showed reduced cumulative population doublings by 10%, although the 
cells were treated after ¾ of their normal replicative life span so it could have been shorter 
if they were treated earlier. Myogenic cell proportion was maintained at 75-80% and cells 
were myogenin negative confirming that these cells had not been triggered to 
differentiate, although no marker of senescence was used. When induced to differentiate 
Myotube formation, in terms of number of nuclei incorporated, was not affected by H2O2 
treatment. However, after H2O2 treatment 33.4% of cells still incorporated BrdU within a 
72-hour period suggesting that the treatment had not induced senescence in the whole 
cell population. Therefore, a more potent inducer of senescence was required. 
The results of the present work showed that DOX treatment induces a senescent 
phenotype in both human skeletal muscle derived MPCs and fibroblasts. Both cell 
populations were 100% positive for the gold standard senescence marker SA β-Gal within 
7 days post DOX treatment and stayed that way throughout the 35 days post DOX 
treatment. Similar results where shown by Bielak-Zmijewska et al., (2014), who treated 
hVSMCs with 0.1 µM DOX for one, three and seven days. They showed increases in SA β-
Gal positive cells up to around 100% positive by 7 days of treatment. Piegari et al., (2013), 
using human cardiac progenitor cells, also showed by 7 days post treatment the number 
of SA β-Gal positive cells had increased to over 75% after 0.1 µM DOX treatment. 
Both skeletal muscle origin cell types had very low expression of Ki67 by four days 
post DOX treatment suggesting the populations were not undergoing cell division. hCPCs 
also showed a slowing of proliferation with over 50% reduction in BrdU expression after 
 CHAPTER 5: DOX-INDUCED SENESCENT PHENOTYPES OF HUMAN SKELETAL MUSCLE 
PRECURSOR CELLS 183 
 
24 hour DOX treatment but complete proliferative arrest after 48 hours of DOX treatment 
with 0.1 µM DOX (Piegari et al., 2013). Similar to the skeletal muscle cell populations in 
the present study, proliferative arrest was maintained 7 days after DOX treatment as 
shown by low BrdU incorporation and very few cells expressing Ki67 (Piegari et al., 2013). 
Whereas, hVSMCs ceased to proliferate, as measured by cell counts, immediately after 
DOX treatment (Bielak-Zmijewska et al., 2014). 
Senescence and cell cycle exit is usually associated with the cell cycle inhibitors p16 
and p21. Both MPC and fibroblast cell types showed elevated p21 mRNA levels within 24 
hours of DOX treatment which was transient for fibroblasts but remained elevated for 
myoblasts. Whereas upregulation of mRNA expression of p16 was delayed until four, and 
ten days after DOX treatment in myoblasts and fibroblasts, respectively. Myoblasts also 
maintained p16 mRNA elevation through to 35 days post DOX treatment, however 
fibroblasts only reached significance again at 35 days post DOX treatment. When 
measured at the protein level, from the image analysis data, the delayed upregulation of 
p16 was confirmed for myoblasts but did not reach significance in the fibroblasts. 
Interestingly, hVSMCs and hCPCs both showed increased p53, phosphorylated p53 and 
p16 immediately after 0.1 µM DOX treatment, but only hVSMCs showed transiently 
increased p21 (Piegari et al., 2013; Bielak-Zmijewska et al., 2014). In the hCPCs p16 
expression increased seven days after DOX treatment in terms of overall expression and 
number of cells staining positive (Piegari et al., 2013). This data taken together would 
suggest that p21 was more likely to be involved in the initialisation of DOX induced 
senescence in the skeletal muscle origin and hVSMCs cell types, whilst p16 is more likely 
involved in the maintenance of the senescent state in all cell types. 
DOX induces senescence by causing DNA damage. The transient increase in double 
strand breaks, as measured by γH2aX, seen in myoblasts, and a trend similar in fibroblasts, 
suggests that DOX treatment did induce DNA damage. The immediate upregulation of p21 
also supports this mechanism, as p21 is the downstream cell cycle inhibitor of the DNA 
damage response. Interestingly, γH2aX expression returned to baseline within four days 
post DOX treatment, suggesting that the DNA damage has been repaired and the double 
stand breaks are no longer present. However, the other senescence markers support 
these cells being senescent at the population level. The 0.1 µM DOX treated hVSMCs and 
hCPCs did not show an upregulation of γH2aX but when they were treated with 1 µM DOX 
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there was a clear elevation in DNA damage (Piegari et al., 2013; Bielak-Zmijewska et al., 
2014). Similarly, to the low dose treated hVSMCs, the DNA damage insult never reached 
significance in the fibroblast populations, the expression of SA β-Gal and lack of Ki67 
would suggest that the DOX dose was sufficient to induce a senescent state even without 
significant increases in DNA double strand breaks.  
These findings show that DOX does induce senescence in both myoblast and 
fibroblast cell populations, but they do not express all the same markers. This is consistent 
with the finding from other human primary cell types supporting the notion that the 
induction of senescence may not be identical (Piegari et al., 2013; Bielak-Zmijewska et al., 
2014; Xu et al., 2015a; Lewis-McDougall et al., 2019). Our results support the notion that 
SA β-Gal is the strongest marker of senescent cells when used in cell populations that do 
not normally express it. Ki67 is a strong corroborator of SA β-Gal to confirm that cells are 
not undergoing division however it does not confirm the cell cycle exit is senescence-
related on its own. Cell cycle inhibitor and DNA damage expression are not uniform 
between the two cell types and are therefore not reliable markers of the senescent state 
in these cell populations. 
This study employed a time course to determine when these cell populations become 
senescent because it was not known how long after DOX treatment skeletal muscle origin 
cells would take to develop a senescent phenotype. Using SA β-Gal as the marker would 
suggest that by four and seven days post DOX treatment, for myoblasts and fibroblasts 
respectively, these cell populations were senescent. However, if p16 protein was used as 
the marker then fibroblasts would never be deemed senescent and the myoblasts could 
only be considered senescent after 14 days post DOX treatment. These discrepancies in 
senescence marker alignment are often overlooked when investigating the secretory 
profile of cell populations. Bielak-Zmijewska et al., (2014) observed significant increases 
in secreted IL6, IL8 and VEGF after three and seven days of DOX treatment, however there 
was no further follow up and therefore it is unclear whether these markers remained 
elevated or returned to a baseline measurement over time. 
The aim of these experiments was to determine when both cell populations had 
reached a senescent state and then to investigate their SASP at that time point. However, 
the inconsistencies in the time course of senescence markers led to examining the mRNA 
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expression of known SASP factors across the time course. Here, again, temporal 
fluctuations in SASP factor expression were seen in both cell types. Although, some factors 
showed similar trends for increased or decreased expression in all cell populations the 
magnitude of the change was very variable between individuals. Therefore, none of this 
small panel of SASP factors showed a clear marker characteristic with large temporal and 
individual variability within and between the cell types.  
These results also highlight the issue of selecting a single time point to determine the 
SASP of a cell population. Both myoblasts and fibroblasts could be considered senescent 
at multiple time points across the time course employed and the SASP profile would be 
different depending on which of the time points was chosen. Therefore, drawing 
conclusion about the SASP profile of a cell type should be interpreted with a lot of caution. 
Additionally, the interindividual variation in SASP profiles which would not be seen by cell 
line studies as the genetic diversity of the samples used in high showing that even when 
cell populations from different individuals are treated in identical conditions their 
secretory profile is variable. What this study did not investigate was the individual cellular 
level of SASP factor expression. From the image analysis data, it is clear that there is high 
variability in cell to cell expression for all markers and therefore there is likely to be cell 
to cell variability in SASP factor expression as well.  
Individual cell SASP has been investigated recently in other fibroblast cell 
populations. IMR-90 cells, a human foetal lung fibroblast cell line, induced to be senescent 
after treatment with the cancer therapeutic, bleomycin  (50 μm), for 3hrs showed that 
they could identify senescent cells, however across their transcriptome there were 
marked differences in expression of key SASP factors such as within the CXCL and 
interleukin families (Wiley et al., 2017). Another study showed that there was more 
heterogeneity in populations of replicative senescent HCA2, human foreskin, fibroblasts 
than when the same cells were induced to become senescent via irradiation at a dosage 
of 50 Gy (Tang et al., 2019). A hypothesis for this difference in heterogeneity between 
senescence induction methods could be that within a replicative senescing cell population 
there is a stochastic element to their senescence induction where cells become senescent 
at different times across the replicative passaging (Shall & Stein, 1978). Whereas, by 
inducing a premature senescent state on the cell population, like through DOX, a 
synchronisation of entering senescence is achieved, thus aligning their senescent 
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phenotype to a greater extent. However, even when there is synchronisation of entry into 
senescence there is still variability at both the cell population level as shown by the data 
presented in this chapter and also the single cell level as shown by the Tang et al., (2019) 
study. Although there is variability, the overall cell population does show an altered 
inflammatory profile. Using the small panel of SAP factors assessed here could potentially 
be useful to identify differences between cell populations extracted from young and old 
human biopsies without the need for expensive whole transcriptome and secreted 
proteome analysis. 
This study also set out to investigate the functional capacity of senescent MPCs. The 
ability of MPCs to fuse together to form myotubes was significantly impaired at four days 
post DOX treatment. The fusion index of untreated cells was lower than that on the early 
passage replicative cells, 60% compared to 80% fused nuclei. This was because the cells 
used for the DOX experiments were of a later passage due to the technical issues 
encountered with the DOX treating cell on glass coverslips. As the results of the replicative 
senescence chapter and work by Alsharidah et al., (2013) showed there is a decline in 
fusion index with increased passaging. The fusion index 35 days after DOX treatment was 
not significantly different to untreated cells. What can be seen from the images is that 
over 35 days myogenic differentiation and fusion starts to occur without the removal of 
serum, this, in conjunction with the lower fusion index of the untreated cells could suggest 
why fusion index in not significantly different between these two time points. 
Additionally, the visual appearance of the myotubes form 35 days after DOX treatment 
and thin and spinally without the large number of nuclei per myotube seen in the 
untreated cells suggesting that thee myotubes formed were of poorer quality. The 
differentiation capacity of DOX induced hCPCs to differentiate into cardiomyocytes and 
smooth muscle cells was also impaired 7 days after DOX treatment (Piegari et al., 2013). 
This would suggest that senescent cells are less able to repair and regenerate than healthy 
non-senescent cells. This was supported by the finding that hCPCs populations extracted 
from aged human heart biopsies were more senescent and differentiated less well 
compared to younger, less senescent cell populations (Lewis-McDougall et al., 2019). 
An interesting observation with regards to the fibroblasts populations was that 
towards the end of the 35 days in culture an extra cellular matrix seems to have been 
formed. This sheet stained strongly for TE7 suggesting it was a collagen structure being 
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extruded from the individual cells. There was no apparent over confluence of any of the 
fibroblast populations, as this connective tissue mesh is a commonly observed structure 
formed in confluent fibroblasts populations (Agley et al., 2015). After treating the cells 
with trypsin, the cells detach in sheets which, when disrupted by cytospun prep, causes 
some nuclei to be detached from the mesh. These nuclei do not co stain with TE7 and are 
the likely cause of the variability seen in the TE7 analysis. It is thought that these cells have 
not changed cell lineage as at early time points, they are still TE7 pure before the laying 
down of the extra cellular connective tissue.  
When the two cell types extracted from the same muscle biopsy samples were 
compared differences in response to the same DOX stimulus were observed. Myoblasts 
seemed to be more sensitive to the DOX stimuli as shown by the fibroblast cell 
populations taking longer to reach 100% SA β-Gal positivity whereas the myoblasts 
reached 100% positivity within four days. The fluorescence images were not taken in the 
same microscopy session and therefore mean fluorescence intensity could not be directly 
compared between the two cells types. Therefore, fold change in mean fluorescence 
intensity relative to each cell type pre-DOX treatment was used for comparison. 
Myoblasts showed significantly increased DNA damage caused by the treatment as 
measured by γH2aX one day after DOX treatment supporting the suggestion that 
myoblasts are more sensitive to the DOX stimulus than fibroblasts. In addition, although 
there was no difference in reduced expression of Ki67 suggesting that all cells had exited 
the cell cycle but in combination with the other markers that the fibroblasts were not as 
quickly entering into a senescent state. 
As the myoblasts entered a senescent state after four days it was decided to compare 
SASP marker expression at this time point and after 35 days when both cell populations 
had been senescent for a long time. The differences in marker expression between the 
two cell populations four days after DOX treatment showed a significantly higher 
expression of IGFBP7 and IL6, as well as, cell cycle inhibitor p21, in myoblasts. However, 
by 35 days the only significant difference within the SASP factors measured between the 
two cell types was elevated MMP3 expression from senescent myoblasts. Overall, these 
results suggest that myoblasts are more sensitive to the DOX induced stimulus that 
skeletal muscle origin fibroblasts from the same muscle biopsy. If fibroblasts are a more 
robust cell type than myoblasts this is an area where further research would be 
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enlightening. The ageing phenotype could be a result of myoblasts accumulating more 
damage as a result of accumulated stimuli whereas fibroblasts retain function for longer 
under the same stress thus allowing them to generate more connective tissue in place of 
myoblasts inability to fully regenerate muscle fibres. 
In conclusion, DOX induces senescent phenotypes in both myoblasts and skeletal 
muscle origin fibroblasts. These cell population are consistently produced without the 
labour intensity or possibility of reduced cell type proportions. The senescent cells express 
SA β-Gal, very low Ki67 and increased p16 expression, the latter only in myoblasts 
populations. Both senescent cell populations show alterations in inflammatory SASP 
factor expression but there is a high degree of individual and temporal variation. This 
heterogeneity highlights key issues with defining the SASP of a specific cell type because 
it is apparent from this study that the SASP is dynamic. However, the successful 
identification of senescent cells using this collection of markers could potentially help 
identify differences between human skeletal muscle cell populations extracted from 
young and old donors. The next chapter applies these markers to determine if differences 
can be seen in a model of the frailest, old patients undergoing surgery after suffering a 
hip fracture. 
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6. Chapter 6: Senescent characterisation 
of skeletal muscle precursor cells from 
old hip fracture patients 
6.1. Introduction 
With an ageing global population, research into the ageing process is important to 
understand what strategies may be effective in slowing the progression of ageing and also 
ameliorating the diseases associated with increasing age. With muscular skeletal disease 
accounting for 7.5% of the disease burden in those over 60 years of age (Dawson & 
Dennison, 2016), as well as, the importance of healthy skeletal muscle for maintaining 
independence and the benefit of physical activity in aged adults (Parise & Yarasheski, 
2000; Pollock et al., 2015, 2017). Skeletal muscle is a key tissue for study with regards to 
potential improvements in the ageing phenotype. 
Sarcopenia, defined as an age-related loss of muscle mass among the elderly 
population, has been associated with various adverse outcomes including frailty, falls and 
bone fractures (Cooper et al., 2012; Dodds & Sayer, 2015). The rate of muscle cross 
sectional loss is reported to be 25-33% in the seventh and eighth decades of life, with the 
rate of decline increasing further into the ninth decade of life (Young et al., 1984; Bassey 
et al., 1992). Investigating muscle satellite cell functioning in these very old and frail 
individuals would be the most likely population to find senescence cell burden, if it is 
indeed an issue within ageing skeletal muscle. This work is needed because the previous 
studies to investigate age-related senescence within human skeletal muscle precursor cell 
populations have only found limited differences when comparing otherwise healthy older 
adults (Alsharidah et al., 2013; Barberi et al., 2013; Bigot et al., 2015). 
As very few differences were seen between young and aged individuals it could also 
be that in otherwise healthy individual’s senescence is not an issue for skeletal muscle 
precursor cells. Alsharidah et al., (2013) used non-diseased otherwise healthy older adults 
whereas, Barberi et al., (2013) included a group of masters athletes, as well as, normal 
aged older adults, as they expected to see differences between the exercisers and non-
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exercisers. Neither study underwent further characterisation of these otherwise healthy 
older donors. Beyond age and sex nothing is known about their physiological health apart 
from them not being master athletes. The participants used could have been anything 
from extremely frail or sarcopenic through to recreationally active individuals. 
To investigate whether senescence is an issue in older skeletal muscle this study set 
out to use old hip fracture patients as a population suggested to be representative of the 
frailest and the worst-case scenario for aged muscle, which would theoretically be the 
most likely to be high in senescent cells. A further characterised phenotype was proposed 
to offer cell type specific factors that may be able to identify senescent cells from young 
and old donor skeletal muscle derived cell populations and therefore determine if 
senescence is involved in the ageing skeletal muscle phenotype. Therefore, this study 
used the same proliferative/senescence marker panel as the previous chapters to 
determine if there are differences in MPCs isolated from young donor and old hip fracture 
patients. 
6.1.1. Aims and Hypothesis 
To compare the senescent phenotype of human primary myogenic cells from old hip 
fracture patients and young donor cell populations after limited time in cell culture. This 
is through proliferative/senescent markers, SASP factor expression and capacity for 
myogenic differentiation. 
It was hypothesised that old hip fracture patient myogenic cell populations would 
have a higher senescent cell burden with increased SA β-Gal, increased expression of p16, 
γH2AX and SASP factors, as well as, impaired myogenic fusion, compared to their young 
donor counterparts.  
6.2. Methods 
6.2.1. Participants 
Young healthy males (n=9, 22±2 years) volunteered to provide muscle biopsies as 
described in the general methods (Section 2.1). Old hip fracture patients (N=6, 2 Male, 82 
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± 8 years) were recruited by a collaborating orthopaedic surgeon at the Guy’s and St 
Thomas’ Foundation Trust. The muscle tissue donated by the hip fracture patients was 
muscle tissue routinely removed from the proximal end of the vastus lateralis during their 
surgical procedure which is normally disposed of. All participants were briefed on 
experimental procedures, including potential discomfort or risks, and provided written 
consent. This study received ethical approval from the UK National Health Service Ethics 
Committee and the London Research Ethics Committee (REC number: 16/LO/1707). Co-
sponsorship was awarded by King’s College London and Guy’s and St Thomas’ Foundation 
Trust. All procedures complied with the human tissue act. 
6.2.2. Human primary muscle derived cells 
The cell extraction, MACS sorting and cell culture techniques used were the same as 
described in the general methods (Chapter 2). Hip fracture patient cells were initially 
expanded and frozen down at various time points after biopsy. They were then defrosted, 
and experiments were performed at the earliest passage when enough cells were 
available for all experiments. Stored samples from the young biopsies described in the 
previous work where used for these experiments along with 3 others which were 
discussed in Chapter 4 when attempting to increase the replicative senescence n 
numbers. 
6.2.3. Experimental assays  
All experimental methods have been described previously for senescent marker and 
SASP factor expression, as well as, the differentiation assay.  
6.3. Results 
6.3.1. Hip fracture cells were slow to expand 
The hip fracture patient muscle samples were originally expanded for different 
lengths of time to reach critical mass to freeze down efficiently. Once defrosted, they each 
also took different amounts of time to expand again to sufficient number for experimental 
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plating. The number of days post biopsy when hip fracture cells were defrosted and the 
days post biopsy when experimental plating took place are shown in Figure 6.1. It was 
observed that all hip fracture cell populations took longer to expand than expected 
compared to the rate of young cells as shown by the number of days required to expand 
for experimental plating. Once hip fracture cell populations had expanded sufficiently, 
they were plated for all possible experiments which was 30±5 days post biopsy. However, 
not all hip fracture cell populations expanded sufficiently to be used for all experiments. 
The samples used for each experiment are described in the relevant sections. Frozen 
samples from young cell populations were chosen to match the same time under culture 
conditions as the hip fracture patients’ cells to provide the closest match between the 
different aged donors. The young cell populations used ranged from 28 to 31 days post 
biopsy (30.5±1). 
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Figure 6.1. Days in culture required to sufficiently expand hip fracture cell populations for all 
experiments. 
Hip fracture patients were expanded after initial extraction then frozen for later experiments. On 
defrosting each hip fracture cell populations took different lengths of time to expand sufficiently 
to undergo experiments. The left-hand column indicates the number of days post biopsy that each 
cell population was cryogenically stored. The right-hand column indicates the days in culture post 
biopsy when each individual cell population was plated for experiments, Mean±SD = 30±5 days 
post biopsy. 
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6.3.2. Variability in desmin expression 
Desmin expression was assessed at the first passage after defrosting and populations 
with low numbers of desmin positive cells were resorted to try to enrich the cell 
populations. However, the CD56+ve sort fractions were always small and the negative 
fractions contained many desmin positive cells. It was decided to recombine the sort 
populations so that experiments could be plated at the earliest possible time point. The 
percentage of desmin positive cells within hip fracture patients’ cell populations at the 
time point of experimental plating (30±5 days post biopsy), along with the desmin 
expression of the young cell populations after comparable time in culture (30.5±1 days 
post biopsy), are shown in Figure 6.3 and representative images of each sample at time 
of experimentation are shown in Figure 6.2. 
6.3.3. Hip fracture patients have more SA β-Gal expressing than young 
donors after similar time in culture 
At the earliest time point possible (30±5 days post biopsy), sub populations of hip 
fracture patient myogenic cells (25,000 cells) were analysed for expression of SA β-Gal 
and compared with young myogenic cell populations after a similar time in culture (30.5±1 
days post biopsy). For this analysis if cell populations with low desmin cell percentages 
were removed there would not be sufficient sample numbers for statistical analysis. It 
was also not possible to only count desmin positive SA β-Gal cells as co-staining of desmin 
with SA β-Gal was not performed. Therefore, it was decided to use all cell populations, 
irrespective of their desmin cell percentage, and to refer to these mixed cell populations 
as muscle-derived cell populations instead of myoblasts. The number of SA β-Gal positive 
cells was significantly higher in the hip fracture muscle derived cell populations 
(76.5±10.7%) compared to the young muscle derived cells (28.2±4.7%, p < 0.001, Figure 
6.4). 
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Figure 6.2. Representative images of myogenic expression at time of plating for each individual 
cell population.  
Sub populations of cells (20,000 cells) from each cell population were either cytospun or plated 
onto glass coverslips at time of experimental plating (young; 30.5±1 days post biopsy and hip 
fracture patients; 30±5 days post biopsy) and stained for desmin (red), TE7 (green) and DAPI (Blue). 
Images acquired using a 20x magnification objective, Scale bar = 100 µm. 
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Figure 6.3. Desmin expression quantification of the cell populations at time of experimental 
plating.  
Sub populations of cells (20,000 cells) from each cell population were either cytospun or plated 
onto glass coverslips at time of experimental plating (30±5 days post biopsy) and stained for nuclei 
and desmin to determine the percentage of desmin positive cells by a bespoke automated image 
analysis program. Data shown as mean of percentage desmin positive cells per field of view, 10 
fields of view per time point, minimum of 100 cells analysed per individual cell population.  
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Figure 6.4 Hip fracture patients myogenic cell populations contain more SA β-gal positive cells 
compared to young cell populations.  
A) Sub populations of cells (25,000 cells) from young and hip fracture cell population were plated 
for SA β-Gal analysis after the same time in culture (young 30.5±1 and hip fracture patients 30±5 
days post biopsy). The percentage of SA β-Gal positive cells was determined at each time point for 
the individual myoblast populations. Data shown as mean of individual cell population determined 
from percentage SA β-Gal positive cells per field of view, 10 fields of view, minimum of 100 cells 
analysed in total per individual cell population. Data was compared by unpaired t-test with Welch’s 
correction which does not assume equal variances between groups which showed a significant 
difference between the two groups (p < 0.001). B) Representative images of SA β-Gal positive cells 
from young and hip fracture patients after the same time in culture 30±x days post biopsy.  Scale 
bar = 100 µm. 
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6.3.4.  No difference in p16 protein between young donors and hip 
fracture patients 
The expression of cell cycle inhibitor p16 within desmin positive cells was determined 
at the time of experimental plating using immunocytochemistry, analysed by a bespoke 
automated image analysis program described in Chapter 3. There was no significant 
difference (p = 0.11) in p16 mean fluorescent intensity between young donors 
(565.6±250.2 AU) and hip fracture patients (791.0±136.2 AU) desmin+ve cells (Figure 6.5). 
There was also no observable pattern in p16 expression between populations with high 
and low numbers of desmin positive cells within either young or hip fracture patient cell 
populations (Figure 6.5). 
6.3.5. Trend for higher γH2aX in hip fracture patient myoblasts 
compared to young donors 
The expression of DNA damage marker γH2aX within desmin positive cells was also 
determined at the time of experimental plating using the same methods as described for 
p16 expression. Here, there was a statistical trend (p = 0.064) for higher γH2aX mean 
fluorescent intensity in hip fracture patients (483.9±144.1 AU), compared to young donor 
(308.3±121.6 AU) desmin+ve cells after a similar time in culture (Figure 6.6). Again, no 
difference was observed for γH2aX expression between populations with high and low 
numbers of desmin positive cells within either young or hip fracture patient cell 
populations (Figure 6.6). 
6.3.6. Hip fracture patients cells do not show impaired differentiation 
capacity 
Four of the hip fracture patients had sufficient cells to undergo the differentiation assay 
(HF1, HF2, HF5 and HF6). However, one of these samples HF6 was only 40% desmin 
positive at the time of plating and was therefore excluded from the fusion index analysis. 
The remaining three high desmin expressing hip fracture cell populations (HF1, HF2 and 
HF5) underwent the differentiation assay and where analysed for fusion index after seven 
days (144 hours). The young cells were assayed during the replicative senescence 
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experiments presented earlier and therefore were only differentiated for 96 hours at early 
passage, 16 days post biopsy, as per that experimental protocol. There was no difference 
(p = 0.42) in fusion index between the hip fracture patient myogenic cells which were 
differentiated for 144 hours (81.7±7.8%) compared to young donor myogenic cells which 
were only differentiated for 96 hours (84.8±4.0%, Figure 6.7).  
6.3.7. Different expression levels of SASP factors between culture 
aged young and hip fracture patient myogenic cell populations 
Three of the hip fracture patients had sufficient cells to undergo the differentiation 
assay (HF2, HF5 and HF6). Although, HF6 was only 40% desmin positive at the time of 
plating due to low N numbers it was included so that statistical analysis could be 
performed. The hip fracture patient cell populations were analysed for expression of eight 
known senescent markers and SASP factors using qRT-PCR. They were compared with 
young donor cell populations after similar time in culture. This time point was 28 days 
post biopsy which was the closest time point that had RNA samples from all young cell 
populations. A final group of early passage, 10 days post biopsy, young myogenic cells 
were also included to determine if differences were due to culture age of cells or if there 
were differences between the age of the cell population donor. Data is presented as fold 
change relative to young D10 as this is the cell population least likely to be senescent as 
shown by the data presented in chapter 4. Hip fracture patient mRNA expression of CXCL5 
(13.8±12.5 fold change) and IL8 (20.4±14.9 fold change) was significantly higher than both 
young D10 (p < 0.001) and Young D28 (p < 0.01). Young D28 were not significantly elevated 
compared to young D10 for either CXCL5 or IL8. The mRNA expression of p16 was 
significantly higher in both hip fracture patients (fold change 45.2±11.8, p < 0.001) as well 
as, young D28 (fold change 31.6±12.6, p < 0.001) compared to young D10 (fold change 
1.2±0.6). Hip fracture patients also expressed significantly more p16 mRNA than young 
D28 (p = 0.003, Figure 6.8). 
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Figure 6.5. No significant increase in nuclear p16 expression in desmin positive hip fracture cells. 
A) Individual cell populations p16 mean fluorescent intensity presented as mean of all desmin 
positive individual nuclei. Data was compared by unpaired t-test with Welch’s correction which 
does not assume equal variances between groups which showed no significant difference between 
the two groups (p = 0.1). B) Representative images of young and hip fracture patient cell 
populations stained for nuclei (blue), desmin (green) and p16 (red). 
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Figure 6.6. Statistical trend for increased γH2aX expression in desmin positive hip fracture cells.  
A) Individual cell populations γH2aX mean fluorescent intensity presented as mean of all desmin 
positive cells. Data was compared by unpaired t-test with Welch’s correction which does not 
assume equal variances between groups which showed a trend for higher γH2aX expression in hip 
fracture patient desmin positive cells (p = 0.064). B) Representative images of young and hip 
fracture patient cell populations stained for nuclei (blue), desmin (green) and γH2aX (red). 
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Figure 6.7. No significant difference in fusion index between hip fracture and young myogenic 
cells. 
A) Myoblasts from young donors and hip fracture patients were induced to differentiate and form 
myotubes. Young myoblasts (n=6) were at early passage (16 days post biopsy) and were imaged 
96h after differentiation induction. Hip fracture myoblasts (n=3) were induced to differentiate at 
the earliest time point possible after defrosting (30±5 days post biopsy) and were imaged 144h 
after differentiation induction. Data was compared by unpaired t-test with Welch’s correction 
which does not assume equal variances between groups which showed no significant difference in 
fusion index between young and hip fracture patient cells (p = 0.42). B) Representative images of 
young and hip fracture patient myoblasts directed to differentiate into myotubes and imaged after 
96h young, and 144h hip fracture patients showing nuclei (blue) and myosin heavy chain (red). 
Scale bar = 100 µm. 
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Figure 6.8. Significant differences in SASP factor expression between hip fracture patients and 
young cell populations after similar time in culture 
mRNA expression of eight known SASP factors presented as population mean fold change relative 
to young D10, early passage young donor myoblasts. * indicate significant difference between the 
two compared groups (two-way ANOVA with Tukey’s multiple comparisons test for differences 
between group for each SASP factor, P <0.05, Young D10 and Young D28 N=6, Hip fracture N=3). 
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6.4. Discussion 
The aim of this study was to investigate the senescent characteristics of skeletal 
muscle derived cells isolated from hip fracture patients’ in comparison to young donor 
myoblasts. This study shows that skeletal muscle derived cells, of which a high proportion 
were desmin+ve MPCs, extracted from hip fracture patients demonstrated higher levels of 
SA β-Gal, but not other senescent markers, p16 and γH2AX, after comparable time in 
culture with myoblasts extracted from young donors. 
Hip fracture patients’ MPCs displayed variability in desmin expression over time in 
culture and in their ability to proliferate as a cell population. All cell populations went 
through the CD56 MACS sorting process in order to isolate and expand the CD56+ve 
myoblast population before being frozen down. After thawing and expanding for 
experimental plating three of the six hip fracture myoblast populations maintained high 
desmin expression (93-79% at time of experimental plating) and the other three had much 
lower desmin expression (20-41% at time of experimental plating). Similarly, to the 
replicative senescent work in chapter 4, re-sorting of these low desmin expressing cell 
populations with CD56 magnetic beads was attempted but the negative fractions 
contained high levels of desmin positive myoblasts. Therefore, the positive and negative 
fractions were recombined, and these samples were only used for analysis where desmin 
positivity could be analysed alongside another marker, i.e. immunocytochemical analysis 
of desmin positive cells for senescent marker expression. This loss of desmin expression 
does not seem to be associated with age as similar results were shown in the young 
replicative senescence experiments to a similar extent. As discussed previously the use of 
an additional sorting marker such as CD82 may improve the myogenic cell enrichment as 
CD56 expression has been shown to fluctuate across the replicative lifespan of myogenic 
cells (Meng et al., 2011). This study did not focus on the CD56-ve fractions, which would 
contain the fibroblasts from these hip fracture patients, but a comparison between the 
fibroblasts of young and hip fracture patients would be of interest to determine if there 
are differences in behaviour of these cell populations. 
As the hip fracture patients were defrosted their proliferative rate was not measured 
because it would not be comparable to the young proliferative experiments which were 
never frozen. However, by observing how long it took to expand these cell populations it 
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is of interest to note the potential differences in the proliferative rate of hip fracture 
patient MPCs, which should be investigated on freshly cultured cells without freezing. This 
unexpectedly slow proliferation prevented the comparison of the cell populations at early 
passage as the mean number of days in culture before experimental plating was 30±5 
days post biopsy. Therefore, young donor cell populations which had been in culture for 
a similar amount of time as the hip fracture patients’ cells were chosen for comparison to 
provide the most like-for-like comparison. The time points for the young samples varied 
between 28 and 31 days post biopsy with a mean of 30.5±1 days post biopsy. When 
comparing the senescent phenotype of hip fracture patients to young donor myoblasts at 
this comparable point in culture, the hip fracture populations displayed increased 
expression of SA β-Gal but not p16 or γH2AX. When investigating myogenic fusion index, 
hip fracture myoblasts did not exhibit impaired differentiation capacity. Lastly, when 
investigating the mRNA expression of a small panel of senescence markers and SASP 
factors, a general trend for increased expression of SASP factors was seen in hip fracture 
cells, compared to both young early passage and after comparable time in culture. 
SA β-Gal is considered the gold standard, most commonly used, method of detecting 
senescent cells in vitro (Dimri et al., 1995). Human myoblasts passaged to replicative 
senescence from healthy and Duchenne muscular dystrophy patients have been shown 
to express SA β-Gal (Nehlin et al., 2011; Renna et al., 2014) and it was shown to be the 
clearest senescent marker in DOX-treated MPCs in Chapter 5. In this study, hip fracture 
patients cell populations were shown to have much higher numbers of SA β-Gal positive 
cells compared to young cell populations after similar time in culture. This is different to 
the results of Bigot et al., (2015) who found both young and old human myogenic cell 
populations had roughly 20% SA β-Gal positive cells. The age of the old participants in the 
Bigot et al., (2015) ranged from 72 to 80 years old, which was slightly younger than the 
participants used in the current study (82 ± 8 years). It is possible that the older donors in 
the current study having higher expression of SA β-Gal could be supporting in human, for 
the first time, the findings of Sousa-Victor et al., (2014) who demonstrated a significant 
increase in SA β-Gal expression in geriatric mice, compared to old mice which were not 
significantly increased over young mice. However, this difference in results may also be 
explained by the later time point, 30±5 days post biopsy, for comparison used in the 
present study. Bigot et al., (2015) measured SA β-Gal before 12 population doublings and 
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within the first half of the cell population life span. Within this study it is likely that SA β-
Gal was measured later in the proliferative lifespans considering the young samples 
reached senescence within 60 days in the replicative senescence experiments. Measuring 
at this later time point could mean that some of the hip fracture cell populations had 
reached, or were close to reaching, replicative senescence. This would also explain the 
slow proliferative rates observed in these cell populations. Additionally, this could suggest 
that these hip fracture patients have shortened replicative capacity compared to young 
donor cells, which would be of interest as this has not been previously shown in adult 
human myogenic cell populations (Alsharidah et al., 2013; Barberi et al., 2013; Bigot et 
al., 2015). A noticeably shortened replicative capacity would support a possible role for 
cellular senescence within skeletal muscle ageing. Although, these cell populations were 
able to expand in culture which would suggest that they are still able to function and 
therefore any reduction in their proliferative capacity may not be limiting their in vivo 
ability to supply sufficient new myonuclei to regenerate muscle. Overall this preliminary 
finding supports the premise of this study that hip fracture patients would be the most 
likely population to exhibit senescent characteristics. 
Although SA β-Gal is the gold standard marker of senescence it is not definitive 
(Kirkland & Tchkonia, 2017). The expression of p16 is often associated with senescent cell 
populations (Tchkonia et al., 2010; Barberi et al., 2013) and was shown to be elevated at 
both mRNA and protein level in DOX-induced senescent myoblasts and in replicative 
senescent myogenic cell populations. In the current study there was no significant 
difference in p16 protein expression between young and old hip fracture patients after 
similar time in culture even though there was striking differences in the expression of SA 
β-Gal. There was however a significant elevation of p16 mRNA in hip fracture cells 
compared to young after the same time in culture, which was above the significant 
increase both cell populations showed over early passage young cells (Figure 6.8). 
Upregulation of RNA always precedes protein expression as it must be present for its 
translation into the protein. However, RNA is not always translated into protein and 
therefore the discrepancy between the results could be due to the degradation of the 
RNA before being translated. More likely is the association with p16 being upregulated in 
deeply senescent cells as shown by the slow increase in p16 expression after DOX 
treatment. In those experiments SA β-Gal expression preceded the increase in p16. 
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Therefore, if these cell populations where left for longer in culture the protein expression 
of p16 may also have increased. As young early passage cells were not stained for p16 
under the same experimental conditions, in the current experiments it is not known if 
both young and hip fracture patients at similar in culture expressed higher levels of p16 
protein when compared to the young early passage. 
Immunocytochemistry was also used to determine γH2aX expression within the 
nucleus of desmin positive cells in young and hip fracture patient cells at comparable 
times in culture. Here, a statistical trend for increased mean nuclear fluorescence 
intensity of γH2aX in hip fracture patient myoblasts was seen. Similarly to SA β-Gal and 
p16, a previous study did not show a difference in γH2aX between young and old adults 
but did see increased expression in senescent cells (Alsharidah et al., 2013). However, in 
the replicative senescence study in this thesis only one of the replicative senescent 
myogenic cell populations showed a significant increase in γH2aX. Therefore, it should be 
remembered that γH2aX is a generic marker of DNA damage, an increase in which is 
associated with, but not specific to senescent cells therefore it cannot be used as a 
senescence marker in isolation (Nakamura et al., 2008). The trend for increased γH2aX 
expression could be the result of using an older population of aged adults in the present 
study which might be revealing that very late in life skeletal muscle cell populations are 
starting to show the signs of senescence burden. Or that the later time point in culture 
than the Alsharidah et al., (2013) study could also be confounding the results as γH2aX is 
increased as cells progress towards replicative senescence. Cells reaching replicative 
senescence start to have uncapped DNA ends as their telomeres reach critically short 
lengths initiating the DNA damage response, including  increased γH2aX expression, 
eventually  leading to proliferative arrest and cellular senescence (Nakamura et al., 2008; 
d’Adda di Fagagna, 2008). 
Overall, the combined results of the markers used have, for the first time, shown 
differences in senescence marker expression between young and old adult human 
myoblasts by using very old hip fracture patient myoblasts. It is unclear from the current 
experiments if this is due to the age of the donor or differences in response to the culture 
environment due to the relative late time point used for comparison, around 30 days in 
culture post biopsy. Having a higher burden of senescent cells can impair tissue 
functioning especially in a regenerative tissue such as skeletal muscle as it reduces the 
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available pool of proliferative cells to generate new myonuclei (Bigot et al., 2008). 
Senescent cells can also impact surrounding cells by their alter secretory phenotype, their 
SASP (Nelson et al., 2012). 
Senescent cells synthesise and secrete a number of proinflammatory cytokines, 
chemokines, GFs, and proteases, collectively termed the SASP factors (Coppé et al., 
2010a). The SASP has been shown to be very specific to the individual even when exposed 
to the same induction stimulus such as DOX treatment as shown in chapter 5. In the 
present study, mRNA expression of a small panel of SASP factors was investigated, 
namely: CXCL5, IGFBP-7, MMP3, PAI-1, TGF-β, IGFBP-3, IL-8. This sub panel of the 
previously used SASP factors included those which showed significant changes and, in the 
case of TGF-β, shown previously to be increased in senescent myoblasts (Alsharidah et al., 
2013). Only three of the hip fracture populations had sufficient cells to undergo RNA 
analysis, one of which was only 40% desmin positive and therefore may not provide the 
most reliable SASP prolife of myogenic cells. However, due to the low n number it was 
retained for this preliminary analysis so allow for statistical analysis to be performed. 
Significantly, increased expression in hip fracture muscle derived cell populations was 
observed for CXCL5, and IL-8 compared to young cells after the same time in culture and 
young early passage cells. Significant increases over young cells after the same time in 
culture suggest that this effect is due to the cell origin and not just due to exposure to 
culture conditions. CXCL-5 is involved in the DDR, being upregulated during replicative 
exhaustion, telomere disruption and oncogenic stress (Coppé et al., 2010b). This would 
support the results of increased senescent markers showing increased SA β-Gal, p16 and 
a trend for increased γH2aX. IL-8 is a proinflammatory cytokine, initiating an immune 
response at the secretory cells location (Acosta et al., 2008). There was also a statistical 
trend for increased IGFBP-3 mRNA expression in hip fracture patients compared to early 
passage young muscle derived cells. IGFBP-3 has been demonstrated to inhibit cell 
division through its interaction with IGF-1 (Kelley et al., 1996), and has been shown to 
interact with the DDR pathway thereby contributing to induction of cellular senescence 
(Elzi et al., 2012; Ozcan et al., 2016).  
Caution should be applied when interpreting these SASP results due to the inclusion 
of one low desmin positive cell population together with only two other cell populations. 
The variability in the cell type SASP shown even after the same DOX stimuli (chapter 5) as 
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well as the interindividual variability suggest that looking at specific SASP factors 
expression could be misleading. Overall, there is a general trend for an increased 
inflammatory SASP in hip fracture patients, but this must be investigated further including 
more participants and more SASP factors.  
Even though the hip fracture patients were showing signs of being more senescent 
and having an increased SASP than young donor cell populations they did not exhibit an 
impairment in differentiation capacity which has been shown in previous studies (Renault 
et al., 2000; Alsharidah et al., 2013; Barberi et al., 2013). Senescent myotubes have been 
reported to be thinner and contain fewer nuclei compared to early passage myotubes, as 
well as the total number of nuclei fusing being lower (Bigot et al., 2008); these traits were 
not observed in the current study as can be seen in Figure 6.7. Observing no difference in 
fusion index is similar to previous studies who showed early passage young and old donor 
cells have a similar fusion index (Alsharidah et al., 2013; Barberi et al., 2013). However, a 
more recent study has shown impaired fusion capacity in old donor myoblasts compared 
to young when they limited fusion index to nuclei within myotubes containing more than 
3 myonuclei (Bechshøft et al., 2019). However, the number of myogenin positive cells was 
not different between the age groups suggesting that the final fusion stage of 
differentiation may be impaired in older adults. This was supported by lower expression 
of myogenic fusion protein myomaker (Bechshøft et al., 2019). Conversely, Bigot et al., 
(2015) have shown that older donor myoblasts show higher fusion into myotubes and a 
lower number of Pax7 positive, undifferentiated, reserve cells. This preliminary study only 
investigated fusion index and therefore conclusions cannot be drawn on the mechanisms 
behind the fusion results observed. There are also inconsistencies in the methodology of 
comparison used due to using pre-existing young differentiation data. The old hip fracture 
patients were differentiated for seven days because previous work has suggested that 
differentiation may not be impaired but delayed so the decision was made to extend the 
differentiation process to seven days instead of stopping after four days, which was when 
the young cells were analysed for fusion index. However, a previous study have allowed 
senescent cells to differentiate for seven days and still see marked impairment of fusion 
index (Alsharidah et al., 2013). Overall, it is of interest to observe no impaired myogenic 
fusion of hip fracture patients even though they express higher levels of senescent 
markers. It is not clear if this is due to inherent factors within these aged hip fracture cell 
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populations or from allowing the cells longer to differentiate making up for any delay in 
activation of the myogenic programme. It would be of interest to determine the 
phenotype of the, unfused, reserve cells in these cell populations to determine if retaining 
fusion competence is at the expense of maintaining a larger cell population which retains 
proliferative potential. 
This study set out to use a more well-defined population of older people than 
previous studies with hospital patients undergoing hip fracture surgery donate muscle 
tissue removed during their surgery. It also attempted to get the oldest participants 
possible and the age criteria was set to 70+ years for recruitment. However, no further 
information is available on the phenotype or lifestyle of the hip fracture patients as ethical 
approval was not granted for access to patient records for these participants. These hip 
fracture patients may have had underlying conditions such as cancer, diabetes, or heart 
disease which directly, or through their prescribed treatments could be affecting the 
myogenic cells investigated. It could also be possible for a hip fracture patient to be a 
highly active individual who fractured their hip by falling off their bike and were not frail. 
Furthermore, the distribution of cell types throughout skeletal muscle is not 
homogeneous, for example there are more connective tissue cells towards the tendinous 
ends of muscles (Gillies & Lieber, 2011). Therefore, the specific site from which the muscle 
biopsy is taken may affect the proportions of the extracted cell population. In this thesis 
all of the young participant muscle biopsies samples were taken from the mid belly of the 
vastus lateralis to standardise the biopsy location. However, as the hip fracture patient 
samples were taken from the site of their operation, they originated from the proximal 
end of the vastus lateralis which is likely to contain more connective tissues cells. 
Therefore, these results must be taken in the context of preliminary results as we are 
unsure if the effects are truly due to differences in the cell populations. 
The slow proliferation of the hip fracture cell populations prevented early passage 
comparisons suggesting that the cells compared are well on their trajectory to replicative 
senescence. As this trajectory is highly individual the different time course to senescence 
could be confounding the results obtained. However, even with these limitations the 
result of this pilot study suggests that there may be an aged population of human who do 
experience signs of senescence within skeletal muscle cell populations. This warrants 
further investigation to understand where these differences are and if they are also 
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present in other aged people or if they are unique to the trauma involved with something 
as severe as a hip fracture. 
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7. Chapter 7: General discussion 
Cellular senescence is a key feature of ageing tissues in both animal models and 
humans therefore the importance of studying cellular senescence is that it provides 
insights into how cellular behaviour and function is altered in ageing tissues. Targeting 
senescence has tremendous potential to significantly improve healthspan and alleviate 
age-associated dysfunctions, frailty and tissue fibrosis (Borghesan et al., 2020). The 
removal of senescent cells has been shown to improve both the healthspan and life span 
of mice in both genetic knock out models as well as free living animals treated with 
senolytic drugs (Kirkland & Tchkonia, 2017). Studies of in vitro senescent cells have shown 
the inherent heterogeneity of senescent cell populations depending on intrinsic and 
extrinsic factors including cell type, senescence inducer, tissue of origin, and 
environmental conditions. Although cellular senescence has been consistently shown in 
many tissues, the findings within post mitotic such as skeletal muscle are both under 
researched and unclear (Tuttle et al., 2020). Therefore, using a human primary cell culture 
system this thesis set out to: 1) characterise the senescent phenotype of human primary 
CD56+ve skeletal muscle precursor cells and the CD56-ve skeletal muscle origin fibroblasts 
after CD56 MACS sorting 2) to investigate this senescent myogenic phenotype within a 
very old, and likely frail, population of patients undergoing hip fracture surgery to 
determine if senescence was present within aged myogenic cell populations 3) 
additionally, automated image analysis programmes were developed for the 
quantification of the immunofluorescence staining in order to help address these aims. 
7.1. Overview of findings 
7.1.1. Image analysis programs 
Determining expression of markers is often performed manually using binary 
classifications as positive or negative based on human observation. This form of analysis, 
although simple, is subject to observer bias and misses a lot of biological information 
within an image (Lee & Kitaoka, 2018). Using image analysis programs allows individual 
pixel values to be quantified within specific regions of interest and therefore gives a better 
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representation of the marker expression level within the cell population. The automation 
of these programs decreases the analyse time substantially as well as removing bias and 
improving the reliability of data acquired. Therefore, automated image analysis programs 
were developed to analyse different image types throughout this thesis.  
The image analysis programs developed were to: 
1) Count the number of cells which expressed a certain cell type marker, e.g. desmin 
as a marker of myoblasts or TE7 as a marker of fibroblasts 
2) Analyse the pixel intensities of a marker, e.g. cell cycle inhibitor p16, within 
regions of interest which define each individual nucleus within an image 
3) Analyse the pixel intensities of a marker, e.g. cell cycle inhibitor p16, within 
regions of interest which define each individual nucleus of a given cell type, as 
defined by a cell type specific marker such as desmin for myoblasts or TE7 for 
fibroblasts, within an image 
4) Count the number of nuclei incorporated within myotubes as a percentage of the 
total number of nuclei within a field of view 
These automated image analysis programs were successfully used throughout this 
thesis showing significant changes in marker expression and fusion index across all 
research questions. Further improvements to the methods to analyse three dimensional 
myotube formation to try to separate overlapping myotubes allowing accurate myotube 
volume measures are under way, as well as, further automation on the output data 
restructuring into the same workflow to allow ease of use for other researchers.    
7.1.2. Replicative senescence 
Previous studies investigating senescence within human primary skeletal muscle cells 
have been hampered by issues of myogenic expression of the cell populations extracted 
from muscle biopsies (Schafer et al., 2005; Alsharidah et al., 2013). This study employed 
a CD56 MACS sort in order to enrich, to greater than 95% desmin expression, the 
myogenic cell population before passaging to replicative senescence to try to prevent the 
issues of variable desmin expression. The purification of myogenic cell populations from 
the other precursor cell populations in skeletal muscle allowed both for a better 
understanding of the phenotype of these myogenic cells but also the opportunity to 
investigate the characteristics of the other precursor cell populations from the same 
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tissue origin. This study allowed for the first investigation and comparison of the CD56-ve, 
predominantly TE7+ve fibroblasts, cell populations from the same muscle biopsy as the 
CD56+ve myoblasts. 
The main findings were that:  
1) CD56 purification does not prevent the accumulation of fibroblasts within highly 
enriched desmin positive cell cultures 
2) The two myogenic cell populations that reached replicative senescence were not 
identical in phenotype at replicative senescence 
3) CD56-ve/TE7+ve fibroblasts do not reach replicative senescence within the same 
time frame as myoblasts from the same muscle biopsy, maintaining high 
proliferative activity and low senescent marker expression 
What was of most interest was the vastly different behaviours of the two different 
cell populations from the same biopsies under cell culture conditions. The TE7+ve 
fibroblasts were the most proliferative of the CD56-ve cell populations becoming roughly 
100% pure across time in culture. They also showed no signs of approaching cellular 
senescence when the myogenic cell populations from the same biopsies were either 
senescent or themselves becoming overrun with fibroblasts. This difference in replicative 
capacity could be due to the myoblasts having undergone more divisions in vivo than the 
fibroblasts therefore reducing their telomere length and proliferative potential ex vivo. Or 
it could be due to the fibroblasts being more resistant to the stresses of the artificial 
culture environment such as, higher than physiological oxygen tension, the potential 
effect of the culture environment are discussed further later in this discussion. Another 
possible explanation is that the fibroblast cell population are maintained by another stem 
cell population external to skeletal muscle providing fibroblasts which have undergone 
fewer divisions than the satellite cells which themselves are thought to not have a 
significant replenishment from an external adult stem cell source. The discrepancy 
between replicative capacity and virality of the skeletal muscle origin fibroblasts highlights 
that all cell populations within skeletal muscle must be considered when evaluating the 
effecting of ageing on this tissue. 
It was also of interest to note that CD56 sorting became less effective at purifying 
desmin positive cells over time in culture. CD56 has been shown to stay present even 
through terminal differentiation of human primary myoblasts (Agley et al., 2015) but has 
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been shown to vary in expression over time in culture (Meng et al., 2011). With the recent 
discovery of CD82 as another marker of myogenic cells it should be investigated to see if 
it also fluctuates over serial passaging (Alexander et al., 2016). Future work to develop a 
method for late passage purification of myoblasts would be of great benefit to senescence 
research as it would be able to prevent the overrunning of fibroblasts seen in the current 
work. Sorting based on markers such as desmin or PAX7 would require either 
permeabilisation of the cell populations, preventing the use of the sorted cells for further 
culture experiments, whereas, the genetic manipulation of these markers to express GFP, 
which would allow the sorting of live cells, requires altering the genetic makeup of the 
cells potentially causing unknown affects to the cells. 
Overall, these replicative senescence experiments have highlighted differences in 
proliferative capacity of the two main human muscle precursor cell populations however 
the technical challenges associated with generating senescent populations of these cells 
types mean that currently other methods are required to analyse the senescent 
phenotype of these cell populations. The next set of experiment sort to address these 
issues.  
7.1.3. DOX induced senescence 
To circumvent the problems observed with the replicative method of senescence 
induction a premature induction of senescence was used on the same cell populations. 
Both myoblasts and fibroblasts were treated with DOX to induce an accelerated senescent 
phenotype in the same cell populations. DOX was chosen as it had been successfully 
developed and utilised for use with other type of human muscle cell populations such as 
cardiac and smooth muscle (Piegari et al., 2013; Bielak-Zmijewska et al., 2014; Lewis-
McDougall et al., 2019). These senescent cell poulations could then be characterised and 
compared to investigate the differing senescent cell phenotypes from the same tissue. 
The main findings were that: 
1) Both myoblasts and fibroblasts are induced to become senescent after DOX 
treatment  
2) The most consistent marker of cellular senescence was SA β-Gal in combination 
with the lack of Ki67. 
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3) Although the entry into senescence was more heterogenous with DOX treatment 
there was still large variability both between and within cell types in regard to 
SASP factor expression 
4) difference senescent profile between myoblasts and fibroblasts from the same 
muscle sample  
 Treating both cell populations with DOX was successful in generating populations 
of senescent cells which maintain their cell type purity across time allowed for the 
senescent phenotyping of these cell populations. Of the markers used in this study, SA β-
Gal was the clearest marker of senescent as both cell types do not express the marker 
when still proliferative. However, the cell cycle inhibitor most frequently associated with 
cellular senescence, p16, was less clear as a marker of senescence. The expression of p16 
did not demark every senescent cell and was only upregulated after extended time in cell 
culture, much later than expression of SA β-Gal and loss of Ki67. These results, in 
combination with the early increase in p21 expression would suggest that p21 is involved 
in the instigation of the senescent state whereas p16 is more a marker of deep 
senescence. Although, further work with these specific cells types is needed to confirm 
this finding. 
The variability in SASP factor expression from the same cell type of different individual 
highlights important issues regarding the use of cell lines in human research. Using cell 
lines, genetic clones of a single cell, masks much of the variability seen when using 
heterogenous populations of cells from different individuals (discussed further in section 
7.3). This work also highlights issues with understanding the in vivo secretion of senescent 
cells marked as senescent via markers such as SA β-Gal. This work shows that the 
expression of these senescent markers does not determine that cell’s specific secretory 
profile. This is further complicated by the differences in SASP factor expression between 
the two different cell types from the same tissue. This is important for understanding 
which cell types are causing the elevated tissue levels of SASP factors in older muscle as 
skeletal muscle consists of multiple cell types which could become senescent and it would 
be unclear which cells were responsible for the elevated SASP factors. 
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7.1.4. Hip fracture patients 
With most previous human primary cell culture studies finding no differences in 
senescence burden within muscle precursor cell populations between young and old 
participants it was thought that senescence may not be an issue in this cell type within 
healthy other humans. However, the findings of Sousa-Victor et al., (2014) showing an 
increased senescent burden in “geriatric” adults it was thought that there may be cases 
where the very old and frail may have increased senescence burden which have not be 
identified when younger, healthier groups of older people have been investigated. This 
study therefore aimed to investigate a population of very old and likely frail individuals 
who were undergoing hip fracture surgery to determine if in extreme cases senescence 
started to become apparent.  
The main findings were that: 
1) Hip fracture patient cells took longer to expand after defrosting than cells from 
healthy young donors  
2) Hip fracture patients had higher senescent markers and elevated SASP factor 
expression compared to young cells at early passage and after similar times in 
culture 
3) Even with higher senescent cell burden hip fracture patients’ myoblasts still 
retain the ability to differentiate to the same level as young early passage cells 
This study must be considered as a pilot study due to the limitations of the cells being 
used having undergone culture expansion. This expansion brings in many other potential 
contributing factors beyond the inherent differences in the cell populations such as, 
resistance to culture stresses or variability in freeze thaw effects on cell populations. 
However, considering these limitations, cell populations from old hip fracture patients 
showed elevated senescence markers compared to those from young individuals after 
similar time under culture conditions. Interestingly, myogenic differentiation did not seem 
to be impaired in these patients even though they had increased numbers of senescent 
cells. An interesting hypothesis to explore further is the difference in fusion between 
young and old donor cells, as Bigot et al., (2015) suggest that cells from older donors fuse 
more readily than young reducing the reserve cell population. The authors suggest that 
these reserve cells are indicative of the cells which will replenish the satellite cell 
population in vivo. This would provide an explanation for the reduction in satellite cell 
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number seen with increasing age. The next step with the current study should investigate 
the makeup of the non-fused cell population and determine if they are indeed more 
satellite cell like and if they are reduced in older individuals. Having shown differences 
between old hip fracture patients and young healthy individuals opens important 
questions about whether these differences are due to the lifestyle habits or the trauma 
of suffering a hip fracture. Therefore, there are many potentially interesting avenues of 
investigation brought to light by these preliminary results which require further 
investigation. 
7.2. Senescent marker panels 
This study utilised a small panel of senescence associated markers however they are 
not an exhaustive list of senescence associated markers. It is becoming more apparent 
that senescent cells exhibit a wide range of expression changes that are not categorically 
expressed in all cells deemed to be senescent (Kirkland & Tchkonia, 2017). Therefore, it is 
commonplace to use multiple markers to identify senescent cells. This is further 
highlighting the diversity of classifying cellular senescence. Due to the many ways of a cell 
entering a senescent state it is likely that there is not a clear phenotype but a general 
pattern of expression changes most clearly identifiable by a change in secretory profile to 
become more inflammatory in nature. However, it has also been shown that some cells 
expressing senescent markers do not have an elevated inflammatory SASP further 
confusing the phenotype. This varied expression was also seen in both cell types 
investigated in the current work. Now that populations of senescent cells have been 
generated from these two cell types further characterisation of their senescence 
associated marker expression could further characterise their cell type specific 
senescence marker expression. However, what is apparent from the current work is that 
the senescent marker expression may not be heterogenous across the same cell 
population or between different individual donors. Using a wider panel of senescence 
associated makers may lead to better understand of the variability in marker expression 
within a cell population and therefore identify more targeted cell type markers. 
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7.3. Investigating the Senescence Associated Secretory 
Phenotype 
One of the most prominent features of senescent cells is their altered secretory 
phenotype, the SASP (Coppé et al., 2008). The chronic expression of SASP factors can lead 
to tissue dysregulation and start a cycle of inducing senescence in neighbouring cells 
(Adams, 2009). Careful investigation into the components of SASPs and their mechanism 
of action, may improve our understanding of the pathological backgrounds of age-
associated diseases (Byun et al., 2015). Studies of SASP expression of different cell types 
have suggested that there may be common senescence-associated gene signatures but 
that there are cell type, tissue, senescence inducer and environmental conditions that can 
influence the makeup of the SASP (Maciel-Barón et al., 2016; Hernandez-Segura et al., 
2017; Casella et al., 2019; Basisty et al., 2020). It was therefore thought to be important 
to try to understand the makeup of the SASP from the main human skeletal muscle cell 
types as it may lead to the discovery of novel cell type specific factors or biomarkers of 
senescence. For example, a previous study found that senescence human myoblasts had 
increased levels of secreted TGF-β which was sufficient to inhibit the differentiation of 
non-senescent myoblasts (Alsharidah et al., 2013). The work presented in this thesis has 
added further evidence of the heterogeneity within the SASP, showing that even when 
induced to become senescent via the same stimulus there is large variation between 
individual donors, between difference cell types from the same tissue, as well as, within 
different cells of the cell types. This phenotypic heterogeneity has led to suggestions that 
there may be different subsets of senescent cells with a population which will require 
single cell technologies to fully understand (Borghesan et al., 2020). The DOX induced 
senescence protocol developed can be used to generate SASP producing senescent cells 
for both myoblasts and fibroblasts to investigate individual cell differences. The DOX 
method also allows for investigation of the effect of SASP section from senescent skeletal 
muscle origin fibroblasts on the functioning of non-senescent myoblasts and vice versa. 
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7.4. Benefits and limitations of a cell culture model for 
human cellular senescence 
This thesis utilised a human primary cell culture model to investigate senescence 
within purified cell populations. The addition of MACS sorting allows for a system where 
cell type specific senescent cells can be investigated allowing for a better understanding 
of cell type differences when using bulk analysis techniques such as RNA and protein 
expression. Using impure cell populations clouds cell type specific expression as has been 
shown by the studies presented in this thesis showing differential expression of SASP 
factors between the two main skeletal muscle precursor cell populations.  
Human primary cell populations also show the differences within a cell type 
extracted from the same donor. This work highlights the importance of using human 
primary cell populations in culture conditions as they demonstrate the heterogeneity 
between different individuals, as well as, within an individual cell population. Cell lines are 
favoured for their ease of use however, using sub clones of clonal populations drastically 
reduces the cell to cell variability. Cell lines have also been immortalised changing a key 
in vivo characteristic which may also affect their functioning under culture conditions. 
The use of cell culture also has the benefit of understanding the effect of senescence 
on cellular function. Studies which characterise cellular markers, such as histological 
studies or RNA seq, are unable to assess functional behaviour of the cells therefore miss 
the most important measure of the effect on the cell. For example, the discrepancy in 
fusion index between induced senescent cells having poor fusion whereas hip fracture 
patient myoblasts with increased senescence do not seem to have impaired fusion shows 
a functional difference even though both populations express the same senescent 
markers. These differences allow for mechanistic manipulation of the cells to either return 
the cells to functioning states or prevent their impact on the functioning of local healthy 
cells. Cell culture systems also allow for the manipulation of cellular processes and 
pathways to determine the effect of certain compounds, such as high levels of SASP 
factors. These experiments could potentially uncover treatments that could potentially 
slow the progression of age-related muscle loss. Thus, prolonging the functional 
independence of older people and potentially help with satellite cell exhaustion 
conditions such as muscular dystrophies. 
 CHAPTER 7: GENERAL DISCUSSION 221 
 
Although there are many benefits to using human primary cell culture, there are 
limitations to all cell culture systems. A specific limitation to skeletal muscle cell culture is 
that satellite cells are usually in a quiescent state within their anatomical niche in vivo. 
The function of the satellite cell anatomical niche is to maintain cellular quiescence by 
preventing satellite cells from being exposed to signal which could cause them to activate 
or become damaged unnecessarily. Cells under culture conditions have been removed 
from this niche environment and have become activated. The length of time in culture 
has been shown to alter the transcriptome of satellite cell populations (Charville et al., 
2015). With suggestion that these changes are started immediately after extraction, 
during the enzymatic isolation process (Machado et al., 2017). The cell extraction and 
sorting protocol employed throughout this thesis incubates all cells extracted from the 
biopsy for 7 days before starting any experiment and therefore changes in the 
transcriptome are likely to have started. What is interested is that previous studies have 
suggested that this length of time in culture is one of the causes of showing no difference 
between young and old cells however the current study using hip fracture patients show 
that some differences may be retained. The cell culture studies may also be limited by the 
fact that culture conditions aim to provide the optimal growth environment for cells. cell 
culture may remove intrinsic differences between young and old in vivo cell populations 
is that the culture environment is a “youthful environment”, so old cells are free from 
extrinsic circulating factors which are present in the aged circulation. A youthful 
environment, fresh media, could alter the phenotype of these cells as would be suggested 
by the findings of Conboy et al., (2005) that old cells behave like young cells in a youthful 
environment. Several studies have shown that changes to the circulatory environment 
are, at least in part, responsible for the impaired regenerative potential in aged muscle. 
Mouse models have shown that rejuvenating the environment within which old muscles 
are exposed improves their regenerative function. Autografting elderly extensor 
digitorum longus muscle into young animals showed better improvement in muscle mass 
and force generation than when young muscles were transplanted into old animals 
(Carlson & Faulkner, 1989). Whereas, Conboy et al., (2005) conjoined the circulatory 
systems of young and old mice, termed heterochronic parabiosis, and showed that the 
young circulatory environment improved the old mouse muscle regeneration. The new 
muscle in the old mice was from the old mice's satellite cells not the young animal 
suggesting an improved rejuvenation in the old satellite cells not just replacement with 
donors from the young animal. However, this artificial culture environment is very 
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different even to the young in vivo environment where the cells are protected in the niche. 
This is strikingly obvious by the fact that all cultured cells are in an activated state whereas 
in vivo they are predominantly quiescent. They rapidly down regulate PAX7 and commit 
to the myogenic lineage and are known as myogenic precursor cells. 
A further issue surrounding the cell culture system used is that of oxygen tension. 
The system used in the present thesis maintains cells under atmospheric oxygen tension, 
21% oxygen. This oxygen tension is much higher than these cells would be exposed to in 
vivo which is suggested to fluctuate from anoxic through to 4% oxygen (Keeley & Mann, 
2019). The hyperoxic conditions in the current cell culture system have been shown to 
affect cellular behaviour. Specifically, with regards to senescence, SASP factor expression 
has been shown to differ at different oxygen tensions adding yet another variable to 
understanding the phenotype of senescent cells. 
Although there are many limitations to cell culture studies their use is invaluable to 
understanding cellular function.  It has often been suggested that cell culture systems do 
not translate well into human interventions very efficiently. However, developments are 
being made to try to make culture systems more physiologically relevant. The culturing of 
cells at tissue specific “physioxic” conditions, alongside 3D culturing utilising biomaterials 
and the development of co-culture systems are all allowing for more physiologically 
relevant manipulations of cells which are more likely to behave like in vivo cell 
populations. However, whilst these developments are moving the cell culture field 
towards more physiological conditions there will always be effects of removing cells from 
their native integrative environment into a model system. These limitations must always 
be considered however they do not outweigh the benefits of using cell culture systems in 
conjunction with other methodologies. 
7.5. Future directions 
This work has shown that artificially induced senescent cells share some 
commonalities to senescent cells from a population of very old, and likely frail, humans. 
However, although there was a general trend for senescent cells to express similar 
markers there was a large inter individual, as well as, cell to cell variability in SASP 
expression within the cell populations. The variability observed is very likely to be 
representative of the inherent in vivo biological variability due to the multitude of intrinsic 
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and extrinsic stimuli individual cells are exposed to. This biological variability is greatly 
reduced by using genetically identical cell lines or littermate animal models. To develop a 
greater understanding of the complex interactions within the human physiological system 
the biological variability needs to be present in the model systems. The first major step 
towards this would be to physiologically characterise the individuals from which the cell 
populations are extracted. Having a better understanding of the overall physiological 
environment from which the cells are taken is more likely to yield interpretable results. 
One of the key overlapping factors of frailty and sarcopenia is low physical activity 
levels of the individuals, which is an important factor when considering rate of muscle 
functionality decline (Fried et al., 2001; Dennison et al., 2017; Harridge & Lazarus, 2017). 
There is still a clear decline in muscle function in highly active master athletes, however, 
the magnitude of muscle function decline is slower than that of sedentary individuals 
(Pollock et al., 2015; Seals et al., 2016). Having shown a significantly increased senescent 
burden in cells from hip fracture patients, a population likely to be sedentary, 
understanding if a lack of physical activity is involved in the senescent phenotype of these 
patients by comparing their cellular function to masters athletes would provide important 
insight into human physiological ageing.  
The current study along with previous studies have used very minimal 
characterisation of the people from which their cell populations are extracted (Lazarus & 
Harridge, 2010). Often just using an age bracket and generic criteria of “otherwise 
healthy”. A deep physiological phenotyping of these individual will provide a much better 
context of the environment from which these cells are extracted. Skeletal muscle is a key 
effected tissue from the benefits of physical activity and therefore understanding the 
physical activity and muscle quality of the muscle from which these samples are taken 
would provide potentially important insight into the ageing and physical activity 
interaction with regards to skeletal muscle loss. Specifically, within the context of cellular 
senescence, exercise is already hypothesised to be a potential senolytic and therefore this 
study lays the foundations for potential experiments investigate the effects of exercise 
within these hip fracture patient populations to reduce senescent burden. 
Alongside this physiological characterisation of the individual donors, the cell 
populations should be characterised as immediately as possible to determine the in vivo 
phenotype. A very recent study employed single cell RNA seq on all extracted nuclei from 
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tissue samples of human skeletal muscle (Rubenstein et al., 2020). This technique 
provides the best in vivo characterisation of all cell types within skeletal muscle. This 
small-scale study has identified 11 mono-nuclear cells types within skeletal muscle. 
Applying this technology on physiological characterised individual of different aged would 
yield key information about the ageing and physical activity interaction within the make-
up of cell populations within skeletal muscle. However, as discussed previously these 
techniques are unable to assess function of these cell populations even if they do 
determine expression differences between groups. Therefore, using this technology 
alongside cell culture of the same cell populations will provide a greater understanding of 
in vivo population phenotype, as well as, the cell populations functional behaviour. Having 
this single cell phenotype will also allow for a better understanding of what effects the 
cell culture environment is having on the transcriptome of the extracted cells. This will 
provide a reference transcriptome to determine the best cell culture parameters to best 
retain the cells in vivo phenotype and therefore better optimise the cell culture models 
for translational findings. Work is currently underway to develop an immediate isolation 
extraction protocol to yield sufficient cells to undertake this analysis from physiological 
characterise young and old individual of differing physical activity levels.  
The development of the DOX induced senescence model has allowed for the probing 
of the mechanisms underpinning he senescent phenotype and functional impairments of 
senescent cells such as, the inhibition of myogenic differentiation. Generating senescent 
cell populations is important due to the limitation of extracting senescent cells from in 
vivo populations which are quickly overrun by proliferating cells after the extraction 
process. Previous work in the Harridge laboratory has characterised the Wnt-β-catenin 
signalling pathway in healthy young human primary cells and showed that interfering with 
this pathway impaired differentiation (Agley et al., 2017). Therefore, investigating this 
signalling pathway within the context of senescence would provide a logical first step into 
probing the resulting impairment in differentiation. The populations of artificially 
generated senescent cells can also be co-cultured with otherwise healthy cells or 
myotubes to determine the effect of the myogenic SASP on healthy cell function. This 
work would provide important information about the ageing process and how the 
senescent bystander effect and inflammageing in the microenvironment may be affecting 
both satellite cell and muscle fibre maintenance. Finally, senolytic drugs can be tested to 
see their efficacy at removing senescent cells within human primary skeletal muscle origin 
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cells and then compared with the effects of exercised human serum at removing 
senescent cells to help understand if exercise may in itself act like a senolytic agent.  
7.6. Final conclusions 
The age-related decline in skeletal muscle mass and function is inevitable being 
observed in even the most highly active of individuals. This phenomenon is an integrative 
physiological problem with multiple causal mechanisms. The present work aimed to 
further investigate what, if any, role the process of cellular senescence was a contributing 
factor within the main cell populations which regenerate skeletal muscle, myoblasts and 
fibroblasts. It aimed to provide a better characterisation of the senescent phenotype of 
the main cell types within skeletal muscle and has shown a chronologically aged human 
population who show signs of increased senescence. This study also highlighted the 
heterogeneity within cell populations deemed to be senescent. When using only a small 
panel of markers interindividual and cell to cell variability was shown in senescent 
phenotype. What ageing research in humans in general is lacking is the use of highly 
characterised individuals in studies. This work showed that using very old hip fracture 
patients successfully identified higher senescence in this likely to be frail population. 
Having a worst-case scenario population thus allows for differences to be determined and 
allow for physiological intervention to be tested. Such as the lifelong involvement in 
exercise training. The use of highly active master athlete would provide an exercise 
continuum with frail hip fracture patients through to these master athletes allowing for a 
whole body physiological, down to an individual cell to cell, characterisation of how 
physical activity in interacting with the inherent ageing process. The integration of 
methodologies such as single cell RNA seq and human primary cell culture on highly 
characterised donor cell populations will provide much needed clarity to answering the 
questions of ageing within skeletal muscle.  
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